ontology,root,fragment,text,statements,llm_used
doid,http://purl.obolibrary.org/obo/DOID_0080437,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_31a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first months or years of life of refractory seizures and global developmental delay from early infancy that has_material_basis_in heterozygous mutation in the DNM1 gene on chromosome 9q34."" ;
    :has_exact_synonym ""DEE31"",
        ""DEE31A"",
        ""developmental and epileptic encephalopathy 31"",
        ""early infantile epileptic encephalopathy 31"" .

","Developmental and Epileptic Encephalopathy 31A (DEE31A), also known exactly as DEE31 and Early Infantile Epileptic Encephalopathy 31, is categorized under autosomal dominant diseases and is a specific type of Developmental and Epileptic Encephalopathy. It is characterized by its material basis in autosomal dominant inheritance. DEE31A is defined as a developmental and epileptic encephalopathy that manifests in the first months or years of life with refractory seizures and global developmental delay from early infancy, caused by a heterozygous mutation in the DNM1 gene located on chromosome 9q34.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0080438,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by global developmental delay and onset in the first months of life of tonic seizures or infantile spasms that has_material_basis_in heterozygous mutation in the SPTAN1 gene on chromosome 9q34."" ;
    :has_exact_synonym ""DEE5"",
        ""early infantile epileptic encephalopathy 5"" .

","Developmental and epileptic encephalopathy 5 (DEE5), also known as early infantile epileptic encephalopathy 5, is a type of autosomal dominant disease, specifically falling under the category of developmental and epileptic encephalopathy. This condition is characterized by global developmental delay and the onset in the first months of life of tonic seizures or infantile spasms. It is defined as a developmental and epileptic encephalopathy that has a material basis in some autosomal dominant inheritance, specifically through a heterozygous mutation in the SPTAN1 gene on chromosome 9q34.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080439,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_14 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by refractory focal seizures developing by 6 months of age and arrest of psychomotor development that has_material_basis_in heterozygous mutation in the KCNT1 gene on chromosome 9q34."" ;
    :has_exact_synonym ""DEE14"",
        ""early infantile epileptic encephalopathy 14"" .

","Developmental and Epileptic Encephalopathy 14 (DEE14), also known as Early Infantile Epileptic Encephalopathy 14, is a type of autosomal dominant disease that falls under the broader category of Developmental and Epileptic Encephalopathies. It is characterized by a specific type of condition that fundamentally has a material basis in autosomal dominant inheritance. More precisely, DEE14 is defined as a developmental and epileptic encephalopathy characterized by refractory focal seizures that begin by 6 months of age and an arrest of psychomotor development. This condition is caused by a heterozygous mutation in the KCNT1 gene located on chromosome 9q34.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080440,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first months of life of erratic, typically myoclonic, refractory seizures that has_material_basis_in homozygous or compound heterozygous mutation in the SLC25A22 gene on chromosome 11p15."" ;
    :has_exact_synonym ""early infantile epileptic encephalopathy 3"" .

","Developmental and Epileptic Encephalopathy 3 (DEE3) is a type of autosomal recessive disease and belongs to the broader category of developmental and epileptic encephalopathies. It is characterized by a material basis in autosomal recessive inheritance. Specifically, DEE3 is defined as a developmental and epileptic encephalopathy that manifests in the first months of life with erratic, typically myoclonic, refractory seizures. This condition is caused by homozygous or compound heterozygous mutations in the SLC25A22 gene located on chromosome 11p15. Additionally, Developmental and Epileptic Encephalopathy 3 is also known by its exact synonym, Early Infantile Epileptic Encephalopathy 3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080441,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_49 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by neonatal onset of seizures, global developmental delay with intellectual disability and lack of speech, hypotonia, spasticity, and coarse facial features that has_material_basis_in homozygous or compound heterozygous mutation in the DENND5A gene on chromosome 11p15."" ;
    :has_exact_synonym ""DEE49"",
        ""early infantile epileptic encephalopathy 49"" .

","Developmental and Epileptic Encephalopathy 49 (DEE49), also known as Early Infantile Epileptic Encephalopathy 49, is a type of autosomal recessive disease and falls under the broader category of developmental and epileptic encephalopathies. It is characterized by a specific condition that inherently has a material basis in autosomal recessive inheritance. DEE49 is defined as a developmental and epileptic encephalopathy marked by the neonatal onset of seizures, global developmental delay with intellectual disability and lack of speech, hypotonia, spasticity, and coarse facial features. This condition is attributed to homozygous or compound heterozygous mutation in the DENND5A gene located on chromosome 11p15.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080442,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_41 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first days or weeks of life of seizures, severely impaired psychomotor development, and brain anomalies including delayed myelination, thin corpus callosum, and cerebral atrophy that has_material_basis_in heterozygous mutation in the SLC1A2 gene on chromosome 11p13."" ;
    :has_exact_synonym ""DEE41"",
        ""early infantile epileptic encephalopathy 41"" .

","Developmental and Epileptic Encephalopathy 41 (DEE41), also known as Early Infantile Epileptic Encephalopathy 41, is a type of autosomal dominant disease that falls under the broader category of developmental and epileptic encephalopathies. It is characterized by the onset of seizures, severely impaired psychomotor development, and brain anomalies, including delayed myelination, thin corpus callosum, and cerebral atrophy within the first days or weeks of life. These symptoms have a material basis in a heterozygous mutation in the SLC1A2 gene located on chromosome 11p13. This condition is also an example of a disorder that, by definition, has some autosomal dominant inheritance aspect.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080443,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_21 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first months of life by intractable seizures and severely impaired psychomotor development that has_material_basis_in homozygous or compound heterozygous mutation in the NECAP1 gene on chromosome 12p13."" ;
    :has_exact_synonym ""DEE21"",
        ""early infantile epileptic encephalopathy 21"" .

","Developmental and Epileptic Encephalopathy 21 (DEE21), also known as early infantile epileptic encephalopathy 21, is a type of autosomal recessive disease and falls under the broader category of developmental and epileptic encephalopathies. It is characterized by a condition that fundamentally has a material basis in autosomal recessive inheritance. Specifically, DEE21 is distinguished by its onset in the first months of life, marked by intractable seizures and severely impaired psychomotor development, which is due to homozygous or compound heterozygous mutation in the NECAP1 gene located on chromosome 12p13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080444,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_27 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by early onset seizures, delayed psychomotor development and intellectual disability with variable severity that has_material_basis_in heterozygous mutation in the GRIN2B gene on chromosome 12p12."" ;
    :has_exact_synonym ""DEE27"",
        ""early infantile epileptic encephalopathy 27"" .

","Developmental and epileptic encephalopathy 27 (DEE27), also known as early infantile epileptic encephalopathy 27, is a specific type of developmental and epileptic encephalopathy and an autosomal dominant disease. It is characterized by being a condition that fundamentally has a material basis in some form of autosomal dominant inheritance. Specifically, DEE27 is defined as a developmental and epileptic encephalopathy marked by early onset seizures, delayed psychomotor development, and intellectual disability of variable severity, which is due to a heterozygous mutation in the GRIN2B gene located on chromosome 12p12.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080445,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_13 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of intractable seizures in the first year of life with impaired development or developmental regression after seizure onset that has_material_basis_in heterozygous mutation in the SCN8A gene on chromosome 12q13."" ;
    :has_exact_synonym ""DEE13"",
        ""early infantile epileptic encephalopathy 13"" .

","Developmental and Epileptic Encephalopathy 13 (DEE13), also known as Early Infantile Epileptic Encephalopathy 13, is a type of autosomal dominant disease and a specific category of Developmental and Epileptic Encephalopathy. It is characterized by a form of ailment that fundamentally arises from autosomal dominant inheritance. DEE13 is defined as a developmental and epileptic encephalopathy marked by the commencement of intractable seizures within the first year of life, coupled with impaired development or developmental regression following the onset of seizures. This condition is attributed to a heterozygous mutation in the SCN8A gene located on chromosome 12q13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080446,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_66 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first days or weeks of life of seizures, global developmental delay with hypotonia, behavioral abnormalities, and dysmorphic features or ophthalmologic defects that has_material_basis_in heterozygous mutation in the PACS2 gene on chromosome 14q32."" ;
    :has_exact_synonym ""DEE66"",
        ""early infantile epileptic encephalopathy 66"" .

","Developmental and Epileptic Encephalopathy 66 (DEE66), also known as Early Infantile Epileptic Encephalopathy 66, is a type of autosomal dominant disease that falls under the broader category of developmental and epileptic encephalopathies. It is characterized by a condition that has a material basis in autosomal dominant inheritance. More specifically, DEE66 is defined as a developmental and epileptic encephalopathy with onset in the first days or weeks of life, featuring seizures, global developmental delay accompanied by hypotonia, behavioral abnormalities, and either dysmorphic features or ophthalmologic defects. This condition is directly linked to a heterozygous mutation in the PACS2 gene located on chromosome 14q32.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080447,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_43 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first year of life of seizures, global developmental delay, and mild to moderate intellectual disability that has_material_basis_in heterozygous mutation in the GABRB3 gene on chromosome 15q11."" ;
    :has_exact_synonym ""DEE43"",
        ""early infantile epileptic encephalopathy 43"" .

","Developmental and Epileptic Encephalopathy 43 (DEE43), also known as Early Infantile Epileptic Encephalopathy 43, is a type of autosomal dominant disease and a form of developmental and epileptic encephalopathy. This condition is characterized by the onset in the first year of life of seizures, global developmental delay, and mild to moderate intellectual disability. It has a material basis in heterozygous mutation in the GABRB3 gene on chromosome 15q11.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080448,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_48 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by seizure onset before 1 year of age, global developmental delay, intellectual disability, absent speech, and minimal or absent motor development that has_material_basis_in homozygous or compound heterozygous mutation in the AP3B2 gene on chromosome 15q25."" ;
    :has_exact_synonym ""DEE48"",
        ""early infantile epileptic encephalopathy 48"" .

","Developmental and Epileptic Encephalopathy 48 (DEE48), also known as Early Infantile Epileptic Encephalopathy 48, is a type of autosomal recessive disease and falls under the broader category of Developmental and Epileptic Encephalopathies. It is a condition that arises from autosomal recessive inheritance, which involves the material basis of the disease. DEE48 is specifically characterized by seizures that begin before the age of 1 year, global developmental delay, intellectual disability, absent speech, and minimal or absent motor development. This condition has its material basis in homozygous or compound heterozygous mutations in the AP3B2 gene on chromosome 15q25.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080449,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_16 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by seizure onset in the first weeks or months of life, delayed or regression of psychomotor development, and hypotonia that has_material_basis_in homozygous or compound heterozygous mutation in the TBC1D24 gene on chromosome 16p13."" ;
    :has_exact_synonym ""DEE16"",
        ""early infantile epileptic encephalopathy 16"" .

","Developmental and epileptic encephalopathy 16 (DEE16), also known as early infantile epileptic encephalopathy 16, is a type of autosomal recessive disease and a specific form of developmental and epileptic encephalopathy. It is characterized by a type of condition that at least has a material basis in autosomal recessive inheritance. DEE16 is defined as a developmental and epileptic encephalopathy where seizures begin in the first weeks or months of life, accompanied by delayed or regression of psychomotor development, and hypotonia. This condition has its material basis in homozygous or compound heterozygous mutations in the TBC1D24 gene located on chromosome 16p13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080450,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_17 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first weeks or months of life of intractable seizures and very poor psychomotor development that has_material_basis_in heterozygous mutation in the GNAO1 gene on chromosome 16q13."" ;
    :has_exact_synonym ""DEE17"",
        ""early infantile epileptic encephalopathy 17"" .

","Developmental and Epileptic Encephalopathy 17 (DEE17), also known as Early Infantile Epileptic Encephalopathy 17, is a type of autosomal dominant disease and falls under the broader category of developmental and epileptic encephalopathies. This specific encephalopathy is characterized by the onset in the first weeks or months of life of intractable seizures and very poor psychomotor development. It has a material basis in a heterozygous mutation in the GNAO1 gene located on chromosome 16q13, demonstrating that it is a condition with at least some basis in autosomal dominant inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080451,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_29 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first months of life of refractory myoclonic seizures, poor overall growth, congenital microcephaly with cerebral atrophy and impaired myelination on brain imaging, spasticity with abnormal movements, peripheral neuropathy, and poor visual fixation that has_material_basis_in homozygous or compound heterozygous mutation in the AARS1 gene on chromosome 16q22."" ;
    :has_exact_synonym ""DEE29"",
        ""early infantile epileptic encephalopathy 29"" .

","Developmental and Epileptic Encephalopathy 29 (DEE29), also known as Early Infantile Epileptic Encephalopathy 29, is an autosomal recessive disease and a type of Developmental and Epileptic Encephalopathy. It is characterized by a condition that fundamentally has a material basis in autosomal recessive inheritance. DEE29 is defined as a developmental and epileptic encephalopathy with onset in the first months of life, featuring refractory myoclonic seizures, poor overall growth, congenital microcephaly with cerebral atrophy, impaired myelination as seen on brain imaging, spasticity with abnormal movements, peripheral neuropathy, and poor visual fixation. The condition is caused by homozygous or compound heterozygous mutations in the AARS1 gene on chromosome 16q22.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080452,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_28 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first months of life of refractory seizures, severe axial hypotonia, and profoundly impaired psychomotor development that has_material_basis_in homozygous or compound heterozygous mutation in the WWOX gene on chromosome 16q23."" ;
    :has_exact_synonym ""DEE28"",
        ""early infantile epileptic encephalopathy 28"" .

","Developmental and epileptic encephalopathy 28 (DEE28), also known as early infantile epileptic encephalopathy 28, is a type of autosomal recessive disease and a subtype of developmental and epileptic encephalopathy. This condition is characterized by its material basis in autosomal recessive inheritance. It is defined as a developmental and epileptic encephalopathy that manifests in the first months of life with refractory seizures, severe axial hypotonia, and profoundly impaired psychomotor development, resulting from homozygous or compound heterozygous mutation in the WWOX gene on chromosome 16q23.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080453,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_25 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_feature ;
            owl:someValuesFrom :intellectual_disability ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in early infancy of refractory seizures, global developmental delay with intellectual disability, persistent neurologic symptoms, and dental anomalies that has_material_basis_in homozygous or compound heterozygous mutation in the SLC13A5 gene on chromosome 17p13."" ;
    :has_exact_synonym ""DEE25"",
        ""developmental and epileptic encephalopathy 25, with amelogenesis imperfecta"",
        ""early infantile epileptic encephalopathy 25"" .

","Developmental and epileptic encephalopathy 25 (DEE25), also known as developmental and epileptic encephalopathy 25, with amelogenesis imperfecta and early infantile epileptic encephalopathy 25, is a type of autosomal recessive disease and a variant of developmental and epileptic encephalopathy. It is characterized by a specific set of features, including onset in early infancy of refractory seizures, global developmental delay with intellectual disability, persistent neurological symptoms, and dental anomalies. The condition primarily arises due to homozygous or compound heterozygous mutation in the SLC13A5 gene on chromosome 17p13. Moreover, DEE25 is defined by its material basis in autosomal recessive inheritance and is associated with intellectual disability as a key feature.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0080454,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_42 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of seizures in the first hours or days of life and global developmental delay with severely impaired intellectual development that has_material_basis_in heterozygous mutation in the CACNA1A gene on chromosome 19p13."" ;
    :has_exact_synonym ""DEE42"",
        ""early infantile epileptic encephalopathy 42"" .

","Developmental and Epileptic Encephalopathy 42 (DEE42), also known as Early Infantile Epileptic Encephalopathy 42, is a type of Autosomal Dominant Disease and falls under the category of Developmental and Epileptic Encephalopathies. This condition is characterized by the onset of seizures in the first hours or days of life and a global developmental delay with severely impaired intellectual development. The underlying cause of DEE42 is a heterozygous mutation in the CACNA1A gene located on chromosome 19p13, which is an example of a condition that has a material basis in Autosomal Dominant Inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080455,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_52 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by infantile onset of refractory seizures and global neurological development delay, and intellectual disability that has_material_basis_in homozygous or compound heterozygous mutation in the SCN1B gene on chromosome 19q13."" ;
    :has_exact_synonym ""DEE52"",
        ""early infantile epileptic encephalopathy 52"" .

","Developmental and epileptic encephalopathy 52 (DEE52), also known as early infantile epileptic encephalopathy 52, is a type of autosomal recessive disease and falls under the broader category of developmental and epileptic encephalopathies. It is a condition that arises due to material basis in autosomal recessive inheritance. Specifically, DEE52 is defined as a developmental and epileptic encephalopathy characterized by the infantile onset of refractory seizures and global neurological development delay, along with intellectual disability. This condition is caused by homozygous or compound heterozygous mutation in the SCN1B gene located on chromosome 19q13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080456,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_46 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first months or years of life of intractable seizures, global developmental delay, failure to thrive, hypotonia, hyperreflexia, and variably impaired intellectual development that has_material_basis_in heterozygous mutation in the GRIN2D gene on chromosome 19q13."" ;
    :has_exact_synonym ""DEE46"",
        ""early infantile epileptic encephalopathy 46"" .

","Developmental and Epileptic Encephalopathy 46 (DEE46), also known as Early Infantile Epileptic Encephalopathy 46, is a type of Autosomal Dominant Disease and falls under the broader category of Developmental and Epileptic Encephalopathies. It is characterized by a specific condition that emerges from a material basis in Autosomal Dominant Inheritance. This encephalopathy is defined by the onset in the first months or years of life of intractable seizures, global developmental delay, failure to thrive, hypotonia, hyperreflexia, and variably impaired intellectual development. The condition has its material basis in a heterozygous mutation in the GRIN2D gene located on chromosome 19q13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080457,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:microcephaly_seizures_and_developmental_delay rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by microcephaly, infantile onset of seizures and developmental delay that has_material_basis_in homozygous or compound heterozygous mutation in the PNKP gene on chromosome 19q13."" ;
    :has_exact_synonym ""developmental and epileptic encephalopathy 10"",
        ""early infantile epileptic encephalopathy 10""@en .

","Microcephaly seizures and developmental delay is classified as a type of autosomal recessive disease and is also recognized as a form of developmental and epileptic encephalopathy. This condition is associated with a material basis in some form of autosomal recessive inheritance. It is specifically characterized as a developmental and epileptic encephalopathy that manifests with microcephaly, the infantile onset of seizures, and developmental delay. This condition arises due to homozygous or compound heterozygous mutations in the PNKP gene located on chromosome 19q13. Furthermore, microcephaly seizures and developmental delay is precisely known as developmental and epileptic encephalopathy 10 and is also referred to as early infantile epileptic encephalopathy 10.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080458,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_35 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by seizure onset in the first months of life, absence of normal development and absence of myelination of early neurological structures that has_material_basis_in homozygous or compound heterozygous mutation in the ITPA gene on chromosome 20p13."" ;
    :has_exact_synonym ""DEE35"",
        ""early infantile epileptic encephalopathy 35"",
        ""ITPA-related encephalopathy""@en .

","Developmental and epileptic encephalopathy 35 (DEE35), also known as ITPA-related encephalopathy or early infantile epileptic encephalopathy 35, is a type of developmental and epileptic encephalopathy. It is characterized as an autosomal recessive disease that fundamentally has a material basis in autosomal recessive inheritance. Specifically, this condition is marked by the onset of seizures in the first months of life, the absence of normal development, and the absence of myelination of early neurological structures. This is due to homozygous or compound heterozygous mutation in the ITPA gene located on chromosome 20p13.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080459,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_12 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of refractory seizures in the first year of life with normal to mild developmental delay before onset of seizures but developmental regression and stagnation after seizure onset that has_material_basis_in homozygous or compound heterozygous mutation in the PLCB1 gene on chromosome 20p12.3."" ;
    :has_exact_synonym ""DEE12"",
        ""early infantile epileptic encephalopathy 12"" .

","Developmental and Epileptic Encephalopathy 12 (DEE12), also known as Early Infantile Epileptic Encephalopathy 12, is classified as a type of autosomal recessive disease and falls under the broader category of Developmental and Epileptic Encephalopathies. This condition originates from a material basis in autosomal recessive inheritance. It is defined as a developmental and epileptic encephalopathy characterized by the onset of refractory seizures within the first year of life. Initially, affected individuals may exhibit normal to mild developmental delays before the onset of seizures; however, post-seizure onset, they experience developmental regression and stagnation. The condition is caused by homozygous or compound heterozygous mutations in the PLCB1 gene located on chromosome 20p12.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080460,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_34 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by infantile onset of refractory migrating focal seizures, developmental regression and severe global impairment that has_material_basis_in homozygous or compound heterozygous mutation in the SLC12A5 gene on chromosome 20q12."" ;
    :has_exact_synonym ""DEE34"",
        ""early infantile epileptic encephalopathy 34"" .

","Developmental and epileptic encephalopathy 34 (DEE34), also known as early infantile epileptic encephalopathy 34, is a type of autosomal recessive disease and a specific form of developmental and epileptic encephalopathy. This condition is characterized by an infantile onset of refractory migrating focal seizures, developmental regression, and severe global impairment. It has a material basis in homozygous or compound heterozygous mutation in the SLC12A5 gene located on chromosome 20q12, indicating that it arises from some autosomal recessive inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080461,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_26 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first years of life of seizures, developmental delay, intellectual disability, poor speech, and behavioral abnormalities that has_material_basis_in heterozygous mutation in the KCNB1 gene on chromosome 20q13."" ;
    :has_exact_synonym ""DEE26"",
        ""early infantile epileptic encephalopathy 26"" .

","Developmental and epileptic encephalopathy 26 (DEE26), also known as early infantile epileptic encephalopathy 26, is a type of autosomal dominant disease and developmental and epileptic encephalopathy. It is characterized by a condition that has a material basis in some autosomal dominant inheritance. Specifically, DEE26 is defined as a developmental and epileptic encephalopathy characterized by the onset in the first years of life of seizures, developmental delay, intellectual disability, poor speech, and behavioral abnormalities. This condition has its material basis in a heterozygous mutation in the KCNB1 gene on chromosome 20q13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080462,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by infantile onset of refractory seizures, delayed neurological development, and persistent neurologic abnormalities that has_material_basis_in heterozygous mutation in the KCNQ2 gene on chromosome 20q13."" ;
    :has_exact_synonym ""early infantile epileptic encephalopathy 7"",
        ""KCNQ2-related epileptic encephalopathy""@en,
        ""KCNQ2-related neonatal epileptic encephalopathy""@en .

","Developmental and Epileptic Encephalopathy 7 (DEE7) is a type of autosomal dominant disease, which also falls under the broader category of developmental and epileptic encephalopathies. It is characterized by a condition that essentially has a material basis in autosomal dominant inheritance. Specifically, DEE7 is defined as a developmental and epileptic encephalopathy characterized by the infantile onset of refractory seizures, delayed neurological development, and persistent neurologic abnormalities, caused by a heterozygous mutation in the KCNQ2 gene on chromosome 20q13. Additionally, DEE7 is known by several exact synonyms, including KCNQ2-related epileptic encephalopathy, KCNQ2-related neonatal epileptic encephalopathy, and Early Infantile Epileptic Encephalopathy 7.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080463,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_33 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first months of life of seizures and severe global developmental delay with impaired intellectual development and poor or absent speech that has_material_basis_in heterozygous mutation in the EEF1A2 gene on chromosome 20q13."" ;
    :has_exact_synonym ""DEE33"",
        ""early infantile epileptic encephalopathy 33"" .

","Developmental and epileptic encephalopathy 33 (DEE33), also known as early infantile epileptic encephalopathy 33, is a type of autosomal dominant disease that falls under the broader category of developmental and epileptic encephalopathies. This condition is characterized by its material basis in at least some form of autosomal dominant inheritance. Specifically, DEE33 is defined as a developmental and epileptic encephalopathy that begins in the first months of life, featuring seizures and severe global developmental delay with impaired intellectual development, along with poor or absent speech. This condition is caused by a heterozygous mutation in the EEF1A2 gene located on chromosome 20q13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080464,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_53 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by infantile onset of intractable seizures, hypotonia, poor or absent global development, severe intellectual disability and spastic quadriplegia that has_material_basis_in homozygous or compound heterozygous mutation in the SYNJ1 gene on chromosome 21q22."" ;
    :has_exact_synonym ""DEE53"",
        ""early infantile epileptic encephalopathy 53"" .

","Developmental and epileptic encephalopathy 53 (DEE53), also known as early infantile epileptic encephalopathy 53, is a type of autosomal recessive disease and a specific form of developmental and epileptic encephalopathy. This condition is characterized by a type of disorder that fundamentally has a material basis in autosomal recessive inheritance. Specifically, DEE53 is defined by the infantile onset of intractable seizures, hypotonia, poor or absent global development, severe intellectual disability, and spastic quadriplegia. This is due to homozygous or compound heterozygous mutations in the SYNJ1 gene located on chromosome 21q22.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080465,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_30 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset in the first few months of life of refractory seizures andseverely impaired or absent developmental progress that has_material_basis_in heterozygous mutation in the SIK1 gene on chromosome 21q22."" ;
    :has_exact_synonym ""DEE30"",
        ""early infantile epileptic encephalopathy 30"" .

","Developmental and Epileptic Encephalopathy 30 (DEE30), also known precisely as Early Infantile Epileptic Encephalopathy 30, is classified as a type of Autosomal Dominant Disease and falls within the broader category of Developmental and Epileptic Encephalopathies. This condition is specifically characterized by an onset in the first few months of life of refractory seizures and severely impaired or absent developmental progress. It stems from a heterozygous mutation in the SIK1 gene on chromosome 21q22, indicating that it has a material basis in some form of autosomal dominant inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080467,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :developmental_and_epileptic_encephalopathy,
        :x_linked_dominant_disease ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by X-linked dominant inheritance of seizure onset in the first months of life, intellectual disability, and poor motor control that has_material_basis_in mutation in the CDKL5 gene on chromosome Xp22."" ;
    :has_exact_synonym ""DEE2"",
        ""EIEE2"",
        ""early infantile epileptic encephalopathy 2"",
        ""X-linked infantile spasm syndrome 2""@en .

","Developmental and Epileptic Encephalopathy 2 (DEE2), also known exactly as EIEE2, X-linked infantile spasm syndrome 2, and early infantile epileptic encephalopathy 2, is a type of X-linked dominant disease that falls under the broader category of developmental and epileptic encephalopathies. It is characterized by a type of condition that invariably has a material basis in some form of X-linked dominant inheritance. Specifically, DEE2 is defined as a developmental and epileptic encephalopathy marked by the X-linked dominant inheritance of seizure onset in the first months of life, along with intellectual disability and poor motor control. This condition has its material basis in a mutation in the CDKL5 gene located on chromosome Xp22.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0080468,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :developmental_and_epileptic_encephalopathy,
        :x_linked_recessive_disease ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by X-linked recessive inheritance of frequent tonic seizures or spasms beginning in infancy that has_material_basis_in mutation in the ARX gene on chromosome Xp21."" ;
    :has_exact_synonym ""DEE1"",
        ""early infantile epileptic encephalopathy 1"",
        ""X-linked infantile spasm syndrome 1""@en .

","Developmental and Epileptic Encephalopathy 1 (DEE1), also known precisely as X-linked Infantile Spasm Syndrome 1 and Early Infantile Epileptic Encephalopathy 1, is a type of X-linked recessive disease. It falls under the broader category of Developmental and Epileptic Encephalopathy and is characterized by a material basis in X-linked recessive inheritance. DEE1 is defined as a developmental and epileptic encephalopathy characterized by frequent tonic seizures or spasms beginning in infancy due to a mutation in the ARX gene on chromosome Xp21.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080470,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_36 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :developmental_and_epileptic_encephalopathy,
        :x_linked_dominant_disease ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by X-linked dominant inheritance of infantile onset of seizures, delayed psychomotor development and in some patients dysmorphic features that has_material_basis_in heterozygous mutation in the ALG13 gene on chromosome Xq23."" ;
    :has_exact_synonym ""congenital disorder of glycosylation, type Is"",
        ""early infantile epileptic encephalopathy 36"" .

","Developmental and epileptic encephalopathy 36 (DEE36) is recognized as a type of developmental and epileptic encephalopathy, as well as a type of X-linked dominant disease. It is characterized by its basis in a certain type of inheritance, specifically something that at least has a material basis in X-linked dominant inheritance. The detailed definition of DEE36 outlines it as a developmental and epileptic encephalopathy characterized by an X-linked dominant inheritance pattern. This condition typically manifests with infantile onset of seizures, delayed psychomotor development, and in some cases, dysmorphic features. These symptoms have a material basis in a heterozygous mutation in the ALG13 gene located on chromosome Xq23. Additionally, DEE36 is also known by its exact synonyms, including congenital disorder of glycosylation, type Is, and early infantile epileptic encephalopathy 36.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080471,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_92 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of seizures in infancy or early childhood, global developmental delay and variable intellectual disability that has_material_basis_in heterozygous mutation in the GABRB2 gene on chromosome 5q34."" .

","Developmental and epileptic encephalopathy 92 (DEE92) is a type of autosomal dominant disease and is categorized under developmental and epileptic encephalopathies. It is characterized by a condition that arises due to at least some form of autosomal dominant inheritance. Specifically, DEE92 is defined as a developmental and epileptic encephalopathy that manifests with seizures beginning in infancy or early childhood, alongside global developmental delay and varying degrees of intellectual disability. This condition has its material basis in a heterozygous mutation in the GABRB2 gene located on chromosome 5q34.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080472,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_91 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of refractory multifocal seizures in the first weeks or years of life, delayed psychomotor development, poor or absent speech, and severe to profound intellectual disability that has_material_basis_in heterozygous mutation in the PPP3CA gene on chromosome 4q24."" ;
    :has_exact_synonym ""infantile or early childhood epileptic encephalopathy 1"" .

","Developmental and Epileptic Encephalopathy 91 (DEE91) is a type of autosomal dominant disease, specifically classified under developmental and epileptic encephalopathies. It is characterized by its nature of having a material basis in autosomal dominant inheritance. DEE91 is defined as a developmental and epileptic encephalopathy that manifests through the onset of refractory multifocal seizures within the first weeks or years of life, accompanied by delayed psychomotor development, poor or absent speech, and severe to profound intellectual disability. This condition is caused by a heterozygous mutation in the PPP3CA gene located on chromosome 4q24. Additionally, DEE91 is also known by its exact synonym, Infantile or Early Childhood Epileptic Encephalopathy 1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080473,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_delay_and_seizures_with_or_without_movement_abnormalities rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :neurodevelopmental_delay ],
        :syndromic_intellectual_disability ;
    :has_definition ""A syndromic intellectual disability characterized by global developmental delay, variable intellectual disability, and early-onset seizures with a myoclonic component that has_material_basis_in heterozygous mutation in the DHDDS gene on chromosome 1p36."" .

","Developmental delay and seizures with or without movement abnormalities is a type of syndromic intellectual disability and also falls under the category of conditions that at least have a phenotype characterized by some neurodevelopmental delay. It is defined as a syndromic intellectual disability characterized by global developmental delay, variable intellectual disability, and early-onset seizures with a myoclonic component. This condition has a material basis in a heterozygous mutation in the DHDDS gene located on chromosome 1p36.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080474,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:pustular_psoriasis_14 rdfs:subClassOf :psoriasis ;
    :has_definition ""A psoriasis characterized by sudden, repeated episodes of high-grade fever, generalized rash, and disseminated pustules, with hyperleukocytosis and elevated serum levels of C-reactive protein that has_material_basis_in homozygous or compound heterozygous mutation in the IL36RN gene on chromosome 2q14."" ;
    :has_exact_synonym ""acrodermatitis continua of Hallopeau"",
        ""deficiency of IL-36R antagonist""@en .

","Pustular psoriasis 14 is identified as a specific type of psoriasis characterized by sudden, repeated episodes of high-grade fever, generalized rash, and disseminated pustules, accompanied by hyperleukocytosis and elevated serum levels of C-reactive protein. This condition arises from homozygous or compound heterozygous mutations in the IL36RN gene located on chromosome 2q14. Additionally, pustular psoriasis 14 is exactly synonymous with acrodermatitis continua of Hallopeau and deficiency of IL-36R antagonist.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080475,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:psoriasis_2 rdfs:subClassOf :psoriasis ;
    :has_definition ""A psoriasis that has_material_basis_in heterozygous mutation in the CARD14 gene on chromosome 17q25."" .

","Psoriasis 2 is a type of psoriasis, which is characterized by a psoriasis that has its material basis in a heterozygous mutation in the CARD14 gene located on chromosome 17q25.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080476,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_1a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous or compound heterozygous mutation in the PEX1 gene on chromosome 7q21."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 1A (Zellweger)""@en .

","Peroxisome biogenesis disorder 1A is a type of peroxisomal biogenesis disorder and is defined as a peroxisomal biogenesis disorder that has its material basis in homozygous or compound heterozygous mutation in the PEX1 gene on chromosome 7q21. It also has the exact synonym ""peroxisome biogenesis disorder 1A (Zellweger).""",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080477,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_2a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous mutation in the PEX5 gene on chromosome 12p13."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 2A (Zellweger)""@en .

",Peroxisome biogenesis disorder 2A is a type of peroxisomal biogenesis disorder and has an exact synonym: peroxisome biogenesis disorder 2A (Zellweger). It is defined as a peroxisomal biogenesis disorder that has its material basis in homozygous mutation in the PEX5 gene on chromosome 12p13.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080478,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_3a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous or compound heterozygous mutation in the PEX12 gene on chromosome 17."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 3A (Zellweger)""@en .

",Peroxisome biogenesis disorder 3a is a type of peroxisomal biogenesis disorder and has the exact synonym peroxisome biogenesis disorder 3A (Zellweger). It is defined as a peroxisomal biogenesis disorder that has a material basis in homozygous or compound heterozygous mutation in the PEX12 gene on chromosome 17.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080479,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_4a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous or compound heterozygous mutation in the PEX6 gene on chromosome 6p21.1."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 4A (Zellweger)""@en .

","Peroxisome biogenesis disorder 4a is a type of peroxisomal biogenesis disorder and has an exact synonym, peroxisome biogenesis disorder 4A (Zellweger). It is defined as a peroxisomal biogenesis disorder that has its material basis in homozygous or compound heterozygous mutation in the PEX6 gene on chromosome 6p21.1.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080480,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_5a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous mutation in the PEX2 gene on chromosome 8q21."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 5A (Zellweger)""@en .

","Peroxisome biogenesis disorder 5A is a type of peroxisomal biogenesis disorder and it is defined by a peroxisomal biogenesis disorder that has a material basis in homozygous mutation in the PEX2 gene on chromosome 8q21. Additionally, it is exactly synonymous with peroxisome biogenesis disorder 5A (Zellweger).",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080481,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_6a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous or compound heterozygous mutation in the PEX10 gene on chromosome 1p36."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 6A (Zellweger)""@en .

",Peroxisome biogenesis disorder 6a is a type of peroxisomal biogenesis disorder and has the exact synonym peroxisome biogenesis disorder 6A (Zellweger). It is defined as a peroxisomal biogenesis disorder that has its material basis in homozygous or compound heterozygous mutation in the PEX10 gene on chromosome 1p36.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080482,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_7a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous or compound heterozygous mutation in the PEX26 gene on chromosome 22q11."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 7A (Zellweger)""@en .

","Peroxisome biogenesis disorder 7a is a type of peroxisomal biogenesis disorder and has an exact synonym, peroxisome biogenesis disorder 7A (Zellweger). It is defined as a peroxisomal biogenesis disorder that has its material basis in homozygous or compound heterozygous mutation in the PEX26 gene on chromosome 22q11.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080483,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_8a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous mutation in the PEX16 gene on chromosome 11p11."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 8A (Zellweger)""@en .

","Peroxisome biogenesis disorder 8a is a type of peroxisomal biogenesis disorder, which is defined as a peroxisomal biogenesis disorder that has its material basis in homozygous mutation in the PEX16 gene on chromosome 11p11. Additionally, peroxisome biogenesis disorder 8a is exactly synonymous with peroxisome biogenesis disorder 8A (Zellweger).",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080484,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_10a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous mutation in the PEX3 gene on chromosome 6q24."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 10A (Zellweger)""@en .

","Peroxisome biogenesis disorder 10a is a type of peroxisomal biogenesis disorder, which is defined as a peroxisomal biogenesis disorder that has its material basis in a homozygous mutation in the PEX3 gene located on chromosome 6q24. Additionally, peroxisome biogenesis disorder 10a is exactly synonymous with peroxisome biogenesis disorder 10A (Zellweger).",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080485,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_11a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous mutation in the PEX13 gene on chromosome 2p15."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 11A (Zellweger)""@en .

","Peroxisome biogenesis disorder 11a is a type of peroxisomal biogenesis disorder, which is defined as a peroxisomal biogenesis disorder that has its material basis in homozygous mutation in the PEX13 gene on chromosome 2p15. Additionally, it has the exact synonym ""peroxisome biogenesis disorder 11A (Zellweger).""",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080486,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_12a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous mutation in the PEX19 gene on chromosome 1q23."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 12A (Zellweger)""@en .

","Peroxisome biogenesis disorder 12a is a type of peroxisomal biogenesis disorder, which is defined as a peroxisomal biogenesis disorder that has its material basis in a homozygous mutation in the PEX19 gene on chromosome 1q23. It is exactly synonymous with peroxisome biogenesis disorder 12A (Zellweger).",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080487,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_13a rdfs:subClassOf :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous mutation in the PEX14 gene on chromosome 1p36."" ;
    :has_exact_synonym ""peroxisome biogenesis disorder 13A (Zellweger)""@en .

","Peroxisome biogenesis disorder 13a is a type of peroxisomal biogenesis disorder and has a definition as a peroxisomal biogenesis disorder that has its material basis in a homozygous mutation in the PEX14 gene on chromosome 1p36. It also has an exact synonym, peroxisome biogenesis disorder 13A (Zellweger).",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080488,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mucolipidosis rdfs:subClassOf :lipid_storage_disease ;
    :has_definition ""A lipid storage disease that is characterized by increased storage of carbohydrates and lipids."" .

","Mucolipidosis is a type of lipid storage disease, characterized by increased storage of carbohydrates and lipids.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080489,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gm1_gangliosidosis_type_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :gm1_gangliosidosis ;
    :has_definition ""A GM1 gangliosidosis that is characterized by neurodegeneration and mild skeletal changes and with age at onset ranges from 3 to 30 years."" ;
    :has_exact_synonym ""adult-onset GM1 gangliosidosis""@en .

","GM1 gangliosidosis type 3 is a form of GM1 gangliosidosis and is also classified as a condition that fundamentally arises from autosomal recessive inheritance. It is defined as a GM1 gangliosidosis variant which is marked by neurodegeneration and mild skeletal changes, with the age at onset spanning from 3 to 30 years. Additionally, it is precisely referred to as adult-onset GM1 gangliosidosis.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080490,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mucolipidosis_type_iv rdfs:subClassOf :mucolipidosis ;
    :has_definition ""A mucolipidosis that is characterized by delayed development and vision impairment that worsens over time."" .

",Mucolipidosis Type IV is a type of mucolipidosis that is defined by delayed development and vision impairment that worsens over time.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080491,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebral_cavernous_malformation_1 rdfs:subClassOf :cerebral_cavernous_malformation ;
    :has_definition ""A cerebral cavernous malformation that has_material_basis_in heterozygous mutation in the KRIT1 gene on chromosome 7q21."" .

","Cerebral cavernous malformation 1 is a type of cerebral cavernous malformation, defined as a cerebral cavernous malformation that has a material basis in a heterozygous mutation in the KRIT1 gene on chromosome 7q21.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080492,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leukocyte_adhesion_deficiency_2 rdfs:subClassOf :leukocyte_adhesion_deficiency ;
    :has_definition ""A leukocyte adhesion deficiency that is characterized by the absence of Sialyl Lewis X of E-selectin resulting in recurrent bacterial infections, severe growth delay and severe intellectual deficit."" .

","Leukocyte adhesion deficiency 2 is a type of leukocyte adhesion deficiency that is defined by the absence of Sialyl Lewis X of E-selectin. This condition results in recurrent bacterial infections, severe growth delay, and severe intellectual deficit.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080493,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ovarian_dysgenesis_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :46_xx_gonadal_dysgenesis,
        :autosomal_recessive_disease ;
    :has_definition ""A 46 XX gonadal dysgenesis that has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding follicle-stimulating hormone receptor on chromosome 2p16."" .

",Ovarian dysgenesis 1 is a type of autosomal recessive disease and a form of 46 XX gonadal dysgenesis that is characterized by having a material basis in autosomal recessive inheritance. It is defined as a 46 XX gonadal dysgenesis that arises due to a homozygous or compound heterozygous mutation in the gene encoding the follicle-stimulating hormone receptor located on chromosome 2p16.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080494,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ovarian_dysgenesis_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :46_xx_gonadal_dysgenesis,
        :x_linked_monogenic_disease ;
    :has_definition ""A 46 XX gonadal dysgenesis that has_material_basis_in mutation in the BMP15 gene on chromosome Xp11."" .

","Ovarian dysgenesis 2 is a type of X-linked monogenic disease, 46 XX gonadal dysgenesis, and it is a condition that at least has a material basis in some X-linked inheritance. It is defined as a 46 XX gonadal dysgenesis that has its material basis in a mutation in the BMP15 gene on chromosome Xp11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080495,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ovarian_dysgenesis_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :46_xx_gonadal_dysgenesis,
        :autosomal_recessive_disease ;
    :has_definition ""A 46 XX gonadal dysgenesis that has_material_basis_in homozygous mutation in the PSMC3IP gene on chromosome 17q12-q21."" .

","Ovarian dysgenesis 3 is classified as an autosomal recessive disease and a type of 46 XX gonadal dysgenesis. It is characterized by a condition that fundamentally arises from some form of autosomal recessive inheritance. Specifically, ovarian dysgenesis 3 is defined as a 46 XX gonadal dysgenesis that originates from a homozygous mutation in the PSMC3IP gene located on chromosome 17q12-q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080496,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ovarian_dysgenesis_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :46_xx_gonadal_dysgenesis,
        :autosomal_recessive_disease ;
    :has_definition ""A 46 XX gonadal dysgenesis that has_material_basis_in homozygous mutation in the MCM9 gene on chromosome 6q22."" .

","Ovarian dysgenesis 4 is a type of autosomal recessive disease, a type of 46 XX gonadal dysgenesis, and a type of condition that at least has a material basis in some autosomal recessive inheritance. It is defined as a 46 XX gonadal dysgenesis that has its material basis in a homozygous mutation in the MCM9 gene on chromosome 6q22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080497,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ovarian_dysgenesis_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :46_xx_gonadal_dysgenesis,
        :autosomal_recessive_disease ;
    :has_definition ""A 46 XX gonadal dysgenesis that has_material_basis_in homozygous mutation in the SOHLH1 gene on chromosome 9q34."" .

","Ovarian dysgenesis 5 is a type of autosomal recessive disease, 46 XX gonadal dysgenesis, and something that at least has a material basis in some autosomal recessive inheritance. It is defined as a 46 XX gonadal dysgenesis that has its material basis in a homozygous mutation in the SOHLH1 gene on chromosome 9q34.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080498,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ovarian_dysgenesis_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :46_xx_gonadal_dysgenesis,
        :autosomal_recessive_disease ;
    :has_definition ""A 46 XX gonadal dysgenesis that has_material_basis_in homozygous mutation in the NUP107 gene on chromosome 12q15."" .

","Ovarian dysgenesis 6 is a type of autosomal recessive disease, which is also classified as a type of 46 XX gonadal dysgenesis and involves a condition that fundamentally has a material basis in autosomal recessive inheritance. It is defined as a 46 XX gonadal dysgenesis that results from a homozygous mutation in the NUP107 gene located on chromosome 12q15.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080499,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ovarian_dysgenesis_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :46_xx_gonadal_dysgenesis,
        :autosomal_recessive_disease ;
    :has_definition ""A 46 XX gonadal dysgenesis that has_material_basis_in homozygous mutation in the MRPS22 gene on chromosome 3q23."" .

","Ovarian dysgenesis 7 is classified as an autosomal recessive disease and is a specific type of 46 XX gonadal dysgenesis. It is characterized by having a material basis in autosomal recessive inheritance. Additionally, ovarian dysgenesis 7 is defined as a 46 XX gonadal dysgenesis that results from a homozygous mutation in the MRPS22 gene located on chromosome 3q23.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080500,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ovarian_dysgenesis_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :46_xx_gonadal_dysgenesis,
        :autosomal_dominant_disease ;
    :has_definition ""A 46 XX gonadal dysgenesis that has_material_basis_in heterozygous mutation in the ESR2 gene on chromosome 14q23."" .

","Ovarian dysgenesis 8 is a type of autosomal dominant disease, and it is also a type of 46 XX gonadal dysgenesis, which indicates that it falls under the category of conditions that have a material basis in some form of autosomal dominant inheritance. Furthermore, ovarian dysgenesis 8 is defined as a 46 XX gonadal dysgenesis that has its material basis in a heterozygous mutation in the ESR2 gene located on chromosome 14q23.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080501,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gm1_gangliosidosis_type_2 rdfs:subClassOf :gm1_gangliosidosis ;
    :has_definition ""A GM1 gangliosidosis that is characterized by slowly progressive generalized neurodegeneration and mild skeletal changes, with onset between 7 months and 3 years of age."" ;
    :has_exact_synonym ""juvenile GM1 gangliosidosis""@en .

","GM1 gangliosidosis type 2 is a type of GM1 gangliosidosis, which is characterized by slowly progressive generalized neurodegeneration and mild skeletal changes, with onset between 7 months and 3 years of age. It is also precisely known as juvenile GM1 gangliosidosis.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080502,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gm1_gangliosidosis_type_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :hepatosplenomegaly ],
        :gm1_gangliosidosis ;
    :has_definition ""A GM1 gangliosidosis that is characterized by rapid psychomotor deterioration beginning within 6 months of birth, generalized central nervous system involvement, hepatosplenomegaly, facial dysmorphism, macular cherry-red spots, skeletal dysplasia, and early death."" .

","GM1 gangliosidosis type 1 is a type of GM1 gangliosidosis and also falls under the category of conditions that have, at the very least, the symptom of hepatosplenomegaly. It is defined as a GM1 gangliosidosis characterized by rapid psychomotor deterioration beginning within 6 months of birth, involving widespread central nervous system implications, hepatosplenomegaly, facial dysmorphism, macular cherry-red spots, skeletal dysplasia, and results in early death.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080503,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_congenital_anomalies_hypotonia_seizures_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :lipid_metabolism_disorder,
        :physical_disorder ;
    :has_definition ""A lipid metabolism disorder that is characterized by severe global developmental delay, hypotonia, and early-onset seizures, associated with multiple cardiac, genitourinary, and gastrointestinal congenital anomalies."" .

","Multiple congenital anomalies hypotonia seizures syndrome is a type of physical disorder, a type of lipid metabolism disorder, and a type of condition that has its basis in some abnormality of prenatal development or birth. It is defined as a lipid metabolism disorder characterized by severe global developmental delay, hypotonia, and early-onset seizures, associated with multiple cardiac, genitourinary, and gastrointestinal congenital anomalies.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080504,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:parkinson_s_disease_22 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :late_onset_parkinson_s_disease ;
    :has_definition ""A late onset Parkinson's disease that has_material_basis_in autosomal dominant inheritance of heterozygous mutation in the coiled-coil-helix-coiled-coil-helix domain containing 2 gene on chromosome 7p11.2."" ;
    :has_exact_synonym ""autosomal dominant Parkinson's disease 22""@en .

","Parkinson's disease 22 is a type of autosomal dominant disease and is also a type of late-onset Parkinson's disease. It is categorized as something that at least has a material basis in some autosomal dominant inheritance. Specifically, Parkinson's disease 22 is defined as a late onset Parkinson's disease that has its material basis in autosomal dominant inheritance of a heterozygous mutation in the coiled-coil-helix-coiled-coil-helix domain containing 2 gene on chromosome 7p11.2. Additionally, it has an exact synonym: autosomal dominant Parkinson's disease 22.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080505,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cornelia_de_lange_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cornelia_de_lange_syndrome ;
    :has_definition ""A Cornelia de Lange syndrome that has_material_basis_in heterozygous mutation in the NIPBL gene, which encodes a component of the cohesin complex, on chromosome 5p13."" .

","Cornelia de Lange Syndrome 1 is a type of autosomal dominant disease and a specific form of Cornelia de Lange Syndrome. It is characterized by a condition that fundamentally arises from autosomal dominant inheritance. Moreover, Cornelia de Lange Syndrome 1 is defined by a Cornelia de Lange syndrome that originates from a heterozygous mutation in the NIPBL gene, encoding a component of the cohesin complex, located on chromosome 5p13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080506,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cornelia_de_lange_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :cornelia_de_lange_syndrome,
        :x_linked_dominant_disease ;
    :has_definition ""A Cornelia de Lange syndrome that has_material_basis_in a mutation in the SMC1A gene, which encodes a subunit of the cohesin complex, on chromosome Xp11."" .

","Cornelia de Lange Syndrome 2 is a type of Cornelia de Lange Syndrome and falls under the category of X-linked dominant diseases. It also represents a condition that fundamentally arises from some form of X-linked dominant inheritance. Specifically, this syndrome is defined by a mutation in the SMC1A gene, which encodes a subunit of the cohesin complex, located on chromosome Xp11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080507,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cornelia_de_lange_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cornelia_de_lange_syndrome ;
    :has_definition ""A Cornelia de Lange syndrome that has_material_basis_in heterozygous mutation in the SMC3 gene on chromosome 10q25.2."" ;
    :has_exact_synonym ""CDLS3"",
        ""Cornelia De Lange syndrome 3 with or without midline brain defects"" .

","Cornelia de Lange Syndrome 3 (CdLS3) is a type of Cornelia de Lange Syndrome, which is an autosomal dominant disease. It specifically has its material basis in some autosomal dominant inheritance. The definition of CdLS3 is a Cornelia de Lange syndrome that results from a heterozygous mutation in the SMC3 gene located on chromosome 10q25.2. CdLS3 is exactly synonymous with CDLS3 and also known as Cornelia De Lange Syndrome 3 with or without midline brain defects.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080508,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cornelia_de_lange_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cornelia_de_lange_syndrome ;
    :has_definition ""A Cornelia de Lange syndrome that has_material_basis_in heterozygous mutation in the RAD21 gene, which encodes a component of the cohesin complex, on chromosome 8q24."" ;
    :has_exact_synonym ""CDLS4"",
        ""Cornelia De Lange syndrome 4 with or without midline brain defects"" .

","Cornelia de Lange Syndrome 4 (CDLS4), also known exactly as Cornelia De Lange Syndrome 4 with or without midline brain defects, is a specific type of Cornelia de Lange Syndrome and an autosomal dominant disease. It is defined by a Cornelia de Lange syndrome that arises from a heterozygous mutation in the RAD21 gene, which is a part of the cohesin complex, located on chromosome 8q24. This condition is an example of a disorder that inherently has a material basis in autosomal dominant inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080509,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cornelia_de_lange_syndrome_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :cornelia_de_lange_syndrome,
        :x_linked_dominant_disease ;
    :has_definition ""A Cornelia de Lange syndrome that has_material_basis_in by mutation in the HDAC8 gene on chromosome Xq13."" .

",Cornelia de Lange Syndrome 5 is a type of Cornelia de Lange Syndrome and an X-linked dominant disease. It is defined as a Cornelia de Lange Syndrome that has a material basis in a mutation in the HDAC8 gene on chromosome Xq13. This implies it is a type of condition that at least has a material basis in some X-linked dominant inheritance.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080510,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:epidermolysis_bullosa_simplex_localized_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :epidermolysis_bullosa_simplex ;
    :has_definition ""An epidermolysis bullosa simplex that is characterized by skin blistering that begins anytime between childhood and adulthood and is usually limited to the hands and feet."" ;
    :has_exact_synonym ""epidermolysis bullosa simplex Weber-Cockayne type""@en .

","Epidermolysis bullosa simplex localized type is a form of autosomal dominant disease and a subtype of epidermolysis bullosa simplex. It is characterized by a condition that has a material basis in autosomal dominant inheritance. This specific type of epidermolysis bullosa simplex is defined by skin blistering that can start anytime between childhood and adulthood, typically confined to the hands and feet. Additionally, it is precisely synonymous with epidermolysis bullosa simplex Weber-Cockayne type.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080511,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:epidermolysis_bullosa_simplex_generalized_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :epidermolysis_bullosa_simplex ;
    :has_definition ""An epidermolysis bullosa simplex that is characterized by widespread blisters that appear at birth or in early infancy."" ;
    :has_exact_synonym ""epidermolysis bullosa simplex Koebner type""@en .

",Epidermolysis bullosa simplex generalized type is a type of autosomal dominant disease and is also known as epidermolysis bullosa simplex Koebner type. It falls under the category of epidermolysis bullosa simplex and is a type of condition that has a material basis in autosomal dominant inheritance. This condition is defined by widespread blisters that appear at birth or in early infancy.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0080512,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meier_gorlin_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :meier_gorlin_syndrome ;
    :has_definition ""A Meier-Gorlin syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the ORC1 gene on chromosome 1p32."" .

","Meier-Gorlin syndrome 1 is a type of Meier-Gorlin syndrome and an autosomal recessive disease. It is characterized by having a material basis in some form of autosomal recessive inheritance. Specifically, this syndrome is defined as a Meier-Gorlin syndrome that has its material basis in homozygous or compound heterozygous mutations in the ORC1 gene located on chromosome 1p32.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080513,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meier_gorlin_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :meier_gorlin_syndrome ;
    :has_definition ""A Meier-Gorlin syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the ORC4 gene on chromosome 2q23."" .

","Meier-Gorlin syndrome 2 is a subtype of Meier-Gorlin syndrome, which is characterized as an autosomal recessive disease. This particular syndrome not only falls under the category of diseases with a material basis in autosomal recessive inheritance but is also specifically defined by having a material basis in homozygous or compound heterozygous mutations in the ORC4 gene located on chromosome 2q23.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080514,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meier_gorlin_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :meier_gorlin_syndrome ;
    :has_definition ""A Meier-Gorlin syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the ORC6 gene on chromosome 16q11."" .

","Meier Gorlin syndrome 3 is a type of Meier Gorlin syndrome and an autosomal recessive disease. It is characterized by a condition that has a material basis in some form of autosomal recessive inheritance. Specifically, this syndrome is defined as a Meier-Gorlin syndrome that has its material basis in homozygous or compound heterozygous mutation in the ORC6 gene located on chromosome 16q11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080515,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meier_gorlin_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :meier_gorlin_syndrome ;
    :has_definition ""A Meier-Gorlin syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the CDT1 gene on chromosome 16q24."" .

","Meier-Gorlin syndrome 4 is a type of Meier-Gorlin syndrome and an autosomal recessive disease. It is characterized by a condition that inherently has a material basis in autosomal recessive inheritance. Specifically, this syndrome is defined as a Meier-Gorlin syndrome that has its material basis in homozygous or compound heterozygous mutation in the CDT1 gene located on chromosome 16q24.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080516,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meier_gorlin_syndrome_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :meier_gorlin_syndrome ;
    :has_definition ""A Meier-Gorlin syndrome that has_material_basis_in homozygous mutation in the CDC6 gene on chromosome 17q21."" .

","Meier-Gorlin syndrome 5 is a type of Meier-Gorlin syndrome and an autosomal recessive disease. It is characterized by having a material basis in autosomal recessive inheritance. Specifically, this syndrome is defined as a Meier-Gorlin syndrome that has its material basis in a homozygous mutation in the CDC6 gene located on chromosome 17q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080517,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meier_gorlin_syndrome_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :meier_gorlin_syndrome ;
    :has_definition ""A Meier-Gorlin syndrome that has_material_basis_in heterozygous mutation in the GMNN gene on chromosome 6p22."" .

","Meier-Gorlin syndrome 6 is a type of Meier-Gorlin syndrome and an autosomal dominant disease, which is characterized by having a material basis in some form of autosomal dominant inheritance. It is defined specifically as a Meier-Gorlin syndrome that has its material basis in a heterozygous mutation in the GMNN gene on chromosome 6p22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080518,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meier_gorlin_syndrome_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :meier_gorlin_syndrome ;
    :has_definition ""A Meier-Gorlin syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the CDC45 gene on chromosome 22q11."" .

","Meier-Gorlin syndrome 7 is a type of autosomal recessive disease and a specific form of Meier-Gorlin syndrome, characterized by having a material basis in some form of autosomal recessive inheritance. It is defined as a Meier-Gorlin syndrome that has its material basis in homozygous or compound heterozygous mutation in the CDC45 gene on chromosome 22q11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080519,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:papa_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by pyoderma gangrenosum, pyogenic arthritis, acne and suppurative hidradenitis and heterozygous mutation in the PSTPIP1 gene on chromosome 15q24."" ;
    :has_exact_synonym ""pyogenic arthritis, pyoderma gangrenosum and acne""@en .

","Papa syndrome is a type of syndrome and an autosomal dominant disease that has a material basis in some autosomal dominant inheritance. It is defined as a syndrome characterized by pyoderma gangrenosum, pyogenic arthritis, acne, and suppurative hidradenitis, with a heterozygous mutation in the PSTPIP1 gene on chromosome 15q24. Furthermore, it has the exact synonym ""pyogenic arthritis, pyoderma gangrenosum, and acne.""",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080520,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:tn_polyagglutination_syndrome rdfs:subClassOf :hematopoietic_system_disease ;
    :has_definition ""A hematopoietic system disease that is characterized by red blood cells that agglutinate upon exposure to almost all human sera, but not to autologous serum or the sera of newborns and has_material_basis_in somatic mutation in the C1GALT1C1 gene on chromosome Xq24."" ;
    :has_exact_synonym ""galactosyltransferase deficiency""@en .

","TN polyagglutination syndrome is a type of hematopoietic system disease. It is defined as a hematopoietic system disease characterized by red blood cells that agglutinate upon exposure to almost all human sera, but not to autologous serum or the sera of newborns. This condition has a material basis in somatic mutations in the C1GALT1C1 gene located on chromosome Xq24. TN polyagglutination syndrome is also exactly synonymous with galactosyltransferase deficiency.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080521,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lung_non_squamous_non_small_cell_carcinoma rdfs:subClassOf :lung_non_small_cell_carcinoma ;
    :has_definition ""A lung non-small cell carcinoma that is characterized by the lack of evidence of squamous differentiation."" ;
    :has_exact_synonym ""non- squamous NSCLC""@en .

","Lung non-squamous non-small cell carcinoma is a type of lung non-small cell carcinoma, which is characterized by the absence of evidence of squamous differentiation. Additionally, it has an exact synonym, ""non-squamous NSCLC.""",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080522,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thyroid_gland_anaplastic_carcinoma rdfs:subClassOf :thyroid_gland_carcinoma ;
    :has_definition ""A thyroid gland carcinoma that is composed of undifferentiated cells."" ;
    :has_exact_synonym ""anaplastic thyroid carcinoma""@en .

",Anaplastic carcinoma is a type of thyroid gland carcinoma that is defined by being composed of undifferentiated cells. It is also exactly synonymous with anaplastic thyroid carcinoma.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080523,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:adult_onset_leukoencephalopathy_with_axonal_spheroids_and_pigmented_glia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        :autosomal_dominant_disease,
        :leukodystrophy ;
    :has_definition ""A leukodystrophy that is characterized by progressive dementia, apraxia, apathy, impaired balance, parkinsonism, spasticity and epilepsy and has_material_basis_in heterozygous mutation in the CSF1R gene on chromosome 5q32."" ;
    :has_exact_synonym ""hereditary diffuse leukoencephalopathy with spheroids""@en .

","Adult onset leukoencephalopathy with axonal spheroids and pigmented glia is a type of autosomal dominant disease, a type of leukodystrophy, and a condition that has a material basis in some autosomal dominant inheritance and whose existence starts during adult onset. It is characterized by progressive dementia, apraxia, apathy, impaired balance, parkinsonism, spasticity, and epilepsy, with its material basis in a heterozygous mutation in the CSF1R gene on chromosome 5q32. This condition is also exactly synonymous with hereditary diffuse leukoencephalopathy with spheroids.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080524,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thyroid_gland_adenocarcinoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :derives_from ;
            owl:someValuesFrom [ owl:intersectionOf [ rdf:first :epithelial_cell ;
                            rdf:rest [ rdf:first [ a owl:Restriction ;
                                            owl:onProperty :has_origin ;
                                            owl:someValuesFrom :gland ] ;
                                    rdf:rest :nil ] ] ] ],
        :adenocarcinoma,
        :thyroid_gland_carcinoma ;
    :has_definition ""A thyroid gland carcinoma that derives_from epithelial cells of glandular origin."" .

","Thyroid gland adenocarcinoma is a type of adenocarcinoma and also a type of thyroid gland carcinoma. It falls under the category of conditions that at least derive from an entity that intersects with epithelial cells and entities that have an origin in some gland. Additionally, thyroid gland adenocarcinoma is defined as a thyroid gland carcinoma that derives from epithelial cells of glandular origin.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080525,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:differentiated_thyroid_gland_carcinoma rdfs:subClassOf :thyroid_gland_adenocarcinoma ;
    :has_definition ""A thyroid gland adenocarcinoma characterized by extensive evidence of follicular cell differentiation."" .

","Differentiated thyroid gland carcinoma is a type of thyroid gland adenocarcinoma, which is characterized by extensive evidence of follicular cell differentiation.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080526,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bronchiectasis_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :bronchiectasis ;
    :has_definition ""A bronchiectasis that has_material_basis_in mutation in the gene encoding the beta subunit of the epithelial sodium channel on chromosome 16p12."" .

","Bronchiectasis 1 is a type of bronchiectasis and an autosomal dominant disease, which is a condition that at least has a material basis in some form of autosomal dominant inheritance. It is defined as a bronchiectasis that has its material basis in a mutation in the gene encoding the beta subunit of the epithelial sodium channel on chromosome 16p12.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080527,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bronchiectasis_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :bronchiectasis ;
    :has_definition ""A bronchiectasis that has_material_basis_in mutation in the gene encoding the alpha subunit of the epithelial sodium channel."" .

","Bronchiectasis 2 is a type of bronchiectasis that is characterized as an autosomal dominant disease. It falls under the category of conditions that have a material basis in autosomal dominant inheritance. Furthermore, bronchiectasis 2 is defined as a form of bronchiectasis that has its material basis in a mutation in the gene encoding the alpha subunit of the epithelial sodium channel.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080528,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bronchiectasis_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :bronchiectasis ;
    :has_definition ""A bronchiectasis that has_material_basis_in mutation in the gene encoding the gamma subunit of the epithelial sodium channel."" .

",Bronchiectasis 3 is a type of bronchiectasis and an autosomal dominant disease that at least has a material basis in some autosomal dominant inheritance. It is defined as a bronchiectasis that has a material basis in mutation in the gene encoding the gamma subunit of the epithelial sodium channel.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080530,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:granular_corneal_dystrophy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :granular_corneal_dystrophy ;
    :has_definition ""A granular corneal dystrophy that is characterized by recurrent erosions and gray crumb-like opacification located_in the cornea, proteinaceous rock candy-like deposits in the anterior stroma and subepithelium, and progressive vision loss later in life as deposits move into the central vision, and has_material_basis_in autosomal dominant inheritance of heterozygous mutation of transforming growth factor beta-induced gene located in chromosome 5q31.1, which encodes keratoepithelin. Abnormalities lead to increased protein deposition and disruption of the corneal surface."" ;
    :has_exact_synonym ""corneal dystrophy, Groenouw type I""@en .

","Granular Corneal Dystrophy 1 is a specific type of Granular Corneal Dystrophy, which is also known by its exact synonym, Corneal Dystrophy, Groenouw Type I. This condition is characterized by recurrent erosions and gray crumb-like opacification located in the cornea, along with proteinaceous rock candy-like deposits in the anterior stroma and subepithelium. It leads to progressive vision loss later in life as the deposits move into the central vision. The material basis for Granular Corneal Dystrophy 1 lies in autosomal dominant inheritance, particularly due to a heterozygous mutation of the transforming growth factor beta-induced gene located on chromosome 5q31.1, which encodes keratoepithelin. This genetic abnormality leads to increased protein deposition and disruption of the corneal surface.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080531,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:dedifferentiated_liposarcoma rdfs:subClassOf :liposarcoma ;
    :has_definition ""A liposarcoma that is characterized as a high-grade tumor that occurs when a lower-grade tumor changes and creates new high-grade cells."" .

",Dedifferentiated liposarcoma is a type of liposarcoma that is defined as a high-grade tumor characterized by the transformation of a lower-grade tumor into a new high-grade tumor through the creation of new high-grade cells.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080532,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:smarca4_deficient_sarcoma_of_thorax rdfs:subClassOf :thoracic_cancer ;
    :has_definition ""A thoracic cancer that is characterized by poorly differentiated neoplasms with epithelioid/rhabdoid cells organized in a solid pattern and has_material_basis_in alterations in the switch/sucrose nonfermenting complex, also known in humans as BRG1-associated factors (BAF chromatin remodeling complex)."" ;
    :has_exact_synonym ""SMARCA4-DTS""@en .

","Smarca4 deficient sarcoma of thorax is a type of thoracic cancer, which has an exact synonym SMARCA4-DTS. It is defined as a thoracic cancer characterized by poorly differentiated neoplasms with epithelioid/rhabdoid cells organized in a solid pattern, and its material basis lies in alterations in the switch/sucrose nonfermenting complex, also known in humans as BRG1-associated factors (BAF chromatin remodeling complex).",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080533,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:carney_stratakis_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by the presence of multicentric paragangliomas and multifocal gastrointestinal stromal sarcoma tumors."" .

",Carney Stratakis syndrome is a type of autosomal dominant disease and a syndrome that has its material basis in some autosomal dominant inheritance. It is defined as a syndrome characterized by the presence of multicentric paragangliomas and multifocal gastrointestinal stromal sarcoma tumors.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080534,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:myxofibrosarcoma rdfs:subClassOf :sarcoma ;
    :has_definition ""A sarcoma that arises from the soft tissue and is characterized by the presence of spindle-shaped cells, cellular pleomorphism, thin-walled blood vessels, fibrous septa, and myxoid stroma."" ;
    :has_exact_synonym ""fibromyxoid sarcoma""@en .

","Myxofibrosarcoma is a type of sarcoma that is defined as a sarcoma arising from the soft tissue, characterized by the presence of spindle-shaped cells, cellular pleomorphism, thin-walled blood vessels, fibrous septa, and myxoid stroma. Additionally, myxofibrosarcoma has an exact synonym, fibromyxoid sarcoma.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080535,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypermanganesemia_with_dystonia rdfs:subClassOf :metal_metabolism_disorder ;
    :has_definition ""A metal metabolism disorder that is characterized by involuntary, sustained muscle contractions (dystonia) and other uncontrolled movements resulting from excessive accumulation of manganese."" .

","Hypermanganesemia with dystonia is a type of metal metabolism disorder, characterized by involuntary, sustained muscle contractions (dystonia) and other uncontrolled movements resulting from excessive accumulation of manganese.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080536,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypermanganesemia_with_dystonia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :hepatic_dysfunction ],
        :hypermanganesemia_with_dystonia ;
    :has_definition ""A hypermanganesemia with dystonia that is characterized by increased serum manganese, motor neurodegeneration with extrapyramidal features, polycythemia, and hepatic dysfunction and has_material_basis_in homozygous mutation in the SLC30A10 gene on chromosome 1q41."" .

","Hypermanganesemia with dystonia 1 is a specific type of hypermanganesemia with dystonia, which is characterized by increased serum manganese, motor neurodegeneration with extrapyramidal features, polycythemia, and hepatic dysfunction. This condition is caused by a homozygous mutation in the SLC30A10 gene located on chromosome 1q41. Additionally, hypermanganesemia with dystonia 1 is classified as a condition that includes at least some hepatic dysfunction as a symptom.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080537,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypermanganesemia_with_dystonia_2 rdfs:subClassOf :hypermanganesemia_with_dystonia ;
    :has_definition ""A hypermanganesemia with dystonia that is characterized predominantly by loss of motor milestones in the first years of life and has_material_basis_in homozygous mutation in the SLC39A14 gene on chromosome 8p21."" .

","Hypermanganesemia with dystonia 2 is a type of hypermanganesemia with dystonia, which is defined as a hypermanganesemia with dystonia predominantly characterized by the loss of motor milestones in the first years of life. It has its material basis in a homozygous mutation in the SLC39A14 gene located on chromosome 8p21.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080538,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:sweeney_cox_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by striking facial dysostosis, including hypertelorism, deficiencies of the eyelids and facial bones, cleft palate/velopharyngeal insufficiency, and low-set cupped ears and has_material_basis_in heterozygous mutation in the TWIST1 gene on chromosome 7p21."" .

","Sweeney Cox Syndrome is a type of syndrome and an autosomal dominant disease that notably involves a material basis in autosomal dominant inheritance. It is defined as a syndrome characterized by distinctive facial dysostosis, which includes hypertelorism, deficiencies of the eyelids and facial bones, cleft palate/velopharyngeal insufficiency, and low-set cupped ears. This condition has its material basis in a heterozygous mutation in the TWIST1 gene located on chromosome 7p21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080539,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peho_syndrome rdfs:subClassOf :brain_disease ;
    :has_definition ""A brain disease that is characterized by extreme cerebellar atrophy due to almost total granule neuron loss."" .

",Peho syndrome is a type of brain disease characterized by extreme cerebellar atrophy due to almost total granule neuron loss.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080540,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:galactosialidosis rdfs:subClassOf :lysosomal_storage_disease ;
    :has_definition ""A lysosomal storage disease that is characterized by combined deficiency of beta-galactosidase and neuraminidase that has_material_basis_in homozygous or compound heterozygous mutation in the CTSA gene on chromosome 20q13."" .

",Galactosialidosis is a type of lysosomal storage disease characterized by a combined deficiency of beta-galactosidase and neuraminidase. This condition has a material basis in homozygous or compound heterozygous mutation in the CTSA gene located on chromosome 20q13.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080541,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperprolinemia rdfs:subClassOf :amino_acid_metabolic_disorder ;
    :has_definition ""An amno acid metabolic disorder that is characterized by the excess of proline in the blood."" .

","Hyperprolinemia is a type of amino acid metabolic disorder, defined as an amino acid metabolic disorder characterized by the excess of proline in the blood.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080542,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperprolinemia_type_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hyperprolinemia ;
    :has_definition ""A hyperprolinemia that has_material_basis_in homozygous or compound heterozygous mutation in the proline dehydrogenase gene on chromosome 22q11."" ;
    :has_exact_synonym ""hyperprolinemia type I""@en .

","Hyperprolinemia type 1 is a type of autosomal recessive disease and a specific form of hyperprolinemia, which inherently has a material basis in autosomal recessive inheritance. It is defined as a hyperprolinemia that arises from homozygous or compound heterozygous mutations in the proline dehydrogenase gene located on chromosome 22q11. Additionally, hyperprolinemia type 1 is exactly synonymous with hyperprolinemia type I.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080543,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperprolinemia_type_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hyperprolinemia ;
    :has_definition ""A hyperprolinemia that has_material_basis_in homozygous or compound heterozygous mutation in the pyrroline-5-carboxylate dehydrogenase gene on chromosome 1p36."" ;
    :has_exact_synonym ""hyperprolinemia type II""@en .

","Hyperprolinemia type 2, also known exactly as hyperprolinemia type II, is a type of autosomal recessive disease and a specific form of hyperprolinemia. It is characterized by having a material basis in some form of autosomal recessive inheritance, specifically defined as a hyperprolinemia that arises from homozygous or compound heterozygous mutations in the pyrroline-5-carboxylate dehydrogenase gene located on chromosome 1p36.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080544,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyper_igm_syndrome rdfs:subClassOf :hyperimmunoglobulin_syndrome ;
    :has_definition ""A hyperimmunoglobin syndrome that is characterized by an immune system that fails to produce normal levels of the antibodies IgA, IgG and IgE but can produce normal or elevated levels of IgM."" ;
    :has_exact_match ""ICD10CM:D80.5"",
        ""MESH:D053306"",
        ""NCI:C3990"",
        ""OMIM:PS308230"",
        ""UMLS_CUI:C0272236"" ;
    :has_exact_synonym ""HIGM"",
        ""hyperimmunoglobulin M syndrome"",
        ""immunodeficiency with hyper-IgM""@en .

","Hyper IgM syndrome is a type of hyperimmunoglobulin syndrome characterized by an immune system that fails to produce normal levels of the antibodies IgA, IgG, and IgE but can produce normal or elevated levels of IgM. It is also known by its exact synonyms: HIGM, hyperimmunoglobulin M syndrome, and immunodeficiency with hyper-IgM. Furthermore, Hyper IgM syndrome is precisely matched with several medical coding and classification systems, including ICD10CM:D80.5, MESH:D053306, NCI:C3990, OMIM:PS308230, and UMLS_CUI:C0272236.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0080545,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyper_ige_syndrome rdfs:subClassOf :hyperimmunoglobulin_syndrome ;
    :has_definition ""A hyperimmunoglobulin syndrome that is characterized by eczema, distinct facial features, a tendency to experience bone fractures and recurrent bacterial infections of the skin and lungs."" ;
    :has_exact_synonym ""hyper immunoglobulin E syndrome""@en .

","Hyper IgE syndrome is a type of hyperimmunoglobulin syndrome that is defined as a hyperimmunoglobulin syndrome characterized by eczema, distinct facial features, a tendency to experience bone fractures, and recurrent bacterial infections of the skin and lungs. It also has the exact synonym hyper immunoglobulin E syndrome.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080546,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:non_alcoholic_fatty_liver rdfs:subClassOf :metabolic_dysfunction_associated_steatotic_liver_disease ;
    :has_definition ""A metabolic dysfunction-associated steatotic liver disease characterized by the absence of inflammation and hepatocyte injury in the form of hepatocyte ballooning."" ;
    :has_exact_synonym ""nonalcoholic fatty liver"",
        ""NAFL""@en .

",Non-alcoholic fatty liver is a type of metabolic dysfunction-associated steatotic liver disease characterized by the absence of inflammation and hepatocyte injury in the form of hepatocyte ballooning. It has the exact synonyms NAFL and nonalcoholic fatty liver.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080547,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:metabolic_dysfunction_associated_steatohepatitis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :liver_inflammation ],
        :metabolic_dysfunction_associated_steatotic_liver_disease ;
    :has_definition ""A metabolic dysfunction-associated steatotic liver disease characterized by the presence of inflammation with hepatocyte injury such as ballooning, with or without fibrosis."" ;
    :has_exact_synonym ""MASH"",
        ""nonalcoholic steatohepatitis"",
        ""NASH""@en,
        ""non-alcoholic steatohepatitis""@en .

","Metabolic Dysfunction Associated Steatohepatitis (MASH), also known as Non-Alcoholic Steatohepatitis (NASH) or Nonalcoholic Steatohepatitis, is a type of Metabolic Dysfunction Associated Steatotic Liver Disease. It is characterized by a metabolic dysfunction-associated steatotic liver disease that includes inflammation with hepatocyte injury such as ballooning, with or without fibrosis. This condition is a subtype of something that at least has liver inflammation as a symptom.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080548,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:noonan_syndrome_with_multiple_lentigines_1 rdfs:subClassOf :noonan_syndrome_with_multiple_lentigines ;
    :has_definition ""A Noonan syndrome with multiple lentigines that has_material_basis_in heterozygous mutation in the PTPN11 gene on chromosome 12q24."" ;
    :has_exact_synonym ""LEOPARD syndrome 1"" .

","Noonan syndrome with multiple lentigines 1 is a type of Noonan syndrome with multiple lentigines, which is defined as a Noonan syndrome with multiple lentigines that has its material basis in a heterozygous mutation in the PTPN11 gene on chromosome 12q24. Additionally, it is exactly synonymous with LEOPARD syndrome 1.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080549,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:noonan_syndrome_with_multiple_lentigines_2 rdfs:subClassOf :noonan_syndrome_with_multiple_lentigines ;
    :has_definition ""A Noonan syndrome with multiple lentigines that has_material_basis_in heterozygous mutation in the RAF1 gene on chromosome 3p25."" ;
    :has_exact_synonym ""LEOPARD syndrome 2"" .

","Noonan Syndrome with Multiple Lentigines 2 is a type of Noonan Syndrome with Multiple Lentigines, which is defined as a Noonan Syndrome with multiple lentigines that has a material basis in a heterozygous mutation in the RAF1 gene on chromosome 3p25. Additionally, Noonan Syndrome with Multiple Lentigines 2 is exactly synonymous with LEOPARD Syndrome 2.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080550,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:noonan_syndrome_with_multiple_lentigines_3 rdfs:subClassOf :noonan_syndrome_with_multiple_lentigines ;
    :has_definition ""A Noonan syndrome with multiple lentigines that has_material_basis_in heterozygous mutation in the BRAF gene on chromosome 7q34."" ;
    :has_exact_synonym ""LEOPARD syndrome 3"" .

","Noonan syndrome with multiple lentigines 3 is a type of Noonan syndrome with multiple lentigines, which is defined as a Noonan syndrome with multiple lentigines that has its material basis in a heterozygous mutation in the BRAF gene located on chromosome 7q34. Additionally, Noonan syndrome with multiple lentigines 3 is exactly synonymous with LEOPARD syndrome 3.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080551,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:naxos_disease rdfs:subClassOf :nonepidermolytic_palmoplantar_keratoderma ;
    :has_definition ""A nonepidermolytic palmoplantar keratoderma that is characterized by palmoplantar keratoderma, woolly hair and arrhythmogenic right ventricular cardiomyopathy and that has_material_basis_in homozygous mutation in the plakoglobin gene on chromosome 17q21."" .

","Naxos disease is a type of nonepidermolytic palmoplantar keratoderma, which is defined as a nonepidermolytic palmoplantar keratoderma characterized by palmoplantar keratoderma, woolly hair, and arrhythmogenic right ventricular cardiomyopathy. It has a material basis in homozygous mutation in the plakoglobin gene on chromosome 17q21.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080552,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by a severe encephalopathy with axial hypotonia, abnormal eye movement, pronounced psychomotor retardation, peripheral neuropathy, cerebellar hypoplasia, and retinitis pigmentosa and has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding phosphomannomutase-2 on chromosome 16p13."" ;
    :has_exact_synonym ""PMM2-congenital disorder of glycosylation""@en,
        ""congenital disorder of glycosylation 1a""@en .

","Congenital Disorder of Glycosylation IA (CDG-IA) is a type of Congenital Disorder of Glycosylation Type I and an autosomal recessive disease. It is characterized by having a material basis in autosomal recessive inheritance and is associated with abnormalities of prenatal development or birth. CDG-IA is defined as a congenital disorder of glycosylation I that is marked by severe encephalopathy with axial hypotonia, abnormal eye movement, pronounced psychomotor retardation, peripheral neuropathy, cerebellar hypoplasia, and retinitis pigmentosa. The disorder has its material basis in homozygous or compound heterozygous mutation in the gene encoding phosphomannomutase-2 on chromosome 16p13. Additionally, CDG-IA is exactly synonymous with PMM2-Congenital Disorder of Glycosylation and Congenital Disorder of Glycosylation 1A.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080553,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_iaa rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by fibroblasts with reduced dolichol profiles and enhanced accumulation of free cholesterol and has_material_basis_in homozygous mutation in the NUS1 gene on chromosome 6q22."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1aa""@en .

","Congenital disorder of glycosylation IAA, also exactly known as congenital disorder of glycosylation 1AA, is a type of congenital disorder of glycosylation type I and an autosomal recessive disease. It is characterized by a condition that fundamentally has an autosomal recessive inheritance and is also based on abnormalities of prenatal development or birth. The disorder is specifically defined by fibroblasts with reduced dolichol profiles and enhanced accumulation of free cholesterol, caused by a homozygous mutation in the NUS1 gene on chromosome 6q22.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080554,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ib rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :bleeding ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :vomiting ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by protein-losing enteropathy, cyclic vomiting, profound hypoglycemia, failure to thrive, liver fibrosis, protein-losing enteropathy with hypoalbuminaemia, life-threatening intestinal bleeding of diffuse origin, protein C and S deficiency, low anti-thrombine III levels and has_material_basis_in compound heterozygous mutation in the gene encoding mannosephosphate isomerase on chromosome 15q24."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1b""@en .

","Congenital Disorder of Glycosylation IB (CDG-Ib) is a subtype of Congenital Disorder of Glycosylation Type I and an autosomal recessive disease. It is characterized by a range of symptoms including bleeding and vomiting, and it has a disease basis in abnormalities of prenatal development or birth. CDG-Ib is specifically defined as a congenital disorder of glycosylation I characterized by features such as protein-losing enteropathy, cyclic vomiting, profound hypoglycemia, failure to thrive, liver fibrosis, hypoalbuminemia, life-threatening intestinal bleeding of diffuse origin, protein C and S deficiency, low anti-thrombin III levels. Its molecular basis is linked to compound heterozygous mutation in the gene encoding mannose phosphate isomerase on chromosome 15q24. Furthermore, CDG-Ib is exactly synonymous with Congenital Disorder of Glycosylation 1b.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0080555,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ic rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by psychomotor retardation with delayed walking and speech, hypotonia, seizures, and sometimes protein-losing enteropathy and has_material_basis_in homozygous or compound heterozygous mutation in the ALG6 gene on chromosome 1p31."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1c""@en .

","Congenital Disorder of Glycosylation IC (CDG-IC) is a subtype of Congenital Disorder of Glycosylation Type I and is also categorized as an autosomal recessive disease. It is characterized by its material basis in autosomal recessive inheritance and is linked to abnormalities in prenatal development or birth. Specifically, CDG-IC is defined by psychomotor retardation with delayed walking and speech, hypotonia, seizures, and sometimes protein-losing enteropathy. This condition is caused by homozygous or compound heterozygous mutation in the ALG6 gene located on chromosome 1p31. Additionally, Congenital Disorder of Glycosylation IC is exactly synonymous with Congenital Disorder of Glycosylation 1C.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080556,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_id rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by severe neurologic involvement associated with dysmorphism and visual impairment and has_material_basis_in homozygous or compound heterozygous mutation in the ALG3 gene on chromosome 3q27."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1d""@en .

","Congenital disorder of glycosylation Id is a type of congenital disorder of glycosylation type I, as well as a type of autosomal recessive disease. It is also a condition that has its material basis in autosomal recessive inheritance and has a disease basis in some abnormality of prenatal development or birth. This disorder is defined as a congenital disorder of glycosylation I that is characterized by severe neurologic involvement associated with dysmorphism and visual impairment, and it has its material basis in homozygous or compound heterozygous mutation in the ALG3 gene on chromosome 3q27. Furthermore, congenital disorder of glycosylation Id has an exact synonym, congenital disorder of glycosylation 1d.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080557,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ie rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by psychomotor delay, seizures, hypotonia, facial dysmorphism and microcephaly and has_material_basis_in homozygous or compound heterozygous mutation in the DPM1 gene on chromosome 20q13."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1e""@en .

","Congenital disorder of glycosylation IE (CDG-IE) is a subtype of congenital disorder of glycosylation type I, as well as a form of autosomal recessive disease. It is classified under conditions that have a material basis in autosomal recessive inheritance and diseases with origins in abnormalities of prenatal development or birth. CDG-IE is specifically defined as a congenital disorder of glycosylation I characterized by psychomotor delay, seizures, hypotonia, facial dysmorphism, and microcephaly, which results from homozygous or compound heterozygous mutations in the DPM1 gene located on chromosome 20q13. Additionally, CDG-IE is exactly synonymous with congenital disorder of glycosylation 1e.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080558,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_if rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by psychomotor delay, seizures, failure to thrive, and cutaneous and ocular anomalies and has_material_basis_in homozygous or compound heterozygous mutation in the MPDU1 gene on chromosome 17p13."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1f""@en .

","Congenital disorder of glycosylation If, also known exactly as congenital disorder of glycosylation 1f, is a type of congenital disorder of glycosylation type I. It falls under the category of autosomal recessive diseases, implying that its material basis is in some form of autosomal recessive inheritance. This condition is linked to abnormalities of prenatal development or birth. It is defined as a congenital disorder of glycosylation I characterized by psychomotor delay, seizures, failure to thrive, and cutaneous and ocular anomalies, with its material basis in homozygous or compound heterozygous mutation in the MPDU1 gene on chromosome 17p13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080559,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ig rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by facial dysmorphism (prominent forehead, large ears, thin upper lip), generalized hypotonia, feeding difficulties, moderate to severe developmental delay, progressive microcephaly, frequent upper respiratory tract infections due to impaired immunity with decreased immunoglobulin levels, and decreased coagulation factors and has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding dolichyl-P-mannose:Man-7-GlcNAc-2-PP-dolichyl-alpha-6-mannosyltransferase on chromosome 22q13."" ;
    :has_exact_synonym ""ALG12-congenital disorder of glycosylation""@en,
        ""congenital disorder of glycosylation 1g""@en .

","Congenital Disorder of Glycosylation Ig (CDG-Ig) is a specific type within the Congenital Disorders of Glycosylation Type I category and is also classified as an autosomal recessive disease. This classification indicates that it has a material basis in autosomal recessive inheritance, which is a type of inheritance pattern that at least has its disease basis in some abnormality of prenatal development or birth. CDG-Ig is characterized by facial dysmorphism (including a prominent forehead, large ears, and a thin upper lip), generalized hypotonia, feeding difficulties, moderate to severe developmental delay, progressive microcephaly, and frequent upper respiratory tract infections due to impaired immunity with decreased immunoglobulin levels, and decreased coagulation factors. The disorder is caused by homozygous or compound heterozygous mutations in the gene encoding dolichyl-P-mannose:Man-7-GlcNAc-2-PP-dolichyl-alpha-6-mannosyltransferase located on chromosome 22q13. Furthermore, CDG-Ig is precisely synonymous with ALG12-Congenital Disorder of Glycosylation and Congenital Disorder of Glycosylation 1g.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080560,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ih rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :seizure ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :vomiting ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :feeding_problem ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :hepatomegaly ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :ascites ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :diarrhea ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :ataxia ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :failure_to_thrive ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :edema ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :left_upper_quadrant_abdominal_rigidity ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by gastrointestinal symptoms (diarrhea, vomiting, feeding problems with failure to thrive, protein-losing enteropathy), edema and ascites (including hydrops fetalis), hepatomegaly, renal tubulopathy, coagulation anomalies due to thrombocytopenia, brain involvement (psychomotor delay, seizures, ataxia), facial dysmorphism (low-set ears and retrognathia), pes equinovarus, and muscular hypotonia and has_material_basis_in heterozygous mutation in the gene encoding dolichyl-P-glucose:Glc-1-Man-9-GlcNAc-2-PP-dolichyl-alpha-3-glucosyltransferase on chromosome 11q14."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1h""@en .

","Congenital Disorder of Glycosylation IH (CDG-IH) is a subtype of Congenital Disorder of Glycosylation Type I and an autosomal recessive disease, which means it has a material basis in autosomal recessive inheritance. This condition is characterized by several symptoms, including ataxia, seizures, hepatomegaly, failure to thrive, left upper quadrant abdominal rigidity, ascites, edema, diarrhea, vomiting, feeding problems, and it also has a basis in abnormalities of prenatal development or birth. Moreover, CDG-IH is defined as a congenital disorder of glycosylation I with a wide range of manifestations such as gastrointestinal symptoms (diarrhea, vomiting, feeding problems with failure to thrive, protein-losing enteropathy), edema and ascites (including hydrops fetalis), hepatomegaly, renal tubulopathy, coagulation anomalies due to thrombocytopenia, brain involvement (psychomotor delay, seizures, ataxia), facial dysmorphism (low-set ears and retrognathia), pes equinovarus, and muscular hypotonia. It is caused by a heterozygous mutation in the gene encoding dolichyl-P-glucose:Glc-1-Man-9-GlcNAc-2-PP-dolichyl-alpha-3-glucosyltransferase on chromosome 11q14. CDG-IH is also known by its exact synonym, Congenital Disorder of Glycosylation 1H.",16,True
doid,http://purl.obolibrary.org/obo/DOID_0080561,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ii rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by iris coloboma, cataract, infantile spasms, developmental delay and abnormal coagulation factors and has_material_basis_in compound heterozygous mutation in the ALG2 gene on chromosome 9q22."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1i""@en .

","Congenital disorder of glycosylation II is a subtype of congenital disorder of glycosylation type I and also falls under the category of autosomal recessive diseases. It is characterized by having a material basis in autosomal recessive inheritance and is associated with abnormalities of prenatal development or birth. Specifically, congenital disorder of glycosylation II is defined as a congenital disorder of glycosylation I that is distinguished by symptoms such as iris coloboma, cataract, infantile spasms, developmental delay, and abnormal coagulation factors, due to compound heterozygous mutation in the ALG2 gene on chromosome 9q22. Additionally, it is exactly synonymous with congenital disorder of glycosylation 1i.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080562,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ij rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by hypotonia, intractable seizures, developmental delay, microcephaly and severe fetal hypokinesia and has_material_basis_in homozygous or compound heterozygous mutation in the DPAGT1 gene, which encodes UDP-GlcNAc:dolichyl-phosphate N-acetylglucosamine phosphotransferase, on chromosome 11q23."" ;
    :has_exact_synonym ""Congenital disorder of glycosylation 1j""@en .

","Congenital Disorder of Glycosylation IJ (CDG-IJ) is a type of Congenital Disorder of Glycosylation Type I and is also classified as an autosomal recessive disease. It is associated with autosomal recessive inheritance and has its disease basis in abnormalities of prenatal development or birth. CDG-IJ is defined as a congenital disorder of glycosylation I characterized by symptoms including hypotonia, intractable seizures, developmental delay, microcephaly, and severe fetal hypokinesia. This condition has its material basis in homozygous or compound heterozygous mutations in the DPAGT1 gene, which is responsible for encoding UDP-GlcNAc:dolichyl-phosphate N-acetylglucosamine phosphotransferase, located on chromosome 11q23. Furthermore, CDG-IJ has an exact synonym: Congenital Disorder of Glycosylation 1j.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080563,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ik rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by severe developmental and psychomotor delay, muscular hypotonia, intractable early-onset seizures, and microcephaly and has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding beta-1,4-mannosyltransferase on chromosome 16p13."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1k""@en .

","Congenital Disorder of Glycosylation IK is a type of Congenital Disorder of Glycosylation Type I and is also classified as an autosomal recessive disease. It is linked to autosomal recessive inheritance and is associated with abnormalities of prenatal development or birth. This disorder, also known exactly as Congenital Disorder of Glycosylation 1K, is defined as a Congenital Disorder of Glycosylation I characterized by severe developmental and psychomotor delay, muscular hypotonia, intractable early-onset seizures, and microcephaly. It has a material basis in homozygous or compound heterozygous mutation in the gene encoding beta-1,4-mannosyltransferase on chromosome 16p13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080564,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_il rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :left_upper_quadrant_abdominal_rigidity ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by progressive microcephaly, hypotonia, developmental delay, drug-resistant infantile epilepsy, and hepatomegaly and has_material_basis_in homozygous mutation in the ALG9 gene on chromosome 11q23."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1l""@en .

","Congenital Disorder of Glycosylation IL is a subtype of Congenital Disorder of Glycosylation Type I and falls under the category of autosomal recessive diseases. This disorder is characterized by having a material basis in autosomal recessive inheritance and manifests symptoms such as left upper quadrant abdominal rigidity. It also has its disease foundation in some abnormalities of prenatal development or birth. Congenital Disorder of Glycosylation IL is specifically defined as a congenital disorder of glycosylation I that is distinguished by progressive microcephaly, hypotonia, developmental delay, drug-resistant infantile epilepsy, and hepatomegaly, all resulting from a homozygous mutation in the ALG9 gene on chromosome 11q23. Additionally, it is precisely synonymous with Congenital Disorder of Glycosylation 1L.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080565,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_im rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by muscular hypotonia and ichthyosis and has_material_basis_in homozygous mutation in the DOLK gene, which encodes the enzyme responsible for the final step of the de novo biosynthesis of dolichol phosphate, on chromosome 9q34."" ;
    :has_exact_synonym ""DOLK-congenital disorder of glycosylation""@en,
        ""congenital disorder of glycosylation 1m""@en,
        ""dolichol kinase deficiency""@en .

","Congenital disorder of glycosylation IM (CDG-IM) is a subtype of congenital disorder of glycosylation type I and is also classified as an autosomal recessive disease. It is defined by a condition that at least has a material basis in autosomal recessive inheritance and involves some abnormality of prenatal development or birth. CDG-IM is characterized by muscular hypotonia and ichthyosis, with its material basis being a homozygous mutation in the DOLK gene. This gene encodes the enzyme responsible for the final step of the de novo biosynthesis of dolichol phosphate, located on chromosome 9q34. Additionally, congenital disorder of glycosylation IM is exactly synonymous with DOLK-congenital disorder of glycosylation, congenital disorder of glycosylation 1m, and dolichol kinase deficiency.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0080566,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_in rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by poorly coordinated suck resulting in difficulty feeding and failure to thrive, myoclonic jerks with hypotonia and brisk reflexes progressing to a seizure disorder, roving eyes, developmental delay, poor to absent visual contact, and sensorineural hearing loss and has_material_basis_in homozygous or compound heterozygous mutation in the RFT1 gene on chromosome 3p21."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1n""@en .

","Congenital disorder of glycosylation I is a subtype of several categories: it is a type of congenital disorder of glycosylation type I, a type of autosomal recessive disease, and it falls under categories that have a material basis in some autosomal recessive inheritance and diseases that have a basis in some abnormality of prenatal development or birth. It is specifically defined as a congenital disorder of glycosylation I characterized by symptoms such as poorly coordinated suck resulting in difficulty feeding and failure to thrive, myoclonic jerks with hypotonia and brisk reflexes progressing to a seizure disorder, roving eyes, developmental delay, poor to absent visual contact, and sensorineural hearing loss. This disorder has a material basis in homozygous or compound heterozygous mutation in the RFT1 gene on chromosome 3p21. Additionally, congenital disorder of glycosylation I is exactly synonymous with congenital disorder of glycosylation 1n.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080567,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ip rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :bleeding ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :vomiting ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by facial dysmorphism (microcephaly, high forehead, low posterior hairline, strabismus), hypotonia, failure to thrive, intractable seizures, developmental delay, persistent vomiting and gastric bleeding and has_material_basis_in homozygous or compound heterozygous mutation in the ALG11 gene on chromosome 13q14."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1p""@en .

","Congenital disorder of glycosylation IP is a type of congenital disorder of glycosylation type I and also falls under the category of autosomal recessive diseases. It is characterized by a material basis in autosomal recessive inheritance and causes symptoms such as bleeding and vomiting. Furthermore, this condition can be based on abnormalities of prenatal development or birth. A specific definition of congenital disorder of glycosylation IP outlines it as a congenital disorder of glycosylation I characterized by facial dysmorphism (including microcephaly, high forehead, low posterior hairline, strabismus), hypotonia, failure to thrive, intractable seizures, developmental delay, persistent vomiting, and gastric bleeding. This disorder is caused by homozygous or compound heterozygous mutations in the ALG11 gene on chromosome 13q14. Additionally, congenital disorder of glycosylation IP is exactly synonymous with congenital disorder of glycosylation 1p.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0080568,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_iq rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :iris_coloboma ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :ataxia ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :visual_impairment ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :hypotonia ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :cerebellar_atrophy ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :congenital_ichthyosiform_erythroderma ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :optic_nerve_hypoplasia ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :aplasia_hypoplasia_of_the_cerebellar_vermis ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :nystagmus ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by a highly variable phenotype typically presenting with severe visual impairment, variable ocular anomalies (such as optic nerve hypoplasia/atrophy, iris and optic nerve coloboma, congenital cataract, glaucoma), intellectual disability, cerebellar abnormalities, nystagmus, hypotonia, ataxia, and/or ichthyosiform skin lesions and has_material_basis_in homozygous or compound heterozygous mutation in the SRD5A3 gene on chromosome 4q12."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1q""@en .

","Congenital disorder of glycosylation IQ is a type of Congenital Disorder of Glycosylation Type I and an autosomal recessive disease. It is characterized by a highly variable phenotype typically presenting with severe visual impairment, variable ocular anomalies such as optic nerve hypoplasia/atrophy, iris and optic nerve coloboma, congenital cataract, glaucoma, intellectual disability, cerebellar abnormalities, nystagmus, hypotonia, ataxia, and/or ichthyosiform skin lesions. This disorder at least has a material basis in some autosomal recessive inheritance and is related to phenotypes like visual impairment, optic nerve hypoplasia, iris coloboma, nystagmus, ataxia, hypotonia, cerebellar atrophy, aplasia hypoplasia of the cerebellar vermis, and congenital ichthyosiform erythroderma. Additionally, it has a basis in some abnormalities of prenatal development or birth. The congenital disorder of glycosylation IQ has its material basis in homozygous or compound heterozygous mutation in the SRD5A3 gene on chromosome 4q12 and has the exact synonym congenital disorder of glycosylation 1q.",15,True
doid,http://purl.obolibrary.org/obo/DOID_0080569,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ir rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :hepatic_dysfunction ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by failure to thrive, developmental delay, hypotonia, strabismus and hepatic dysfunction and has_material_basis_in compound heterozygous mutation in the DDOST gene on chromosome 1p36."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1r""@en .

","Congenital Disorder of Glycosylation IR is classified as a type of Congenital Disorder of Glycosylation Type I, and it also falls under the category of autosomal recessive diseases. This disorder is characterized by having a material basis in autosomal recessive inheritance and is associated with symptoms such as hepatic dysfunction. Furthermore, it has a basis in abnormalities of prenatal development or birth. Congenital Disorder of Glycosylation IR is defined as a Congenital Disorder of Glycosylation I that is marked by failure to thrive, developmental delay, hypotonia, strabismus, and hepatic dysfunction, which is due to compound heterozygous mutation in the DDOST gene on chromosome 1p36. Additionally, Congenital Disorder of Glycosylation IR is exactly synonymous with Congenital Disorder of Glycosylation 1R.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080570,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_it rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by a wide range of clinical manifestations, most commonly presenting with bifid uvula with or without cleft palate at birth, associated with growth delay, hepatopathy with elevated aminotransferase serum levels, myopathy (including exercise-related fatigue, exercise intolerance, muscle weakness), intermittent hypoglycemia, and dilated cardiomyopathy and/or cardiac arrest, due to decreased phosphoglucomutase 1 enzyme activity and has_material_basis_in homozygous or compound heterozygous mutation in the PGM1 gene on chromosome 1p31."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1t""@en .

","The congenital disorder of glycosylation is a type of congenital disorder of glycosylation type I and also falls under the category of autosomal recessive diseases. It is characterized by having a material basis in autosomal recessive inheritance and presents symptoms such as muscle weakness. Additionally, this disorder can have its basis in abnormalities of prenatal development or birth. The congenital disorder of glycosylation is specifically identified as congenital disorder of glycosylation I, which displays a wide range of clinical manifestations. These commonly include a bifid uvula with or without cleft palate at birth, associated with growth delay, hepatopathy with elevated aminotransferase serum levels, myopathy that encompasses exercise-related fatigue, exercise intolerance, and muscle weakness, intermittent hypoglycemia, and potentially dilated cardiomyopathy and/or cardiac arrest. This is due to decreased phosphoglucomutase 1 enzyme activity and is caused by homozygous or compound heterozygous mutation in the PGM1 gene on chromosome 1p31. Moreover, it is exactly synonymous with congenital disorder of glycosylation 1t.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080571,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_iu rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by respiratory distress and severe hypotonia at birth, severe global developmental delay, early-onset intractable seizures, myopathic fascies with craniofacial dysmorphism (trigonocephaly/progressive microcephaly, low anterior hairline, arched eyebrows, hypotelorism, strabismus, small nose, prominent philtrum, thin upper lip, high-arched palate, micrognathia, malocclusion), severe, congenital flexion joint contractures and elevated serum creatine kinase levels and has_material_basis_in homozygous or compound heterozygous mutation in the DPM2 gene on chromosome 9q34."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1u""@en .

","Congenital Disorder of Glycosylation IU, also known precisely as Congenital Disorder of Glycosylation 1U, is a specific subtype of Congenital Disorder of Glycosylation Type I and falls under the broader category of autosomal recessive diseases. This condition is characterized by its material basis in autosomal recessive inheritance and is noted for having its disease basis in abnormalities of prenatal development or birth. It is defined by symptoms such as respiratory distress, severe hypotonia at birth, significant global developmental delays, early-onset intractable seizures, and myopathic fascies with craniofacial dysmorphisms like trigonocephaly/progressive microcephaly, low anterior hairline, arched eyebrows, hypotelorism, strabismus, a small nose, prominent philtrum, thin upper lip, high-arched palate, micrognathia, malocclusion, severe congenital flexion joint contractures, and elevated serum creatine kinase levels. The material basis for this disorder is found in homozygous or compound heterozygous mutations in the DPM2 gene on chromosome 9q34.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080572,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_iw rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by developmental delay, intellectual disability, failure to thrive, hypotonia and seizures and has_material_basis_in homozygous mutation in the STT3A gene on chromosome 11q24."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1w""@en .

","Congenital disorder of glycosylation Iw (CDG-Iw) is a type of congenital disorder of glycosylation type I and an autosomal recessive disease. It is characterized by its material basis in autosomal recessive inheritance and is associated with abnormalities of prenatal development or birth. CDG-Iw is defined as a congenital disorder of glycosylation I characterized by developmental delay, intellectual disability, failure to thrive, hypotonia, and seizures. This condition has its material basis in a homozygous mutation in the STT3A gene on chromosome 11q24. Additionally, congenital disorder of glycosylation Iw is exactly synonymized with congenital disorder of glycosylation 1w.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080573,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_ix rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_i ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by intrauterine growth retardation, microcephaly, failure to thrive, developmental delay, intellectual disability, hypotonia, seizures, optic nerve atrophy and respiratory difficulties and has_material_basis_in homozygous mutation in the STT3B gene on chromosome 3p23."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1x""@en .

","Congenital disorder of glycosylation IX is a type of congenital disorder of glycosylation type I and is also classified as an autosomal recessive disease. It is characterized by having a material basis in autosomal recessive inheritance and is associated with abnormalities of prenatal development or birth. Specifically, congenital disorder of glycosylation IX is defined as a congenital disorder of glycosylation I that is characterized by intrauterine growth retardation, microcephaly, failure to thrive, developmental delay, intellectual disability, hypotonia, seizures, optic nerve atrophy, and respiratory difficulties. This condition has its material basis in a homozygous mutation in the STT3B gene on chromosome 3p23. Additionally, congenital disorder of glycosylation IX is exactly synonymous with congenital disorder of glycosylation 1x.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080574,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_iy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :vomiting ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :congenital_disorder_of_glycosylation_type_i,
        :x_linked_recessive_disease ;
    :has_definition ""A congenital disorder of glycosylation I that is characterized by neurologic abnormalities (global developmental delay in language, social skills and fine and gross motor development, intellectual disability, hypotonia, microcephaly, seizures/epilepsy), facial dysmorphism (deep set eyes, large ears, hypoplastic vermillion of upper lip, large mouth with widely spaced teeth), feeding problems often due to chewing difficulties and aversion to food with certain textures, failure to thrive, gastrointestinal abnormalities (reflux or vomiting) and strabismus and has_material_basis_in hemizygous mutation in the SSR4 gene on chromosome Xq28."" ;
    :has_exact_synonym ""congenital disorder of glycosylation 1y""@en .

","Congenital disorder of glycosylation Iy (CDG-Iy) is a type of congenital disorder of glycosylation type I and is also classified as a type of X-linked recessive disease. It is associated with X-linked recessive inheritance, which manifests through various symptoms including vomiting and has a foundation in abnormalities of prenatal development or birth. CDG-Iy is characterized by neurologic abnormalities such as global developmental delays in language, social skills, and motor development, intellectual disability, hypotonia, microcephaly, and seizures/epilepsy. Facial dysmorphism features include deep-set eyes, large ears, a hypoplastic vermillion of the upper lip, and a large mouth with widely spaced teeth. Patients may also experience feeding problems often due to chewing difficulties and aversion to food with certain textures, failure to thrive, gastrointestinal abnormalities like reflux or vomiting, and strabismus. The disorder stems from a hemizygous mutation in the SSR4 gene on chromosome Xq28. Additionally, congenital disorder of glycosylation Iy is exactly synonymous with congenital disorder of glycosylation 1y.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080575,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:larsen_like_syndrome_b3gat3_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by laxity, dislocations and contractures of the joints, short stature, foot deformities (e.g. clubfeet), broad tips of fingers and toes, short neck, dysmorphic facial features (hypertelorism, downslanting palpebral fissures, upturned nose with anteverted nares, high arched palate) and various cardiac malformations and has_material_basis_in homozygous mutation in the B3GAT3 gene on chromosome 11q12."" ;
    :has_exact_synonym ""Larsen-like syndrome, B3GAT3 type""@en,
        ""multiple joint dislocations-short stature-craniofacial dysmorphism-congenital heart defects syndrome""@en .

","Larsen-like syndrome B3GAT3 type is a type of autosomal recessive disease and syndrome, which also falls under the category of conditions with a material basis in autosomal recessive inheritance. It is defined as a syndrome characterized by joint laxity, dislocations, and contractures, short stature, foot deformities such as clubfeet, broad fingertips and toes, a short neck, dysmorphic facial features including hypertelorism, downslanting palpebral fissures, an upturned nose with anteverted nares, a high arched palate, and various cardiac malformations. This condition is caused by a homozygous mutation in the B3GAT3 gene located on chromosome 11q12. Furthermore, Larsen-like syndrome B3GAT3 type is synonymously known as Larsen-like syndrome, B3GAT3 type, and multiple joint dislocations-short stature-craniofacial dysmorphism-congenital heart defects syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080576,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spondyloepimetaphyseal_dysplasia_genevieve_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spondyloepimetaphyseal_dysplasia ;
    :has_definition ""A spondyloepimetaphyseal dysplasia that is characterized by infantile-onset severe developmental delay and skeletal dysplasia, including short stature, premature carpal ossification, platyspondyly, longitudinal metaphyseal striations, and small epiphyses and has_material_basis_in homozygous or compound heterozygous mutation in the NANS gene on chromosome 9q22."" .

","Spondyloepimetaphyseal dysplasia Genevieve type is a specific kind of spondyloepimetaphyseal dysplasia, which falls under the category of autosomal recessive diseases. This condition is characterized by infantile-onset severe developmental delay and skeletal dysplasia, which includes symptoms such as short stature, premature carpal ossification, platyspondyly, longitudinal metaphyseal striations, and small epiphyses. The genetic basis for this condition is related to homozygous or compound heterozygous mutations in the NANS gene located on chromosome 9q22. Furthermore, it is described as a type of disorder that inherently has a material basis in some form of autosomal recessive inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080577,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:polygenic_disease rdfs:subClassOf :genetic_disease ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :disease ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :polygenic_inheritance ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A genetic disease that is characterized by the additive contributions of variants in multiple genes at different loci."" .

","Polygenic disease, which is a type of genetic disease, is characterized by the additive contributions of variants in multiple genes at different loci. This is defined as a genetic disease that intersects with diseases that at least have a material basis in some form of polygenic inheritance.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080578,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:digenic_disease rdfs:subClassOf :polygenic_disease ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :disease ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :digenic_inheritance ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A polygenic disease that is characterized by expression of a phenotype that requires the presence of pathogenic variants in two different genes."" .

","A digenic disease is characterized as a type of polygenic disease that manifests through the expression of a phenotype, which necessitates the presence of pathogenic variants in two distinct genes. It is defined as a condition that intersects with diseases having at least a material basis in digenic inheritance. This implies that for a disease to be considered digenic, it must involve pathological variations in two separate genes, positioning it within the broader category of polygenic diseases.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080579,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:3_methylcrotonyl_coa_carboxylase_1_deficiency rdfs:subClassOf :3_methylcrotonyl_coa_carboxylase_deficiency ;
    :has_definition ""A 3-Methylcrotonyl-CoA carboxylase deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding the alpha subunit of 3-methylcrotonyl-CoA carboxylase on chromosome 3q27."" .

",3-Methylcrotonyl-CoA carboxylase 1 deficiency is a type of 3-Methylcrotonyl-CoA carboxylase deficiency. It is defined as a 3-Methylcrotonyl-CoA carboxylase deficiency that has a material basis in homozygous or compound heterozygous mutation in the gene encoding the alpha subunit of 3-methylcrotonyl-CoA carboxylase on chromosome 3q27.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080580,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:3_methylcrotonyl_coa_carboxylase_2_deficiency rdfs:subClassOf :3_methylcrotonyl_coa_carboxylase_deficiency ;
    :has_definition ""A 3-Methylcrotonyl-CoA carboxylase deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding the beta subunit of 3-methylcrotonyl-CoA carboxylase on chromosome 5q13."" .

",3-Methylcrotonyl-CoA carboxylase 2 deficiency is a type of 3-Methylcrotonyl-CoA carboxylase deficiency. It is defined as a 3-Methylcrotonyl-CoA carboxylase deficiency that has a material basis in homozygous or compound heterozygous mutation in the gene encoding the beta subunit of 3-methylcrotonyl-CoA carboxylase on chromosome 5q13.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080581,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperekplexia_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hyperekplexia ;
    :has_definition ""A hyperekplexia that is characterized by extreme hypertonia, stiff and rigid appeareance and that has_material_basis_in homozygous mutation in the ATAD1 gene on chromosome 10q23."" ;
    :has_exact_match ""OMIM:618011"" .

","Hyperekplexia 4 is a type of autosomal recessive disease, specifically a form of hyperekplexia that is characterized by extreme hypertonia, a stiff and rigid appearance, and has its material basis in a homozygous mutation in the ATAD1 gene on chromosome 10q23. Moreover, it is a condition that has at least a material basis in some autosomal recessive inheritance. Additionally, Hyperekplexia 4 has an exact match with OMIM:618011.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080582,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypotrichosis_14 rdfs:subClassOf :hypotrichosis ;
    :has_definition ""A hypotrichosis that is characterized by sparse to absent lanugo-like scalp hair, sparse and brittle eyebrows, and sparse eyelashes and body hair and that has_material_basis_in homozygous or compound heterozygous mutation in the LSS gene on chromosome 21q22."" .

","Hypotrichosis 14 is a specific type of hypotrichosis. It is defined by the presence of sparse to absent lanugo-like scalp hair, sparse and brittle eyebrows, sparse eyelashes, and sparse body hair. The material basis for hypotrichosis 14 is found in homozygous or compound heterozygous mutations in the LSS gene located on chromosome 21q22.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080583,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:wolfram_syndrome_mitochondrial_form rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :mitochondrial_inheritance ],
        :wolfram_syndrome ;
    :has_definition ""A Wolfram syndrome that has_material_basis_in mutation in mtDNA."" ;
    :has_exact_synonym ""DIDMOAD, mitochondrial form""@en,
        ""diabetes mellitus AND insipidus with optic atrophy AND deafness mitochondrial form""@en .

","Wolfram Syndrome Mitochondrial Form is a type of Wolfram Syndrome and is also a type of condition that has a material basis in mitochondrial inheritance. This form of Wolfram Syndrome is defined by having a material basis in mutation in mtDNA. Furthermore, it has exact synonyms including DIDMOAD, mitochondrial form, and diabetes mellitus AND insipidus with optic atrophy AND deafness mitochondrial form.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080584,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_wolfram_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :wolfram_syndrome ;
    :has_definition ""A Wolfram syndrome that is characterized by congenital progressive hearing impairment, diabetes mellitus, and optic atrophy and that has_material_basis_in autosomal dominant inheritance of a heterozygous mutation in the WFS1 gene on chromosome 4p16."" .

","Autosomal dominant Wolfram syndrome is a type of Wolfram syndrome and an autosomal dominant disease. It is characterized by congenital progressive hearing impairment, diabetes mellitus, and optic atrophy. This condition is associated with a heterozygous mutation in the WFS1 gene on chromosome 4p16 and has its material basis in some autosomal dominant inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080585,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:van_maldergem_syndrome_1 rdfs:subClassOf :van_maldergem_syndrome ;
    :has_definition ""A Van Maldergem syndrome that has_material_basis_in homozygous mutation in the DCHS1 gene on chromosome 11p15."" .

",Van Maldergem Syndrome 1 is a type of Van Maldergem Syndrome and is defined as a Van Maldergem syndrome that has its material basis in homozygous mutation in the DCHS1 gene located on chromosome 11p15.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080586,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:van_maldergem_syndrome_2 rdfs:subClassOf :van_maldergem_syndrome ;
    :has_definition ""A Van Malergem syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the FAT4 gene on chromosome 4q28."" .

",Van Maldergem Syndrome 2 is a type of Van Maldergem Syndrome and is defined as a Van Maldergem Syndrome that has its material basis in homozygous or compound heterozygous mutation in the FAT4 gene on chromosome 4q28.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080587,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_myasthenic_syndrome_22 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_myasthenic_syndrome ;
    :has_definition ""A congenital myasthenic syndrome characterized by neonatal hypotonia, neonatal feeding problems, and nasal dysarthria and that has_material_basis_in homozygous or compound heterozygous mutation in the PREPL gene on chromosome 2p21."" .

","Congenital myasthenic syndrome 22 is a type of congenital myasthenic syndrome and an autosomal recessive disease. It is a condition that fundamentally has a material basis in autosomal recessive inheritance and is associated with abnormalities of prenatal development or birth. It is defined as a congenital myasthenic syndrome characterized by neonatal hypotonia, neonatal feeding problems, and nasal dysarthria, which arises from homozygous or compound heterozygous mutation in the PREPL gene on chromosome 2p21.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080588,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:agammaglobulinemia_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :agammaglobulinemia,
        :autosomal_dominant_disease ;
    :has_definition ""An agammaglobulinemia that has_material_basis_in heterozygous mutation in the LRRC8A gene on chromosome 9q34."" .

","Agammaglobulinemia 5 is a type of autosomal dominant disease and a type of agammaglobulinemia, which is characterized by having at least a material basis in some autosomal dominant inheritance. It is defined as an agammaglobulinemia that has a material basis in a heterozygous mutation in the LRRC8A gene on chromosome 9q34.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080589,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:klippel_feil_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :klippel_feil_syndrome ;
    :has_definition ""A Klippel-Feil syndrome that has_material_basis_in heterozygous mutation in the GDF6 gene on chromosome 8q22."" .

","Klippel Feil Syndrome 1 is a type of Klippel Feil Syndrome and an autosomal dominant disease, which specifically has a material basis in some autosomal dominant inheritance. It is defined as a Klippel-Feil syndrome that has a material basis in a heterozygous mutation in the GDF6 gene on chromosome 8q22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080590,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:klippel_feil_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :klippel_feil_syndrome ;
    :has_definition ""A Klippel-Feil syndrome that has_material_basis_in homozygous mutation in the MEOX1 gene on chromosome 17q21."" .

","Klippel Feil Syndrome 2 is a type of Klippel Feil Syndrome and an autosomal recessive disease. It is a type of condition that at least has a material basis in some autosomal recessive inheritance. Specifically, it is defined as a Klippel-Feil Syndrome that has its material basis in homozygous mutation in the MEOX1 gene on chromosome 17q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080591,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:klippel_feil_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :klippel_feil_syndrome ;
    :has_definition ""A Klippel-Feil syndrome that has_material_basis_in heterozygous mutation in the GDF3 gene on chromosome 12p13."" .

",Klippel Feil Syndrome 3 is a type of Klippel Feil Syndrome and an autosomal dominant disease. It is defined as a Klippel-Feil Syndrome that has a material basis in a heterozygous mutation in the GDF3 gene on chromosome 12p13. This syndrome is also a type of condition that at least has a material basis in some autosomal dominant inheritance.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080592,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:klippel_feil_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :klippel_feil_syndrome ;
    :has_definition ""A Klippel-Feil syndrome that has_material_basis_in homozygous mutation in the MYO18B gene on chromosome 22q12."" .

","Klippel Feil Syndrome 4 is a type of Klippel Feil Syndrome and an autosomal recessive disease. It is characterized by a condition that fundamentally relies on some form of autosomal recessive inheritance. Specifically, this syndrome is defined by having a material basis in a homozygous mutation in the MYO18B gene located on chromosome 22q12.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080593,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:orofacial_cleft_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :orofacial_cleft ;
    :has_definition ""An orofacial cleft that has_material_basis_in variation in an enhancer of the IRF6 gene on chromosome 1q32."" .

","Orofacial cleft 6 is a type of orofacial cleft and a type of autosomal dominant disease, which is characterized by having a material basis in some autosomal dominant inheritance. It is defined as an orofacial cleft that has its material basis in variation in an enhancer of the IRF6 gene located on chromosome 1q32.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080594,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyper_ige_recurrent_infection_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hyper_ige_syndrome ;
    :has_definition ""A hyper IgE syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the DOCK8 gene on chromosome 9p24."" .

","Hyper IgE recurrent infection syndrome 2 is a type of autosomal recessive disease and a type of Hyper IgE syndrome. It is characterized by a condition that essentially has a material basis in autosomal recessive inheritance. Additionally, it is defined as a Hyper IgE syndrome that arises from homozygous or compound heterozygous mutation in the DOCK8 gene located on chromosome 9p24.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080595,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyper_ige_recurrent_infection_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hyper_ige_syndrome ;
    :has_definition ""A hyper IgE syndrome that has_material_basis_in homozygous mutation in the ZNF341 gene on chromosome 20q11."" .

","Hyper IgE recurrent infection syndrome 3 is a type of autosomal recessive disease, and it is a subtype of hyper IgE syndrome. It is characterized as something that fundamentally stems from autosomal recessive inheritance. Specifically, the syndrome has a definition as a hyper IgE syndrome that is caused by a homozygous mutation in the ZNF341 gene located on chromosome 20q11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080596,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyper_ige_recurrent_infection_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hyper_ige_syndrome ;
    :has_definition ""A hyper IgE syndrome that has_material_basis_in homozygous mutation in the IL6ST gene on chromosome 5q11."" .

","Hyper IgE recurrent infection syndrome 4 is a type of autosomal recessive disease and a subtype of Hyper IgE syndrome, which inherently involves a material basis in autosomal recessive inheritance. It is defined as a Hyper IgE syndrome that has its material basis in a homozygous mutation in the IL6ST gene located on chromosome 5q11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080597,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:kleefstra_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome that is characterized by developmental delay and intellectual disability, severely limited or absent speech, and weak muscle tone."" .

","Kleefstra syndrome is a type of syndrome defined by developmental delay and intellectual disability, severely limited or absent speech, and weak muscle tone.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080598,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:kleefstra_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :kleefstra_syndrome ;
    :has_definition ""A Kleefstra syndrome that is characterized by delayed psychomotor development, variable intellectual disability, and mild dysmorphic features and has_material_basis_in heterozygous mutation in the KMT2C gene on chromosome 7q36."" .

","Kleefstra syndrome 2 is a type of Kleefstra syndrome and an autosomal dominant disease, which at least has a material basis in some form of autosomal dominant inheritance. It is defined as a Kleefstra syndrome characterized by delayed psychomotor development, variable intellectual disability, and mild dysmorphic features, with its material basis in a heterozygous mutation in the KMT2C gene on chromosome 7q36.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080599,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:coronavirus_infectious_disease rdfs:subClassOf :viral_infectious_disease ;
    :has_definition ""A viral infectious disease that has_material_basis_in Coronavirus."" .

",Coronavirus infectious disease is a type of viral infectious disease and is defined as a viral infectious disease that has a material basis in Coronavirus.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080600,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:covid_19 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :cough ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :dyspnea ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :fever ],
        [ a owl:Restriction ;
            owl:onProperty :transmitted_by ;
            owl:someValuesFrom [ owl:unionOf [ rdf:first :droplet_spread_transmission ;
                            rdf:rest [ rdf:first :airborne_transmission ;
                                    rdf:rest :nil ] ] ] ],
        :coronavirus_infectious_disease ;
    :has_definition ""A Coronavirus infectious disease that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2."" ;
    :has_exact_synonym ""COVID19"",
        ""SARS-CoV-2 infection"",
        ""2019 Novel Coronavirus (2019-nCoV)""@en,
        ""2019-nCoV infection""@en,
        ""Wuhan coronavirus infection""@en,
        ""Wuhan seafood market pneumonia virus infection""@en .

","COVID-19 is a type of coronavirus infectious disease that is transmitted through droplet spread transmission and airborne transmission. It is characterized by symptoms such as fever, cough, and dyspnea (shortness of breath). The disease is defined as a Coronavirus infectious disease characterized by fever, cough, and shortness of breath, and it has a material basis in SARS-CoV-2. COVID-19 is also known by several exact synonyms including 2019 Novel Coronavirus (2019-nCoV), 2019-nCoV infection, COVID19, SARS-CoV-2 infection, Wuhan coronavirus infection, and Wuhan seafood market pneumonia virus infection.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0080601,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:germ_cell_benign_neoplasm rdfs:subClassOf :cell_type_benign_neoplasm ;
    :has_definition ""A benign neoplasm that derives_from germ cells."" .

","A germ cell benign neoplasm is a type of cell type benign neoplasm, which is defined as a benign neoplasm that derives from germ cells.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080602,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:benign_teratoma rdfs:subClassOf :germ_cell_benign_neoplasm ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :benign_neoplasm ;
                    rdf:rest [ rdf:first [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                                                    owl:onProperty :derives_from ;
                                                    owl:someValuesFrom :ectoderm ] ;
                                            rdf:rest [ rdf:first [ a owl:Restriction ;
                                                            owl:onProperty :derives_from ;
                                                            owl:someValuesFrom :endoderm ] ;
                                                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                                                    owl:onProperty :derives_from ;
                                                                    owl:someValuesFrom :mesoderm ] ;
                                                            rdf:rest :nil ] ] ] ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A germ cell benign neoplasm that derives_from mature tissue elements or a limited amount of immature tissue elements."" .

","A benign teratoma is identical to an entity that is both a benign neoplasm and intersects with an entity that is derived from at least some ectoderm, endoderm, and mesoderm. Further, a benign teratoma is classified as a type of germ cell benign neoplasm. Additionally, it is defined as a germ cell benign neoplasm that originates from mature tissue elements or a limited amount of immature tissue elements.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080603,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ankylosing_spondylitis_1 rdfs:subClassOf :ankylosing_spondylitis ;
    :has_definition ""A ankylosing spondylitis that has_material_basis_in variation in the HLA-B27 allele on chromosome 6p21.3."" .

","Ankylosing spondylitis 1 is a type of ankylosing spondylitis, defined as an ankylosing spondylitis that has a material basis in variation in the HLA-B27 allele on chromosome 6p21.3.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080604,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ankylosing_spondylitis_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :ankylosing_spondylitis,
        :autosomal_dominant_disease ;
    :has_definition ""A ankylosing spondylitis that has_material_basis_in variation in the HLA-B27 allele on chromosome 9q31-q34."" .

",Ankylosing spondylitis 2 is a type of ankylosing spondylitis and is categorized as an autosomal dominant disease. It is defined by a specific form of ankylosing spondylitis that has a material basis in variation in the HLA-B27 allele located on chromosome 9q31-q34. This type of ankylosing spondylitis is also characterized as a condition that necessarily has a material basis in some form of autosomal dominant inheritance.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080605,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ankylosing_spondylitis_3 rdfs:subClassOf :ankylosing_spondylitis ;
    :has_definition ""A ankylosing spondylitis that has_material_basis_in variation in the HLA-B allele on chromosome 2q36.1-q36.3."" .

",Ankylosing spondylitis 3 is a type of ankylosing spondylitis which is defined as an ankylosing spondylitis that has a material basis in variation in the HLA-B allele on chromosome 2q36.1-q36.3.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080606,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anterior_segment_dysgenesis_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :anterior_segment_dysgenesis,
        :autosomal_dominant_disease ;
    :has_definition ""An anterior segment dysgenesis that has_material_basis_in heterozygous mutation in the PITX3 gene on chromosome 10q24."" .

","Anterior segment dysgenesis 1 is a type of autosomal dominant disease, and it is also a type of anterior segment dysgenesis. This condition is characterized by having at least a material basis in some autosomal dominant inheritance. Specifically, anterior segment dysgenesis 1 is defined as an anterior segment dysgenesis that has its material basis in a heterozygous mutation in the PITX3 gene located on chromosome 10q24.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080607,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anterior_segment_dysgenesis_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :anterior_segment_dysgenesis,
        :autosomal_recessive_disease ;
    :has_definition ""An anterior segment dysgenesis that has_material_basis_in homozygous, compound heterozygous, or heterozygous mutation in the FOXE3 gene on chromosome 1p33."" .

","Anterior segment dysgenesis 2 is a type of anterior segment dysgenesis and an autosomal recessive disease. It is defined as an anterior segment dysgenesis that has a material basis in homozygous, compound heterozygous, or heterozygous mutation in the FOXE3 gene on chromosome 1p33. This condition is also characterized by having a material basis in some form of autosomal recessive inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080608,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anterior_segment_dysgenesis_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :anterior_segment_dysgenesis,
        :autosomal_dominant_disease ;
    :has_definition ""An anterior segment dysgenesis that has_material_basis_in heterozygous mutation in the FOXC1 gene on chromosome 6p25."" .

","Anterior segment dysgenesis 3 is a type of autosomal dominant disease and a type of anterior segment dysgenesis, characterized by having a material basis in autosomal dominant inheritance. It is defined as an anterior segment dysgenesis that has its material basis in heterozygous mutation in the FOXC1 gene on chromosome 6p25.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080609,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anterior_segment_dysgenesis_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :anterior_segment_dysgenesis,
        :autosomal_dominant_disease ;
    :has_definition ""An anterior segment dysgenesis that has_material_basis_in heterozygous mutation in the PITX2 gene on chromosome 4q25."" .

","Anterior segment dysgenesis 4 is a type of autosomal dominant disease and also a type of anterior segment dysgenesis, indicating it is something that at least has a material basis in autosomal dominant inheritance. It is defined as an anterior segment dysgenesis that has its material basis in heterozygous mutation in the PITX2 gene on chromosome 4q25.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080610,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anterior_segment_dysgenesis_5 rdfs:subClassOf :anterior_segment_dysgenesis ;
    :has_definition ""An anterior segment dysgenesis that has_material_basis_in heterozygous mutation in the PAX6 gene on chromosome 11p13."" .

","Anterior segment dysgenesis 5 is a type of anterior segment dysgenesis, defined as an anterior segment dysgenesis that has its material basis in a heterozygous mutation in the PAX6 gene located on chromosome 11p13.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080611,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anterior_segment_dysgenesis_6 rdfs:subClassOf :anterior_segment_dysgenesis ;
    :has_definition ""An anterior segment dysgenesis that has_material_basis_in compound heterozygous mutation in the CYP1B1 gene on chromosome 2p22."" .

",Anterior segment dysgenesis 6 is a type of anterior segment dysgenesis and is defined as an anterior segment dysgenesis that has its material basis in compound heterozygous mutation in the CYP1B1 gene on chromosome 2p22.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080612,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anterior_segment_dysgenesis_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :anterior_segment_dysgenesis,
        :autosomal_recessive_disease ;
    :has_definition ""An anterior segment dysgenesis that has_material_basis_in homozygous or compound heterozygous mutation in the PXDN gene on chromosome 2p25."" .

","Anterior segment dysgenesis 7 is a type of anterior segment dysgenesis and an autosomal recessive disease, which specifically involves a material basis in autosomal recessive inheritance. It is defined as an anterior segment dysgenesis that is caused by homozygous or compound heterozygous mutations in the PXDN gene on chromosome 2p25.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080613,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anterior_segment_dysgenesis_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :anterior_segment_dysgenesis,
        :autosomal_recessive_disease ;
    :has_definition ""An anterior segment dysgenesis that has_material_basis_in homozygous or compound heterozygous mutation in the CPAMD8 gene on chromosome 19p13."" .

","Anterior segment dysgenesis 8 is a type of anterior segment dysgenesis and an autosomal recessive disease. It is characterized by a condition that has a material basis in autosomal recessive inheritance. Specifically, it is defined as an anterior segment dysgenesis that results from homozygous or compound heterozygous mutations in the CPAMD8 gene located on chromosome 19p13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080614,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oculocutaneous_albinism_type_vi rdfs:subClassOf :oculocutaneous_albinism ;
    :has_definition ""An oculocutaneous albinism that has_material_basis_in an autosomal recessive null mutation of the SLC24A5 gene on chromosome 15q21.1."" .

",Oculocutaneous albinism type VI is a type of oculocutaneous albinism. It is defined as an oculocutaneous albinism that has a material basis in an autosomal recessive null mutation of the SLC24A5 gene on chromosome 15q21.1.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080615,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nephroma rdfs:subClassOf :kidney_benign_neoplasm,
        :kidney_cortex_disease ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :benign_neoplasm ;
                    rdf:rest [ rdf:first [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                                                    owl:onProperty :disease_has_location ;
                                                    owl:someValuesFrom :cortex ] ;
                                            rdf:rest [ rdf:first [ a owl:Restriction ;
                                                            owl:onProperty :disease_has_location ;
                                                            owl:someValuesFrom :kidney ] ;
                                                    rdf:rest :nil ] ] ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A kidney benign neoplasm that is located_in the kidney cortex."" ;
    :has_exact_synonym ""benign nephroma"" .

","Nephroma is defined as a benign neoplasm located in the kidney cortex, which is an intersection of benign neoplasms and diseases that have their location in both the cortex and the kidney. It is a type of kidney cortex disease and also a type of kidney benign neoplasm. Additionally, nephroma is precisely referred to as a benign nephroma.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080616,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:kidney_cortex_disease rdfs:subClassOf :kidney_disease ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :disease ;
                    rdf:rest [ rdf:first [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                                                    owl:onProperty :disease_has_location ;
                                                    owl:someValuesFrom :cortex ] ;
                                            rdf:rest [ rdf:first [ a owl:Restriction ;
                                                            owl:onProperty :disease_has_location ;
                                                            owl:someValuesFrom :kidney ] ;
                                                    rdf:rest :nil ] ] ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A kidney disease that is located_in the kidney cortex."" .

","Kidney cortex disease is equivalent to a condition that is both a disease and intersects with conditions that are diseases located in the cortex and diseases located in the kidney. Furthermore, kidney cortex disease is classified as a type of kidney disease. It is defined as a kidney disease that is located in the kidney cortex.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080617,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lymph_node_benign_neoplasm rdfs:subClassOf :immune_system_organ_benign_neoplasm,
        :lymph_node_disease ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :benign_neoplasm ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :disease_has_location ;
                                    owl:someValuesFrom :lymph_node ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""An immune system organ benign neoplasm that is located_in the lymph nodes."" .

","Lymph node benign neoplasm is defined as an immune system organ benign neoplasm that is located in the lymph nodes. It is the same as something that is both a benign neoplasm and a disease located in at least some lymph nodes. Additionally, it is a type of immune system organ benign neoplasm and also a type of lymph node disease.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080618,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lymph_node_carcinoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :derives_from ;
            owl:someValuesFrom :epithelial_cell ],
        :carcinoma,
        :lymph_node_cancer ;
    :has_definition ""A lymph node cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells."" .

","Lymph node carcinoma is a type of lymph node cancer and a type of carcinoma, which is something that at least derives from some epithelial cell. It is defined as a lymph node cancer that has a material basis in abnormally proliferating cells which derive from epithelial cells.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080619,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:auditory_system_benign_neoplasm rdfs:subClassOf :auditory_system_disease,
        :sensory_organ_benign_neoplasm ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :benign_neoplasm ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :disease_has_location ;
                                    owl:someValuesFrom :auditory_system ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A sensory system benign neoplasm that is located in the auditory system."" .

","Auditory system benign neoplasm is the same as something that is an intersection of a benign neoplasm and something that is at least a disease located in the auditory system. It is a type of sensory organ benign neoplasm and also a type of auditory system disease. Additionally, an auditory system benign neoplasm is defined as a sensory system benign neoplasm that is located in the auditory system.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080620,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_glucocorticoid_deficiency rdfs:subClassOf :adrenal_gland_disease ;
    :has_definition ""An adrenal cortex disease that is characterized by insufficent production of glucocorticoids."" .

",Familial glucocorticoid deficiency is a type of adrenal gland disease and it is defined as an adrenal cortex disease characterized by insufficient production of glucocorticoids.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080621,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:glucocorticoid_deficiency_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :familial_glucocorticoid_deficiency ;
    :has_definition ""A familial glucocorticoid deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding melanocortin-2 receptor, which is also referred to as adrenocorticotropin receptor, on chromosome 18p11."" .

","Glucocorticoid Deficiency 1 is a type of autosomal recessive disease and familial glucocorticoid deficiency. It is characterized by a material basis in autosomal recessive inheritance. Specifically, it is defined as a familial glucocorticoid deficiency that arises from homozygous or compound heterozygous mutations in the gene encoding the melanocortin-2 receptor, also known as the adrenocorticotropin receptor, located on chromosome 18p11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080622,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:peroxisome_biogenesis_disorder_2b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that has_material_basis_in homozygous mutation in the PEX5 gene on chromosome 12p13.3."" .

","Peroxisome biogenesis disorder 2b is a type of peroxisomal biogenesis disorder and an autosomal recessive disease, which essentially means it is a condition that at least has a material basis in autosomal recessive inheritance. It is specifically defined as a peroxisomal biogenesis disorder that has a material basis in homozygous mutation in the PEX5 gene on chromosome 12p13.3.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080623,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:heimler_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :peroxisomal_biogenesis_disorder ;
    :has_broad_synonym ""Deafness-enamel hypoplasia-nail defects syndrome"" ;
    :has_definition ""A peroxisomal biogenesis disorder that is characterized by sensorineural hearing loss, generalised enamel hypoplasia of the permanent dentition with normal primary dentition, and nail defects and has_material_basis_in homozygous or compound heterozygous mutations in the PEX1 gene on chromosome 7q21."" ;
    :has_exact_synonym ""peroxisomal biogenesis disorder 1C"" .

","Heimler syndrome 1 is a type of autosomal recessive disease, peroxisomal biogenesis disorder, and something that at least has a material basis in some autosomal recessive inheritance. It is defined as a peroxisomal biogenesis disorder characterized by sensorineural hearing loss, generalized enamel hypoplasia of the permanent dentition with normal primary dentition, and nail defects. This condition has its material basis in homozygous or compound heterozygous mutations in the PEX1 gene on chromosome 7q21. Furthermore, Heimler syndrome 1 has a broad synonym, Deafness-enamel hypoplasia-nail defects syndrome, and an exact synonym, peroxisomal biogenesis disorder 1C.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080624,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:heimler_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :peroxisomal_biogenesis_disorder ;
    :has_definition ""A peroxisomal biogenesis disorder that is characterized by sensorineural hearing loss, generalised enamel hypoplasia of the permanent dentition with normal primary dentition, and nail defects and has_material_basis_in compound heterozygous mutation in the PEX6 gene on chromosome 6p21."" ;
    :has_exact_synonym ""peroxisomal biogenesis disorder 4C"" .

","Heimler Syndrome 2 is a type of autosomal recessive disease, peroxisomal biogenesis disorder, and something that at least has a material basis in some autosomal recessive inheritance. It is characterized by sensorineural hearing loss, generalized enamel hypoplasia of the permanent dentition with normal primary dentition, and nail defects. This condition is due to compound heterozygous mutation in the PEX6 gene on chromosome 6p21. Furthermore, Heimler Syndrome 2 has an exact synonym, peroxisomal biogenesis disorder 4C.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080625,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:severe_congenital_neutropenia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_dominant_disease,
        :severe_congenital_neutropenia ;
    :has_definition ""A severe congenital neutropenia that has_material_basis_in heterozygous mutation in the neutrophil elastase gene on chromosome 19p13."" .

","Severe congenital neutropenia 1 is identified as a type of severe congenital neutropenia and an autosomal dominant disease, which essentially has its material basis in autosomal dominant inheritance. It is also characterized by conditions that have their basis in some abnormalities of prenatal development or birth. Furthermore, it is defined specifically as a severe congenital neutropenia that results from a heterozygous mutation in the neutrophil elastase gene located on chromosome 19p13.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080626,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:corticosterone_methyloxidase_deficiency_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :adrenal_gland_disease,
        :autosomal_recessive_disease ;
    :has_definition ""An adrenal gland disease that is characterized by excessive amounts of sodium released in the urine, along with insufficient release of potassium in the urine, usually beginning in the first few weeks of life."" ;
    :has_exact_synonym ""aldosterone synthase deficiency"" .

","Corticosterone methyloxidase deficiency 1 is a type of autosomal recessive disease and adrenal gland disease, which also has a material basis in autosomal recessive inheritance. It is defined as an adrenal gland disease that is characterized by excessive amounts of sodium released in the urine, along with insufficient release of potassium in the urine, usually beginning in the first few weeks of life. Additionally, it has an exact synonym, aldosterone synthase deficiency.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080627,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:alopecia_mental_retardation_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome that is characterized by loss of hair on the scalp, eyebrows, eyelashes, axillas and pubic hair, in addition to mild to severe intellectual disability."" .

","Alopecia mental retardation syndrome is a type of syndrome that is characterized by the loss of hair on the scalp, eyebrows, eyelashes, axillas, and pubic hair, in addition to mild to severe intellectual disability.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080628,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:alopecia_mental_retardation_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :alopecia_mental_retardation_syndrome,
        :autosomal_recessive_disease ;
    :has_definition ""An alopecia-mental retardation syndrome that has_material_basis_in homozygous mutation in the AHSG gene on chromosome 3q27."" .

",Alopecia mental retardation syndrome 1 is a type of alopecia mental retardation syndrome and a type of autosomal recessive disease. It is also a type of condition that has a material basis in some form of autosomal recessive inheritance. Alopecia mental retardation syndrome 1 is defined as an alopecia-mental retardation syndrome that has its material basis in a homozygous mutation in the AHSG gene located on chromosome 3q27.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080629,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:alopecia_mental_retardation_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :alopecia_mental_retardation_syndrome,
        :autosomal_recessive_disease ;
    :has_definition ""An alopecia-mental retardation syndrome that has_material_basis_in variation in chromosome 3q26.2-q26.31."" .

","Alopecia mental retardation syndrome 2 is a type of autosomal recessive disease and a subtype of alopecia mental retardation syndrome. It is characterized by a condition that at least has a material basis in some form of autosomal recessive inheritance. Specifically, this syndrome is defined by an alopecia-mental retardation syndrome that has its material basis in variation in chromosome 3q26.2-q26.31.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080630,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma rdfs:subClassOf :b_cell_acute_lymphoblastic_leukemia ;
    :has_definition ""A B-cell acute lymphoblastic leukemia that is characterized by the presence of too many B-cell lymphoblasts in the blood and bone marrow."" ;
    :has_exact_synonym ""B lymphoblastic leukemia/lymphoma"",
        ""B-ALL"",
        ""precursor B lymphoblastic lymphoma/leukemia"" .

","B lymphoblastic leukemia/lymphoma is a type of B-cell acute lymphoblastic leukemia characterized by the presence of too many B-cell lymphoblasts in the blood and bone marrow. It has exact synonyms including B lymphoblastic leukemia/lymphoma, B-ALL, and precursor B lymphoblastic lymphoma/leukemia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080631,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:elsahy_waters_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :ptosis ],
        :syndrome ;
    :has_definition ""A syndrome that is characterized by brachycephaly, facial asymmetry, marked hypertelorism, proptosis, blepharochalasis, midface hypoplasia, broad nose with concave nasal ridge, and prognathism; radicular dentin dysplasia with consequent obliterated pulp chambers, apical translucent cysts, recurrent infections, and early loss of teeth; vertebral fusions, particularly at C2-C3; and moderate mental retardation."" ;
    :has_exact_synonym ""branchioskeletogenital syndrome"" .

","Elsahy-Waters syndrome is a type of syndrome which is also known exactly as branchioskeletogenital syndrome. This syndrome is characterized by a variety of symptoms including brachycephaly, facial asymmetry, marked hypertelorism, proptosis, blepharochalasis, midface hypoplasia, a broad nose with a concave nasal ridge, and prognathism. Additionally, it features radicular dentin dysplasia leading to obliterated pulp chambers, apical translucent cysts, recurrent infections, and early loss of teeth; vertebral fusions, particularly at C2-C3; and moderate mental retardation. Among its symptoms, it at least has ptosis.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080632,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:fazio_londe_disease rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :progressive_bulbar_palsy ;
    :has_definition ""A progressive bulbar palsy that is characterized by motor, sensory and cranial neuronopathy and that has_material_basis_in homozygous mutation in the C20ORF54 gene on chromosome 20p13."" ;
    :has_exact_synonym ""riboflavin transporter deficiency neuronopathy"" .

","Fazio Londe disease is a type of autosomal recessive disease and progressive bulbar palsy, which is something that at least has a material basis in some autosomal recessive inheritance. It is characterized by motor, sensory, and cranial neuronopathy and has its material basis in homozygous mutation in the C20ORF54 gene on chromosome 20p13. Additionally, Fazio Londe disease has an exact synonym: riboflavin transporter deficiency neuronopathy.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080633,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_cardiac_valvular_defect rdfs:subClassOf :physical_disorder ;
    :has_definition ""A physical disorder that has_material_basis_in homozygous or compound heterozygous mutation in the PLD1 gene on chromosome 3q26."" .

",A developmental cardiac valvular defect is a type of physical disorder defined by a material basis in homozygous or compound heterozygous mutation in the PLD1 gene on chromosome 3q26.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080634,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nanophthalmos rdfs:subClassOf :microphthalmia ;
    :has_definition ""A microphthalmia that is characterized by a small eye with a short axial length, severe hyperopia, an elevated lens/eye ratio, and a high incidence of angle-closure glaucoma."" .

","Nanophthalmos is a type of microphthalmia and is defined as a microphthalmia that is characterized by a small eye with a short axial length, severe hyperopia, an elevated lens/eye ratio, and a high incidence of angle-closure glaucoma.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080635,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:optic_disc_anomalies_with_retinal_and_or_macular_dystrophy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :microphthalmia ;
    :has_definition ""A microphthalmia that has_material_basis_in homozygous mutation in the SIX6 gene on chromosome 14q23."" .

","Optic disc anomalies with retinal and/or macular dystrophy represent a condition that is classified as an autosomal recessive disease, a type of microphthalmia, and a condition that at least has a material basis in some form of autosomal recessive inheritance. Additionally, this particular form of microphthalmia is defined by having its material basis in a homozygous mutation in the SIX6 gene located on chromosome 14q23.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080636,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia rdfs:subClassOf :microphthalmia ;
    :has_definition ""A microphthalmia that occurs as part of a syndrome that affects other organs and tissues in the body."" .

","Syndromic microphthalmia is a type of microphthalmia defined as a form of microphthalmia that occurs as part of a syndrome, affecting other organs and tissues in the body.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080637,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:isolated_microphthalmia rdfs:subClassOf :microphthalmia ;
    :has_definition ""A microphthalmia that occurs by itself."" .

","Isolated microphthalmia, which is a type of microphthalmia, is defined as a microphthalmia that occurs by itself.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080638,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_cell_acute_lymphoblastic_leukemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :lymphocyte_of_b_lineage ],
        :acute_lymphoblastic_leukemia,
        :lymphoma ;
    :has_definition ""An acute lymphocytic leukemia characterized by too many B-cell lymphoblasts (immature white blood cells) in the bone marrow and blood."" ;
    :has_exact_synonym ""B acute lymphoblastic leukemia"",
        ""B-cell acute lymphocytic leukemia"" .

","B cell acute lymphoblastic leukemia is a type of lymphoma, a type of acute lymphoblastic leukemia, and a type of condition that at least has a material basis in some lymphocyte of B lineage. It is characterized by too many B-cell lymphoblasts (immature white blood cells) in the bone marrow and blood. Additionally, it has exact synonyms including B acute lymphoblastic leukemia and B-cell acute lymphocytic leukemia.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080639,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bone_sarcoma rdfs:subClassOf :bone_cancer ;
    :has_definition ""A bone cancer that has_material_basis_in abnormally proliferating cells derives from embryonic mesoderm."" .

","Bone sarcoma, a type of bone cancer, is defined as a bone cancer whose material basis is in abnormally proliferating cells derived from embryonic mesoderm.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080640,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gallbladder_benign_neoplasm rdfs:subClassOf :biliary_tract_benign_neoplasm,
        :gallbladder_disease ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :benign_neoplasm ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :disease_has_location ;
                                    owl:someValuesFrom :gallbladder ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A biliary tract benign neoplasm that is located_in the gallbladder."" .

","A gallbladder benign neoplasm is the same as an entity that intersects with being both a benign neoplasm and a disease that is located in the gallbladder. It is a type of biliary tract benign neoplasm and also classified as a type of gallbladder disease. Furthermore, a gallbladder benign neoplasm is defined as a biliary tract benign neoplasm that is located in the gallbladder.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080641,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:tongue_carcinoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :derives_from ;
            owl:someValuesFrom :epithelial_cell ],
        :carcinoma,
        :tongue_cancer ;
    :has_definition ""A tongue cancer that derives_from epithelial cells that cover the surface of the tongue."" .

","Tongue carcinoma is a type of carcinoma and also a type of tongue cancer, which is something that at least derives from epithelial cells. It is defined as a tongue cancer that derives from epithelial cells covering the surface of the tongue.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080642,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:middle_east_respiratory_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :cough ],
        :coronavirus_infectious_disease ;
    :has_definition ""A Coronavirus infectious disease that is characterized by severe respiratory illness, including fever, cough, and shortness of breath and that has_material_basis_in MERS-CoV."" .

","Middle East Respiratory Syndrome (MERS) is a type of coronavirus infectious disease, which is also a type of condition that at least has symptoms including cough. MERS is defined as a coronavirus infectious disease characterized by severe respiratory illness, including fever, cough, and shortness of breath, and it has a material basis in MERS-CoV.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080643,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma_with_bcr_abl1 rdfs:subClassOf :b_lymphoblastic_leukemia_lymphoma ;
    :has_definition ""A B-lymphoblastic leukemia/lymphoma that derives_from B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein."" ;
    :has_exact_synonym ""B-ALL with BCR-ABL1"",
        ""B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1"" .

","B lymphoblastic leukemia/lymphoma with BCR-ABL1 is a type of B lymphoblastic leukemia/lymphoma. It is defined as a B-lymphoblastic leukemia/lymphoma that derives from B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9, resulting in the production of the p190 kd or p210 kd fusion protein. Furthermore, it has exact synonyms: B-ALL with BCR-ABL1 and B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080644,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma_mll_rearranged rdfs:subClassOf :b_lymphoblastic_leukemia_lymphoma ;
    :has_definition ""A B-lymphoblastic leukemia/lymphoma that is characterized by the presence of lymphoblasts that carry a translocation between the KMT2A gene at 11q23.3 and another gene partner resulting in the production of a KMT2A related fusion protein."" ;
    :has_exact_synonym ""B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged"",
        ""B-ALL KMT2A rearranged"",
        ""B-lymphoblastic leukemia/lymphoma KMT2A rearranged"",
        ""B-lymphoblastic leukemia/lymphoma with t(v;11q23.3);KMT2A rearranged"" .

","B lymphoblastic leukemia/lymphoma MLL rearranged is a type of B lymphoblastic leukemia/lymphoma. It is defined as a B-lymphoblastic leukemia/lymphoma characterized by the presence of lymphoblasts that carry a translocation between the KMT2A gene at 11q23.3 and another gene partner, resulting in the production of a KMT2A related fusion protein. This condition is also exactly synonymous with B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged, B-ALL KMT2A rearranged, B-lymphoblastic leukemia/lymphoma KMT2A rearranged, and B-lymphoblastic leukemia/lymphoma with t(v;11q23.3); KMT2A rearranged.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080645,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma_with_etv6_runx1 rdfs:subClassOf :b_lymphoblastic_leukemia_lymphoma ;
    :has_definition ""A B-lymphoblastic leukemia/lymphoma that is characterized by the presence of lymphoblasts that carry a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein."" ;
    :has_exact_synonym ""B-ALL with ETV6-RUNX1"",
        ""B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1"" .

","B lymphoblastic leukemia/lymphoma with ETV6 RUNX1 is a type of B lymphoblastic leukemia/lymphoma. It is defined as a B-lymphoblastic leukemia/lymphoma characterized by the presence of lymphoblasts that carry a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1), resulting in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein. This condition also has exact synonyms, including B-ALL with ETV6-RUNX1 and B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080646,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma_with_hyperdiploidy rdfs:subClassOf :b_lymphoblastic_leukemia_lymphoma ;
    :has_definition ""A B-lymphoblastic leukemia/lymphoma that is composed of B-lymphoblasts which contain more than 50 and usually less than 66 chromosomes."" ;
    :has_exact_synonym ""B-ALL with hyperdiploidy"" .

","B lymphoblastic leukemia/lymphoma with hyperdiploidy is a type of B lymphoblastic leukemia/lymphoma. It is defined as a B-lymphoblastic leukemia/lymphoma that is composed of B-lymphoblasts which contain more than 50 and usually less than 66 chromosomes. Furthermore, it has an exact synonym: B-ALL with hyperdiploidy.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080647,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma_with_hypodiploidy rdfs:subClassOf :b_lymphoblastic_leukemia_lymphoma ;
    :has_definition ""A B-lymphoblastic leukemia/lymphoma that is composed of B-lymphoblasts which contain less than 46 chromosomes."" ;
    :has_exact_synonym ""B-ALL with hypodiploidy"" .

","B lymphoblastic leukemia/lymphoma with hypodiploidy is a type of B lymphoblastic leukemia/lymphoma. It is defined as a B-lymphoblastic leukemia/lymphoma that is composed of B-lymphoblasts which contain less than 46 chromosomes. Moreover, it has the exact synonym B-ALL with hypodiploidy.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080648,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma_with_il3_igh rdfs:subClassOf :b_lymphoblastic_leukemia_lymphoma ;
    :has_definition ""A B-lymphoblastic leukemia/lymphoma that is characterized by the presence of lymphoblasts that carry a translocation between the IL3 gene on chromosome 5 and the IGH locus on chromosome 14, (q31.1;q32.3)."" ;
    :has_exact_synonym ""B-ALL with IL3-IGH"",
        ""B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH"" .

","B lymphoblastic leukemia/lymphoma with IL3 IGH represents a form of B-lymphoblastic leukemia/lymphoma. It is defined as a B-lymphoblastic leukemia/lymphoma characterized by the presence of lymphoblasts that exhibit a translocation between the IL3 gene on chromosome 5 and the IGH locus on chromosome 14, specifically at (q31.1;q32.3). Furthermore, it is exactly synonymous with B-ALL with IL3-IGH and B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080649,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma_with_tcf3_pbx1 rdfs:subClassOf :b_lymphoblastic_leukemia_lymphoma ;
    :has_definition ""A B-lymphoblastic leukemia/lymphoma that is characterized by the presence of lymphoblasts that carry a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1."" ;
    :has_exact_synonym ""B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)"",
        ""B-ALL with TCF3-PBX1"",
        ""B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1"" .

","B lymphoblastic leukemia/lymphoma with TCF3 PBX1 is a type of B lymphoblastic leukemia/lymphoma. It is defined as a B-lymphoblastic leukemia/lymphoma characterized by the presence of lymphoblasts that carry a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1. This condition has several exact synonyms, including B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1), B-ALL with TCF3-PBX1, and B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080650,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma_bcr_abl1_like rdfs:subClassOf :b_lymphoblastic_leukemia_lymphoma ;
    :has_definition ""A B-lymphoblastic leukemia/lymphoma that has a gene expression profile similar to that of B-ALL with t(9;22)(q34.1;q11.2) BCR-ABL1, but lacks that gene fusion."" ;
    :has_exact_synonym ""B lymphoblastic leukemia/lymphoma, BCR-ABL1-like"",
        ""B-ALL BCR-ABL1–like"" .

","B lymphoblastic leukemia/lymphoma BCR-ABL1-like is a type of B lymphoblastic leukemia/lymphoma. It is defined as a B-lymphoblastic leukemia/lymphoma that has a gene expression profile similar to that of B-ALL with t(9;22)(q34.1;q11.2) BCR-ABL1 but lacks that gene fusion. Additionally, it has exact synonyms including ""B lymphoblastic leukemia/lymphoma, BCR-ABL1-like"" and ""B-ALL BCR-ABL1–like.""",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080651,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:b_lymphoblastic_leukemia_lymphoma_with_iamp21 rdfs:subClassOf :b_lymphoblastic_leukemia_lymphoma ;
    :has_definition ""A B-lymphoblastic leukemia/lymphoma that is characterized by amplification of a portion of chromosome 21."" ;
    :has_exact_synonym ""B-ALL with iAMP21"",
        ""Intrachromosomal amplification of chromosome 21 (iAMP21)"" .

","B lymphoblastic leukemia/lymphoma with iAMP21 is a type of B lymphoblastic leukemia/lymphoma. It is defined as a B-lymphoblastic leukemia/lymphoma characterized by the amplification of a portion of chromosome 21. Additionally, this condition has exact synonyms, which include B-ALL with iAMP21 and Intrachromosomal amplification of chromosome 21 (iAMP21).",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080652,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:calcium_oxalate_nephrolithiasis rdfs:subClassOf :nephrolithiasis ;
    :has_definition ""A nephrolithiasis that is characterized by characterized by stones composed of calcium oxalate and that has_material_basis_in compound heterozygous mutation in the SLC26A1 gene on chromosome 4p16."" .

",Calcium oxalate nephrolithiasis is a type of nephrolithiasis that is defined as a nephrolithiasis characterized by stones composed of calcium oxalate. This condition has a material basis in a compound heterozygous mutation in the SLC26A1 gene on chromosome 4p16.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080653,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:urolithiasis rdfs:subClassOf :urinary_system_disease ;
    :has_definition ""A urinary system disease that is characterized by the formation of stony concretions in the bladder or urinary tract."" .

","Urolithiasis is a type of urinary system disease, which is defined as a urinary system disease characterized by the formation of stony concretions in the bladder or urinary tract.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080654,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:uric_acid_urolithiasis rdfs:subClassOf :urolithiasis ;
    :has_definition ""An urolithiasis in which the composition of the stones is predominantly urate."" .

",Uric acid urolithiasis is a type of urolithiasis that is defined by the composition of the stones being predominantly urate.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080655,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypophosphatemic_nephrolithiasis_osteoporosis rdfs:subClassOf :kidney_disease ;
    :has_definition """"""A kidney disease that is characterized by formation of renal calcium
stones or bone demineralization."""""" .

",Hypophosphatemic nephrolithiasis osteoporosis is a type of kidney disease characterized by the formation of renal calcium stones or bone demineralization.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080656,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:45_x_46_xy_mixed_gonadal_dysgenesis rdfs:subClassOf :mixed_gonadal_dysgenesis ;
    :has_definition ""A mixed gonadal dysgenesis that is characterized by asymmetrical gonadal development in an individual with mosaic karyotype 45,X/46,XY."" .

","45 x 46 XY mixed gonadal dysgenesis is a type of mixed gonadal dysgenesis. It is defined as a mixed gonadal dysgenesis characterized by asymmetrical gonadal development in an individual with a mosaic karyotype of 45,X/46,XY.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080661,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nonsyndromic_aplasia_cutis_congenita rdfs:subClassOf :skin_disease ;
    :has_definition ""A skin disease characterized by localized areas of missing skin that resemble ulcers or oopen wounds in new borns and that has_material_basis_in heterozygous mutation in the BMS1 gene on chromosome 10q11."" .

","Nonsyndromic aplasia cutis congenita is a type of skin disease, which is defined as a skin disease characterized by localized areas of missing skin that resemble ulcers or open wounds in newborns. This condition has a material basis in a heterozygous mutation in the BMS1 gene on chromosome 10q11.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080662,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:atrial_standstill_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :heart_conduction_disease ;
    :has_definition ""A heart conduction disease that is characterized by a transient or permanent absence of electrical and mechanical atrial activity and that has_material_basis_in coinheritance of a variant in the SCN5A gene in combination with a rare connexin-40 genotype."" .

","Atrial standstill 1 is a type of autosomal dominant disease and a type of heart conduction disease, which at least has a material basis in some autosomal dominant inheritance. It is defined as a heart conduction disease characterized by a transient or permanent absence of electrical and mechanical atrial activity, which has its material basis in the coinheritance of a variant in the SCN5A gene in combination with a rare connexin-40 genotype.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080663,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:atrial_standstill_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :heart_conduction_disease ;
    :has_definition ""A heart conduction disease that is characterized by a transient or permanent absence of electrical and mechanical atrial activity and has_material_basis_in homozygous mutation in the NPPA gene on chromosome 1p36."" .

","Atrial standstill 2 is a type of autosomal recessive disease and a type of heart conduction disease, which at least has a material basis in some autosomal recessive inheritance. It is defined as a heart conduction disease characterized by a transient or permanent absence of electrical and mechanical atrial activity, with its material basis in a homozygous mutation in the NPPA gene on chromosome 1p36.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080664,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diaphyseal_medullary_stenosis_with_malignant_fibrous_histiocytoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :osteochondrodysplasia ;
    :has_definition ""An osteochondrodysplasia that is characterized by pathologic fractures due to abnormal cortical growth and diaphyseal medullary stenosis and that has_material_basis_in heterozygous mutation in the MTAP gene on chromosome 9p21."" ;
    :has_exact_synonym ""Hardcastle syndrome"",
        ""bone dysplasia-medullary fibrosarcoma syndrome"",
        ""diaphyseal medullary stenosis-malignant fibrous histiocytoma syndrome"" .

","Diaphyseal medullary stenosis with malignant fibrous histiocytoma, also known exactly as Hardcastle syndrome, bone dysplasia-medullary fibrosarcoma syndrome, and diaphyseal medullary stenosis-malignant fibrous histiocytoma syndrome, is a type of osteochondrodysplasia and an autosomal dominant disease. This condition is characterized as an osteochondrodysplasia that leads to pathologic fractures due to abnormal cortical growth and diaphyseal medullary stenosis. It has a material basis in a heterozygous mutation in the MTAP gene on chromosome 9p21. Moreover, it is considered to be something that at least has a material basis in some form of autosomal dominant inheritance.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080665,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:warfarin_resistance rdfs:subClassOf :inherited_metabolic_disorder ;
    :has_definition ""An inherited metabolic disorder that is characterized by a high tolerance for the drug warfarin."" .

","Warfarin resistance is a type of inherited metabolic disorder, defined as an inherited metabolic disorder characterized by a high tolerance for the drug warfarin.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080666,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:warfarin_sensitivity rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :inherited_metabolic_disorder ;
    :has_definition ""An inherited metabolic disorder that is characterized by a low tolerance for the drug warfarin."" .

","Warfarin sensitivity is a type of autosomal dominant disease and an inherited metabolic disorder, which at least has a material basis in some autosomal dominant inheritance. It is defined as an inherited metabolic disorder characterized by a low tolerance for the drug warfarin.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080667,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spinal_muscular_atrophy_type_0 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :childhood_onset ],
        :childhood_spinal_muscular_atrophy ;
    :has_definition ""A childhood spinal muscular atrophy that is evident before birth and characterized by diminished movement in the womb, joint deformities, extremely weak muscle tone and very weak respiratory muscles."" ;
    :has_exact_synonym ""very severe spinal muscular atrophy"" .

","Spinal Muscular Atrophy Type 0 is a form of childhood spinal muscular atrophy that begins in childhood, specifically with an onset that starts during childhood. It is defined as a childhood spinal muscular atrophy evident before birth, characterized by diminished movement in the womb, joint deformities, extremely weak muscle tone, and very weak respiratory muscles. Additionally, it is exactly synonymous with very severe spinal muscular atrophy.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080669,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:posterior_polymorphous_corneal_dystrophy_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :posterior_polymorphous_corneal_dystrophy ;
    :has_definition ""A posterior polymorphous corneal dystrophy that is characterized by an irregular posterior corneal surface with occasional opacities of variable size and shape and that has_material_basis_in heterozygous mutation in the GRHL2 gene on chromosome 8q22."" .

",Posterior polymorphous corneal dystrophy 4 is a type of posterior polymorphous corneal dystrophy and an autosomal dominant disease that at least has a material basis in some autosomal dominant inheritance. It is defined as a posterior polymorphous corneal dystrophy characterized by an irregular posterior corneal surface with occasional opacities of variable size and shape. It has a material basis in heterozygous mutation in the GRHL2 gene on chromosome 8q22.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080670,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meesmann_corneal_dystrophy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :meesmann_corneal_dystrophy ;
    :has_definition ""A Messmann corneal dystrophy that is characterized by the presence of multitudinous microcysts within the anterior epithelium and that has_material_basis_in heterozygous mutation in the KRT12 gene on chromosome 17q21."" .

","Meesmann corneal dystrophy 1 is a type of Meesmann corneal dystrophy and an autosomal dominant disease. It is characterized by the presence of numerous microcysts within the anterior epithelium, a condition that arises from a heterozygous mutation in the KRT12 gene on chromosome 17q21. This condition also falls under the category of disorders that have a material basis in some form of autosomal dominant inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080671,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meesmann_corneal_dystrophy_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :meesmann_corneal_dystrophy ;
    :has_definition ""A Messmann corneal dystrophy that is characterized by fragility of the anterior corneal epithelium and the presence of intraepithelial microcysts and that has_material_basis_in heterozygous mutation in the KRT3 gene on chromosome 12q13."" .

","Meesmann corneal dystrophy 2 is a subtype of Meesmann corneal dystrophy and an autosomal dominant disease, which inherently has a material basis in autosomal dominant inheritance. It is defined as a Meesmann corneal dystrophy characterized by the fragility of the anterior corneal epithelium, the presence of intraepithelial microcysts, and has its material basis in a heterozygous mutation in the KRT3 gene on chromosome 12q13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080672,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:fibrochondrogenesis_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :fibrochondrogenesis ;
    :has_definition ""A fibrochondrogenesis that is characterized by a flat midface with a small nose and anteverted nares, significant shortening of all limb segments but relatively normal hands and feet, and a small bell-shaped thorax with a protuberant abdomen and that has_material_basis_in compound heterozygous mutation in the COL11A1 gene on chromosome 1p21."" .

","Fibrochondrogenesis 1 is a type of autosomal recessive disease and a subtype of fibrochondrogenesis, characterized by a condition that fundamentally has a material basis in some form of autosomal recessive inheritance. Specifically, fibrochondrogenesis 1 is defined by a flat midface with a small nose and anteverted nares, significant shortening of all limb segments but with relatively normal hands and feet, and a small bell-shaped thorax with a protuberant abdomen. This condition has its material basis in compound heterozygous mutations in the COL11A1 gene located on chromosome 1p21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080673,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:fibrochondrogenesis_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :autosomal_recessive_disease,
        :fibrochondrogenesis ;
    :has_definition ""A fibrochondrogenesis that has_material_basis_in homozygous or heterozygous mutation in the COL11A2 gene on chromosome 6p21.3."" .

","Fibrochondrogenesis 2 is a type of fibrochondrogenesis and is characterized as an autosomal dominant disease as well as an autosomal recessive disease. It is associated with conditions that have their material basis in either some form of autosomal dominant inheritance or autosomal recessive inheritance. Additionally, fibrochondrogenesis 2 is defined as a fibrochondrogenesis that has its material basis in homozygous or heterozygous mutation in the COL11A2 gene on chromosome 6p21.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080674,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:luminal_breast_carcinoma_b rdfs:subClassOf :breast_carcinoma ;
    :has_definition ""A breast carcinoma that is characterized by low to moderate expression of genes characteristic of luminal epithelial cells including estrogen receptor (ER), and high expression of GGH, LAPTM4B, and CCNE1."" ;
    :has_exact_synonym ""Luminal B Breast Carcinoma"" .

","Luminal breast carcinoma B is a type of breast carcinoma, which is characterized by low to moderate expression of genes characteristic of luminal epithelial cells including estrogen receptor (ER), and high expression of GGH, LAPTM4B, and CCNE1. Additionally, it has the exact synonym Luminal B Breast Carcinoma.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080675,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:stickler_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :stickler_syndrome ;
    :has_definition ""A Stickler syndrome that has_material_basis_in heterozygous mutation in the COL11A1 gene on chromosome 1p21."" .

","Stickler Syndrome 2 is a type of Stickler Syndrome and an autosomal dominant disease, characterized by having a material basis in autosomal dominant inheritance. Furthermore, it is defined as a Stickler Syndrome that arises from a heterozygous mutation in the COL11A1 gene located on chromosome 1p21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080676,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:stickler_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :stickler_syndrome ;
    :has_definition ""A Stickler syndrome that has_material_basis_in heterozygous mutation in the COL2A1 gene on chromosome 12q13."" .

","Stickler syndrome 1 is a type of Stickler syndrome and an autosomal dominant disease, which specifically has a material basis in autosomal dominant inheritance. Furthermore, it is defined as a Stickler syndrome that arises from a heterozygous mutation in the COL2A1 gene located on chromosome 12q13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080677,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otospondylomegaepiphyseal_dysplasia_autosomal_dominant rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :osteochondrodysplasia ;
    :has_definition ""An osteochondrodysplasia that is characterized by by autosomal dominant inheritance of mutations in the COL11A2 gene."" .

","Otospodylomegaepiphyseal dysplasia autosomal dominant is a type of disease that falls under several classifications: it is an autosomal dominant disease, an osteochondrodysplasia, and is characterized by a material basis that involves autosomal dominant inheritance. Additionally, this condition is defined as an osteochondrodysplasia that is characterized by autosomal dominant inheritance of mutations in the COL11A2 gene.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080678,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mucolipidosis_iii_gamma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :mucolipidosis ;
    :has_definition ""A mucolipidosis that has_material_basis_in mutation in the gene encoding the gamma subunit of N-acetylglucosamine-1-phosphotransferase and that is characterized by short stature, skeletal abnormalities, cardiomegaly, and developmental delay."" .

","Mucolipidosis III gamma is a type of mucolipidosis and an autosomal recessive disease, which is characterized by having a material basis in autosomal recessive inheritance. It is defined as a mucolipidosis that has its material basis in mutation in the gene encoding the gamma subunit of N-acetylglucosamine-1-phosphotransferase, characterized by short stature, skeletal abnormalities, cardiomegaly, and developmental delay.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080679,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neuronal_intestinal_dysplasia_type_a rdfs:subClassOf :intestinal_pseudo_obstruction ;
    :has_definition ""An intestinal pseudo-obstruction that is characterized by congenital hypoplasia or aplasia of the sympathetic innervation of the intestine."" .

",Neuronal intestinal dysplasia type A is a type of intestinal pseudo obstruction and it is defined as an intestinal pseudo-obstruction characterized by congenital hypoplasia or aplasia of the sympathetic innervation of the intestine.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080680,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neuronal_intestinal_dysplasia_type_b rdfs:subClassOf :intestinal_pseudo_obstruction ;
    :has_definition ""An intestinal pseudo-obstruction that is affects the parasympathetic submucous plexus."" .

",Neuronal intestinal dysplasia type B is a type of intestinal pseudo-obstruction and is defined as an intestinal pseudo-obstruction that affects the parasympathetic submucous plexus.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080681,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_chronic_idiopathic_intestinal_pseudo_obstruction rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :intestinal_pseudo_obstruction,
        :x_linked_recessive_disease ;
    :has_definition ""An intestinal pseudo-obstruction that has_material_basis_in mutations in the FLNA gene on chromosome Xq28."" .

","X-linked chronic idiopathic intestinal pseudo-obstruction is a type of intestinal pseudo-obstruction and a form of X-linked recessive disease. It is characterized by a condition that fundamentally arises from some form of X-linked recessive inheritance. Specifically, this condition is defined as an intestinal pseudo-obstruction that has its material basis in mutations in the FLNA gene located on chromosome Xq28.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080682,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_familial_visceral_neuropathy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :intestinal_pseudo_obstruction ;
    :has_definition ""An intestinal pseudo-obstruction that is inherited as an autosomal dominant trait."" .

","Autosomal dominant familial visceral neuropathy is a type of disease characterized by several aspects. Firstly, it falls under the category of autosomal dominant diseases. Additionally, it is identified as a type of intestinal pseudo-obstruction. This condition also has a basis in autosomal dominant inheritance, indicating the genetic pattern it follows. The definition of autosomal dominant familial visceral neuropathy further elaborates it as an intestinal pseudo-obstruction that is inherited as an autosomal dominant trait.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080683,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nonsyndromic_congenital_nail_disorder rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :nail_disease,
        :physical_disorder ;
    :has_definition ""A nail disease that is characterized by underdevelopment of nails."" .

","Nonsyndromic congenital nail disorder is a type of physical disorder, nail disease, and something that at least has its basis in some abnormality of prenatal development or birth. It is defined as a nail disease characterized by the underdevelopment of nails.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080684,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diffuse_midline_glioma_h3_k27m_mutant rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :derives_from ;
            owl:someValuesFrom :glial_cell ],
        :histone_mutated_tumor ;
    :has_definition ""A histone mutated tumor that is characterized by the presence of histone H3 K27M mutation located throughout the midline structures of the central nervous system."" ;
    :has_exact_synonym ""diffuse intrinsic pontine glioma"" .

","Diffuse midline glioma H3 K27M mutant is characterized as a type of histone mutated tumor and is also classified as something deriving from glial cells. Specifically, it is defined as a histone mutated tumor characterized by the presence of histone H3 K27M mutation, which is located throughout the midline structures of the central nervous system. Additionally, it has the exact synonym ""diffuse intrinsic pontine glioma.""",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080685,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:aortic_dissection rdfs:subClassOf :aortic_disease ;
    :has_definition ""An aortic disease that is characterized by tearing of the intimal layer of the aorta resulting in separation of the layers of the aortic wall."" .

","Aortic dissection is a type of aortic disease characterized by the tearing of the intimal layer of the aorta, which results in the separation of the layers of the aortic wall.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080686,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:tubular_aggregate_myopathy_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :myopathy ;
    :has_definition ""A myopathy that is characterized by the presence of tubular aggregates in myofibrils and has_material_basis_in heterozygous mutation in the ORAI1 gene on chromosome 12q24."" ;
    :has_narrower_match ""ORDO:2593"" .

","Tubular aggregate myopathy 2 is a type of myopathy and also a type of autosomal dominant disease, which is a classification that at least has a material basis in some autosomal dominant inheritance. It is specifically defined as a myopathy characterized by the presence of tubular aggregates in myofibrils, stemming from a heterozygous mutation in the ORAI1 gene on chromosome 12q24. Additionally, tubular aggregate myopathy 2 has a narrower match, ORDO:2593.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080687,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:reducing_body_myopathy_1b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :myopathy,
        :x_linked_monogenic_disease ;
    :has_definition ""A myopathy that is characterized by by the presence of intracytoplasmic inclusion bodies strongly stained by menadione-linked alpha-glycerophosphate dehydrogenase in the absence of substrate, alpha-glycerophosphate, with late childhood or adult onset, and that has_material_basis_in mutation in the FHL1 gene on chromosome Xq26."" .

","Reducing body myopathy 1b is a type of myopathy and an X-linked monogenic disease, which falls under the category of conditions that, at the very least, have a material basis in X-linked inheritance. It is defined as a myopathy characterized by the presence of intracytoplasmic inclusion bodies that are strongly stained by menadione-linked alpha-glycerophosphate dehydrogenase in the absence of its substrate, alpha-glycerophosphate, typically manifesting in late childhood or adulthood. This condition has its material basis in mutations in the FHL1 gene located on chromosome Xq26.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080688,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mosaic_variegated_aneuploidy_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome that is characterized by cell mosaicism where at least one-quarter of cells have an abnormal number of chromosomes."" .

","Mosaic variegated aneuploidy syndrome is a type of syndrome characterized by cell mosaicism, where at least one-quarter of cells have an abnormal number of chromosomes.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080689,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mosaic_variegated_aneuploidy_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :mosaic_variegated_aneuploidy_syndrome ;
    :has_definition ""A mosaic variegated aneuploidy syndrome that has_material_basis_in homozygous mutation in the TRIP13 gene on chromosome 5p15 that results in no detectable TRIP13 protein."" .

","Mosaic variegated aneuploidy syndrome 3 is a type of autosomal recessive disease, a type of mosaic variegated aneuploidy syndrome, and a type of condition that at least has its material basis in some autosomal recessive inheritance. It is defined as a mosaic variegated aneuploidy syndrome that has its material basis in a homozygous mutation in the TRIP13 gene on chromosome 5p15, resulting in no detectable TRIP13 protein.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080690,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ra_sopathy rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome that has_material_basis_in mutations in genes that alter the Ras subfamily and mitogen-activated protein kinases that control signal transduction."" ;
    :has_exact_synonym ""RAS/mitogen-activated protein kinase syndrome"" .

",RASopathy is a type of syndrome characterized by a syndrome that has its material basis in mutations in genes that alter the Ras subfamily and mitogen-activated protein kinases controlling signal transduction. It is also exactly synonymous with RAS/mitogen-activated protein kinase syndrome.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080691,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:noonan_syndrome_like_disorder_with_loose_anagen_hair rdfs:subClassOf :ra_sopathy ;
    :has_definition ""A RASopathy that is characterized by macrocephaly, high forehead, wide-set eyes or hypertelorism, palpebral ptosis, and low-set and posteriorly rotated ears, pluckable, sparse, thin and slow-growing hair, frequent congenital heart defects, darkly pigmented skin with eczema or ichthyosis, short stature and developmental delay."" .

","Noonan syndrome-like disorder with loose anagen hair is a type of RASopathy. This disorder is defined as a RASopathy characterized by several physical attributes and conditions, including macrocephaly, a high forehead, wide-set eyes or hypertelorism, palpebral ptosis, and low-set and posteriorly rotated ears. Additionally, it involves pluckable, sparse, thin, and slow-growing hair, frequent congenital heart defects, darkly pigmented skin with eczema or ichthyosis, short stature, and developmental delay.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080692,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:noonan_syndrome_like_disorder_with_loose_anagen_hair_1 rdfs:subClassOf :noonan_syndrome_like_disorder_with_loose_anagen_hair ;
    :has_definition ""A Noonan-like syndrome with loose anagen hair that has_material_basis_in heterozygous mutation in the SHOC2 gene on chromosome 10q25."" .

",Noonan syndrome-like disorder with loose anagen hair 1 is a type of Noonan syndrome-like disorder with loose anagen hair. It is defined as a Noonan-like syndrome with loose anagen hair that has a material basis in a heterozygous mutation in the SHOC2 gene located on chromosome 10q25.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080693,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:noonan_syndrome_like_disorder_with_loose_anagen_hair_2 rdfs:subClassOf :noonan_syndrome_like_disorder_with_loose_anagen_hair ;
    :has_definition ""A Noonan syndrome-like disorder with loose anagen hair that has_material_basis_in heterozygous mutation in the PPP1CB gene on chromosome 2p23."" .

",Noonan syndrome-like disorder with loose anagen hair 2 is a type of Noonan syndrome-like disorder with loose anagen hair. It is defined as a Noonan syndrome-like disorder with loose anagen hair that has its material basis in a heterozygous mutation in the PPP1CB gene on chromosome 2p23.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080694,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:galloway_mowat_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome that is characterized by developmental delay, progressive microcephaly, cerebral and cerebellar atrophy with extrapyramidal involvement, and optic atrophy."" .

","Galloway Mowat syndrome is a type of syndrome that is defined by developmental delay, progressive microcephaly, cerebral and cerebellar atrophy with extrapyramidal involvement, and optic atrophy.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080695,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:burn_mc_keown_syndrome rdfs:subClassOf :syndrome ;
    :has_definition """"""A syndrome that is characterized by bilateral choanal atresia, cranio-facial dysmorphism, 
hearing loss, heart abnormalities, and short stature."""""" ;
    :has_exact_synonym ""Choanal atresia - deafness - cardiac defects - dysmorphism syndrome"" .

","Burn Mc Keown syndrome is a type of syndrome that is characterized by bilateral choanal atresia, cranio-facial dysmorphism, hearing loss, heart abnormalities, and short stature. It is also known by its exact synonym, Choanal atresia - deafness - cardiac defects - dysmorphism syndrome.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080696,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:winchester_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :osteolysis ],
        :syndrome ;
    :has_definition ""A syndrome that is characterized by a loss of bone tissue particularly in the hands and feet."" .

","Winchester syndrome is a type of syndrome that is characterized by a loss of bone tissue, particularly in the hands and feet. It falls into a category of conditions that at least have the phenotype of osteolysis.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080697,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:opitz_gbbb_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :syndrome,
        :x_linked_recessive_disease ;
    :has_definition ""A syndrome that is a congenital midline malformation syndrome that is characterized by hypertelorism, hypospadias, cleft lip/palate, laryngotracheoesophageal abnormalities, imperforate anus, developmental delay, and cardiac defects and that has_material_basis_in mutation in the MID1 gene on chromosome Xp22."" ;
    :has_exact_synonym ""Opitz G/BBB Syndrome""@en,
        ""Opitz GBBB syndrome type I""@en .

","Opitz GBBB syndrome is a type of syndrome and a specific X-linked recessive disease. It is characterized as a congenital midline malformation syndrome, which is marked by hypertelorism, hypospadias, cleft lip/palate, laryngotracheoesophageal abnormalities, imperforate anus, developmental delay, and cardiac defects. The basis of this syndrome is a mutation in the MID1 gene on chromosome Xp22. Additionally, Opitz GBBB syndrome is also known by its exact synonyms: Opitz G/BBB Syndrome and Opitz GBBB syndrome type I.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080698,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:teebi_hypertelorism_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :teebi_hypertelorism_syndrome ;
    :has_definition ""A Teebi hypertelorism syndrome that has_material_basis_in mutation in heterozygous mutation in the SPECC1L gene on chromosome 22q11.2 or heterozygous deletion at chromosome 22q11.2."" ;
    :has_exact_synonym ""Opitz GBBB syndrome type II""@en,
        ""SPECC1L-related hypertelorism syndrome""@en,
        ""Teebi hypertelorism syndrome-1""@en .

","Teebi hypertelorism syndrome 1 is a type of autosomal dominant disease, which also falls under the broader category of Teebi hypertelorism syndrome. It is characterized by at least having a material basis in some form of autosomal dominant inheritance. Specifically, this syndrome is defined by having a material basis in mutations, including a heterozygous mutation in the SPECC1L gene on chromosome 22q11.2 or a heterozygous deletion at chromosome 22q11.2. Moreover, Teebi hypertelorism syndrome 1 is precisely known by several exact synonyms, including Opitz GBBB syndrome type II, SPECC1L-related hypertelorism syndrome, and Teebi hypertelorism syndrome-1.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080699,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:glutathione_synthetase_deficiency rdfs:subClassOf :amino_acid_metabolic_disorder ;
    :has_definition ""An amino acid metabolic disorder characterized by the lack of glutathione production."" .

",Glutathione synthetase deficiency is a type of amino acid metabolic disorder characterized by the lack of glutathione production.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080700,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:caudal_regression_syndrome rdfs:subClassOf :physical_disorder ;
    :has_definition ""A physical disorder that is characterized by impairment of the development of the lower half of the body."" ;
    :has_exact_synonym ""caudal dysgenesis syndrome"",
        ""caudal dysplasia sequence"",
        ""caudal regression sequence"",
        ""sacral agenesis"",
        ""sacral defect with anterior meningocele"" .

","Caudal regression syndrome is a type of physical disorder characterized by impairment of the development of the lower half of the body. It is also known by several exact synonyms, including caudal dysgenesis syndrome, caudal dysplasia sequence, caudal regression sequence, sacral agenesis, and sacral defect with anterior meningocele.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080701,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:prothrombin_thrombophilia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :thrombophilia ;
    :has_definition ""A thrombophilia that is characterized by increases the risk of blood clots including deep vein thrombosis and pulmonary embolism and that has_material_basis_in heterozygous mutation in the thrombin gene (F2 gene) on chromosome 11p11."" .

","Prothrombin thrombophilia is a type of thrombophilia and an autosomal dominant disease, which is characterized by an increased risk of blood clots, including deep vein thrombosis and pulmonary embolism. It has a material basis in a heterozygous mutation in the thrombin gene (F2 gene) on chromosome 11p11. This condition is also described as having a material basis in some autosomal dominant inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080702,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:medulloblastoma_wnt_activated rdfs:subClassOf :medulloblastoma ;
    :has_definition ""A medulloblastoma that is characterized as a molecular subtype by activation of the WNT pathway and TP53 mutations may be present or absent."" .

","Medulloblastoma WNT activated is a type of medulloblastoma that is characterized as a molecular subtype by the activation of the WNT pathway, and TP53 mutations may be present or absent.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080703,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:medulloblastoma_shh_activated rdfs:subClassOf :medulloblastoma ;
    :has_definition ""A medulloblastoma that is characterized as a molecular subtype by activation of the sonic hedgehog (SHH) pathway and TP53 mutations that may be present or absent."" .

",Medulloblastoma SHH activated is a type of medulloblastoma and it is defined as a medulloblastoma that is characterized as a molecular subtype by the activation of the sonic hedgehog (SHH) pathway and TP53 mutations that may be present or absent.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080704,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:medulloblastoma_shh_activated_and_tp53_mutant rdfs:subClassOf :medulloblastoma_shh_activated ;
    :has_definition ""A medulloblastoma SHH activated that is characterized as a molecular subtype by activation of the sonic hedgehog (SHH) pathway and the presence of TP53 mutations."" .

",Medulloblastoma SHH activated and TP53 mutant is a type of Medulloblastoma SHH activated. It is defined as a molecular subtype of Medulloblastoma SHH activated that is characterized by the activation of the sonic hedgehog (SHH) pathway and the presence of TP53 mutations.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080705,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:medulloblastoma_shh_activated_and_tp53_wild_type rdfs:subClassOf :medulloblastoma_shh_activated ;
    :has_definition ""A medulloblastoma SHH activated that is characterized as a molecular subtype by activation of the sonic hedgehog (SHH) pathway and the absence of TP53 mutations."" ;
    :has_exact_synonym ""Medulloblastoma SHH-Activated TP53-Wildtype"" .

","Medulloblastoma SHH activated and TP53 wild type is a specific type of medulloblastoma SHH activated. It is defined as a molecular subtype characterized by the activation of the sonic hedgehog (SHH) pathway and the absence of TP53 mutations. This particular subtype also has an exact synonym, Medulloblastoma SHH-Activated TP53-Wildtype.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080706,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:medulloblastoma_non_wnt_non_shh rdfs:subClassOf :medulloblastoma ;
    :has_definition ""A medulloblastoma that is characterized as a molecular subtype that is not associated with activation of the WNT pathway or sonic hedgehog (SHH) pathway and TP53 mutations are absent."" .

","Medulloblastoma non-WNT non-SHH is a type of medulloblastoma, defined as a molecular subtype that is not associated with the activation of the WNT pathway or the sonic hedgehog (SHH) pathway, and it lacks TP53 mutations.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080707,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:medulloblastoma_non_wnt_non_shh_group_3 rdfs:subClassOf :medulloblastoma_non_wnt_non_shh ;
    :has_definition ""A medulloblastoma non-WNT/non-SHH that is characterized as a molecular subtype by absent TP53 mutations and MYC amplifications that may be present."" .

","Medulloblastoma non-WNT/non-SHH Group 3 is a type of medulloblastoma non-WNT/non-SHH, defined by being a molecular subtype characterized by the absence of TP53 mutations and the possible presence of MYC amplifications.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080708,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:medulloblastoma_non_wnt_non_shh_group_4 rdfs:subClassOf :medulloblastoma_non_wnt_non_shh ;
    :has_definition ""A medulloblastoma non-WNT/non-SHH that is characterized as a molecular subtype by the absence of MYC amplifications and TP53 mutations, while chromosome 17 abnormalities may be present."" .

","Medulloblastoma non-WNT/non-SHH group 4 is a type of medulloblastoma non-WNT/non-SHH that is defined as a molecular subtype. It is characterized by the absence of MYC amplifications and TP53 mutations, although abnormalities in chromosome 17 may be present.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080709,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nk_cell_deficiency rdfs:subClassOf :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease that results from defeciency in the number or function of CD56+CD3− NK cell in peripheral blood."" .

","NK cell deficiency is a type of primary immunodeficiency disease, defined as a primary immunodeficiency disease that results from a deficiency in the number or function of CD56+CD3− NK cells in peripheral blood.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080710,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:t_cell_and_nk_cell_immunodeficiency rdfs:subClassOf :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease that involves multiple components of the immune system, including both T cell and NK cell immunodeficiency."" .

","T cell and NK cell immunodeficiency is a type of primary immunodeficiency disease that involves multiple components of the immune system, including both T cell and NK cell deficiencies.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080711,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multisystem_inflammatory_syndrome_in_children rdfs:subClassOf :coronavirus_infectious_disease ;
    :has_definition ""A Coronavirus infectious disease that is characterized by a patient aged less than 21 years with fever, laboratory evidence of inflammation, and evidence of clinically severe illness requiring hospitalization, with multisystem organ involvement (cardiovascular, dermatologic, gastrointestinal, hematologic, neurologic, renal, or respiratory) who tested positive for SARS-CoV-2 or had exposure to COVID-19."" ;
    :has_exact_synonym ""MIS-C"",
        ""multisystem inflammatory disorder in children and adolescents"",
        ""paediatric inflammatory multisystemic syndrome"" .

","Multisystem inflammatory syndrome in children (MIS-C) is a type of coronavirus infectious disease characterized by a patient aged less than 21 years who presents with fever, laboratory evidence of inflammation, and evidence of clinically severe illness requiring hospitalization, including multisystem organ involvement (such as cardiovascular, dermatologic, gastrointestinal, hematologic, neurologic, renal, or respiratory). This condition occurs in those who have tested positive for SARS-CoV-2 or had exposure to COVID-19. MIS-C is also known by other exact synonyms including multisystem inflammatory disorder in children and adolescents, and paediatric inflammatory multisystemic syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080712,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gene_duplication_disease rdfs:subClassOf :monogenic_disease ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :disease ;
                    rdf:rest [ rdf:first [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                                                    owl:onProperty :has_material_basis_in ;
                                                    owl:someValuesFrom :gene ] ;
                                            rdf:rest [ rdf:first [ a owl:Restriction ;
                                                            owl:onProperty :has_material_basis_in ;
                                                            owl:someValuesFrom :duplication ] ;
                                                    rdf:rest :nil ] ] ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A monogenic disease that is the result of a mutation that involves the production of one or more copies of a gene."" ;
    :has_exact_synonym ""gene duplication syndrome"" .

","Gene duplication disease is equivalent to a condition that intersects with both a disease and another condition that arises from at least something having a material basis in a gene and at least something having a material basis in duplication. It is categorized as a type of monogenic disease. Furthermore, gene duplication disease is defined as a monogenic disease resulting from a mutation that leads to the production of one or more copies of a gene. Additionally, gene duplication disease is precisely synonymous with gene duplication syndrome.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080714,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_alpha_tryptasemia_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :derives_from ;
            owl:someValuesFrom :mast_cell ],
        [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :gene ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :duplication ] ;
                            rdf:rest :nil ] ] ],
        :gene_duplication_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by high blood tryptase levels and that has_material_basis_in inherited extra copies of the alpha tryptase gene (TPSAB1), effecting multiple organ systems including skin and connective tissues, the gastrointestinal and cardiovascular systems."" .

","Hereditary alpha tryptasemia syndrome is a syndrome and a type of gene duplication disease. It is characterized by its intersection with entities that have a material basis in genes and duplications. Additionally, it derives from mast cells. The syndrome is defined by high blood tryptase levels, resulting from inherited extra copies of the alpha tryptase gene (TPSAB1), affecting multiple organ systems including the skin and connective tissues, as well as the gastrointestinal and cardiovascular systems.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080715,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_82 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of seizures in the first year of life, hypotonia, feeding difficulties, severely impaired intellectual development, and global developmental delay that has_material_basis_in homozygous or compound heterozygous mutation in the GOT2 gene on chromosome 16q21."" ;
    :has_exact_synonym ""DEE82"",
        ""early infantile epileptic encephalopathy 82"" .

","Developmental and Epileptic Encephalopathy 82 (DEE82), also known as Early Infantile Epileptic Encephalopathy 82, is a type of autosomal recessive disease and falls under the category of Developmental and Epileptic Encephalopathies. This condition is characterized by seizures in the first year of life, hypotonia, feeding difficulties, severely impaired intellectual development, and global developmental delay. It has a material basis in homozygous or compound heterozygous mutation in the GOT2 gene on chromosome 16q21, indicating that it arises from some form of autosomal recessive inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080716,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:infantile_liver_failure_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :liver ],
        :liver_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by acute liver failure, that occurs in the first year of life, which manifests with failure to thrive, hypotonia, moderate global developmental delay, seizures, abnormal liver function tests, microcytic anemia and elevated serum lactate."" .

","Infantile liver failure syndrome is a type of syndrome and liver disease, which is specifically located in the liver. It is defined as a syndrome characterized by acute liver failure occurring in the first year of life, manifesting with failure to thrive, hypotonia, moderate global developmental delay, seizures, abnormal liver function tests, microcytic anemia, and elevated serum lactate.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080717,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:infantile_liver_failure_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :infantile_liver_failure_syndrome ;
    :has_definition ""An infantile liver failure syndrome that has_material_basis_in homozygous mutation in the LARS gene (LARS1) on chromosome 5q32."" .

","Infantile liver failure syndrome 1 is a type of infantile liver failure syndrome and an autosomal recessive disease. It is characterized by having a material basis in autosomal recessive inheritance. Specifically, this syndrome is defined by an infantile liver failure condition that results from a homozygous mutation in the LARS gene (LARS1) located on chromosome 5q32.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080718,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gne_myopathy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :myopathy ;
    :has_definition ""A myopathy that is characterized by progressive skeletal muscle atrophy, distal muscle weakness and bilateral foot drop caused by weakness of the anterior tibialis muscles with onset in early adulthood, and that has_material_basis_in mutations in the GNE gene which encodes the rate-limiting enzyme of sialic acid biosynthesis."" ;
    :has_exact_match ""MESH:C536816"" ;
    :has_exact_synonym ""Distal myopathy, Nonaka type"",
        ""Hereditary Inclusion Body Myopathy"",
        ""Nonaka myopathy"",
        ""inclusion body myopathy 2"" ;
    :has_related_synonym ""Distal Myopathy with Rimmed Vacuoles"" .

","GNE myopathy is a type of autosomal recessive disease and myopathy that has a material basis in autosomal recessive inheritance and is characterized by symptoms such as muscle weakness. It is defined as a myopathy characterized by progressive skeletal muscle atrophy, distal muscle weakness, and bilateral foot drop caused by weakness of the anterior tibialis muscles with onset in early adulthood. This condition has its material basis in mutations in the GNE gene, which encodes the rate-limiting enzyme of sialic acid biosynthesis. GNE myopathy is also known by exact synonyms such as Distal Myopathy, Nonaka Type; Hereditary Inclusion Body Myopathy; Nonaka Myopathy; and Inclusion Body Myopathy 2. Furthermore, it has a related synonym, Distal Myopathy with Rimmed Vacuoles, and has an exact match with the MESH identifier C536816.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0080719,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_myopathy_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_dominant_disease,
        :autosomal_recessive_disease,
        :congenital_myopathy ;
    :has_definition ""A congenital myopathy that is characterized by childhood onset of congenital joint contractures, external ophthalmoplegia, and proximal muscle weakness, and that has_material_basis_in heterozygous, compound heterozygous, or homozygous mutation in the gene encoding myosin heavy chain IIa ( (MYHC2A or MYH2) on chromosome 17p13."" ;
    :has_exact_synonym ""inclusion body myopathy 3"",
        ""proximal myopathy and ophthalmoplegia"" .

","Congenital Myopathy 6 is a type of congenital myopathy, which is characterized by being both an autosomal dominant and autosomal recessive disease. This condition has a material basis in either autosomal dominant or autosomal recessive inheritance and is notable for having symptoms such as muscle weakness. It is defined as a congenital myopathy characterized by childhood onset of congenital joint contractures, external ophthalmoplegia, and proximal muscle weakness. This condition stems from heterozygous, compound heterozygous, or homozygous mutations in the gene encoding myosin heavy chain IIa (MYHC2A or MYH2) on chromosome 17p13. Additionally, Congenital Myopathy 6 is also known by its exact synonyms, including Inclusion Body Myopathy 3 and Proximal Myopathy and Ophthalmoplegia.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0080720,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_congenital_deafness_with_onychodystrophy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :physical_disorder,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by autosomal dominant inheritance of congenital deafness and onychodystrophy and that has_material_basis_in heterozygous mutation in the ATP6V1B2 gene on chromosome 8p21."" .

","Autosomal dominant congenital deafness with onychodystrophy is a syndrome characterized by congenital deafness and onychodystrophy, with its material basis in a heterozygous mutation in the ATP6V1B2 gene on chromosome 8p21. It is classified as a type of autosomal dominant disease, physical disorder, and syndrome that has its foundation in autosomal dominant inheritance and is rooted in some abnormality of prenatal development or birth.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080721,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:calvarial_doughnut_lesions_with_bone_fragility rdfs:subClassOf :osteochondrodysplasia ;
    :has_definition ""An osteochondrodysplasia that is characterized by low bone mineral density, multiple spinal and peripheral fractures beginning in childhood, and sclerotic doughnut-shaped lesions in the cranial bones."" .

","Calvarial doughnut lesions with bone fragility are a type of osteochondrodysplasia characterized by low bone mineral density, multiple spinal and peripheral fractures beginning in childhood, and sclerotic doughnut-shaped lesions in the cranial bones.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080722,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:kenny_caffey_syndrome_type_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :kenny_caffey_syndrome ;
    :has_definition ""A Kenny-Caffey syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the TBCE gene, encoding tubulin-specific chaperone E, on chromosome 1q42."" .

","Kenny Caffey Syndrome Type 1 is a type of Kenny Caffey Syndrome and an autosomal recessive disease, which indicates that it has a material basis in some form of autosomal recessive inheritance. Furthermore, it is defined as a Kenny-Caffey syndrome that arises from homozygous or compound heterozygous mutations in the TBCE gene, which encodes the tubulin-specific chaperone E, located on chromosome 1q42.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080723,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:kenny_caffey_syndrome_type_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :kenny_caffey_syndrome ;
    :has_definition ""A Kenny-Caffey syndrome that has_material_basis_in heterozygous mutation in the FAM111A gene on chromosome 11q12."" ;
    :has_exact_match ""MESH:C537020"" .

","Kenny Caffey Syndrome Type 2 is a type of Kenny Caffey Syndrome and an autosomal dominant disease. It specifically arises from a heterozygous mutation in the FAM111A gene on chromosome 11q12, categorizing it under conditions with a material basis in autosomal dominant inheritance. Furthermore, Kenny Caffey Syndrome Type 2 is precisely identified with the MESH code: C537020.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080724,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:kenny_caffey_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :skeletal_dysplasia ],
        :osteochondrodysplasia,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by growth retardation with proportionate short stature, cortical thickening and medullary stenosis of the long bones, delayed anterior fontanelle closure, hypocalcemia due to congenital hypoparathyroidism and facial dysmorphism, including prominent forehead, microphthalmia, and micrognathia."" .

","Kenny Caffey syndrome is a type of syndrome, osteochondrodysplasia, and a condition that has a phenotype of skeletal dysplasia. It is defined as a syndrome characterized by growth retardation with proportionate short stature, cortical thickening and medullary stenosis of the long bones, delayed anterior fontanelle closure, hypocalcemia due to congenital hypoparathyroidism, and facial dysmorphism, including prominent forehead, microphthalmia, and micrognathia.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080725,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:basan_syndrome rdfs:subClassOf :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia that is characterized by neonatal blisters and milia and congenital absence of dermatoglyphics on the hands and feet."" .

","Basan syndrome is a type of ectodermal dysplasia, which is defined as an ectodermal dysplasia characterized by neonatal blisters and milia, along with the congenital absence of dermatoglyphics on the hands and feet.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080726,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_classic_type_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that has_material_basis_in heterozygous mutation in the collagen alpha-2(V) gene on chromosome 2q31 and that is characterized by the absence of widened atrophic scars."" .

",Ehlers Danlos syndrome classic type 2 is a type of Ehlers Danlos syndrome and an autosomal dominant disease that at least has a material basis in some autosomal dominant inheritance. It is defined as an Ehlers-Danlos syndrome that has a material basis in heterozygous mutation in the collagen alpha-2(V) gene on chromosome 2q31 and is characterized by the absence of widened atrophic scars.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080727,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_arthrochalasia_type_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that is characterized by hypermobility in infants with dislocations of both hips at birth and has_material_basis_in heterozygous mutation in the COL1A1 gene on chromosome 17q21."" .

","Ehlers-Danlos syndrome arthrochalasia type 1 is a specific type of Ehlers-Danlos syndrome and an autosomal dominant disease, which means it stems from an inheritance pattern that at least has a material basis in autosomal dominant inheritance. This syndrome is defined as an Ehlers-Danlos syndrome that is characterized by hypermobility in infants with dislocations of both hips at birth. This condition has its material basis in a heterozygous mutation in the COL1A1 gene located on chromosome 17q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080728,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_arthrochalasia_type_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that has_material_basis_in heterozygous mutation in the COL1A2 gene on chromosome 7q21."" .

","Ehlers Danlos Syndrome Arthrochalasia Type 2 is a type of Ehlers Danlos Syndrome and an autosomal dominant disease. It is characterized by having a material basis in some form of autosomal dominant inheritance. Specifically, it is defined as an Ehlers-Danlos syndrome that has a material basis in a heterozygous mutation in the COL1A2 gene on chromosome 7q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080729,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:brittle_cornea_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :cornea ],
        :autosomal_recessive_disease,
        :corneal_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that has_material_basis_in homozygous mutation in the PRDM5 gene on chromosome 4q27."" .

","Brittle Cornea Syndrome 2 is characterized as a type of autosomal recessive disease, corneal disease, and Ehlers-Danlos syndrome. This syndrome is defined by an Ehlers-Danlos syndrome that arises from a homozygous mutation in the PRDM5 gene on chromosome 4q27. It is also described as having a material basis in some form of autosomal recessive inheritance and is located in the cornea.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080730,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_cardiac_valvular_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that is characterized by severe problems with heart valves and that has_material_basis_in homozygous or compound heterozygous mutation in the COL1A2 gene on chromosome 7q21."" .

","Ehlers Danlos syndrome cardiac valvular type is a subtype of Ehlers Danlos syndrome, and it is categorized as an autosomal recessive disease. This specific type is characterized by severe issues with the heart valves. The underlying cause of the disease is either homozygous or compound heterozygous mutations in the COL1A2 gene located on chromosome 7q21. Furthermore, it falls under the category of diseases that have a material basis in some form of autosomal recessive inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080731,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_classic_like_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that is characterized by hyperextensible skin, hypermobile joints, and tissue fragility and that has_material_basis_in omozygous or heterozygous mutation in the tenascin-XB gene (TNXB) on chromosome 6p21."" .

","Ehlers Danlos Syndrome Classic Like 1 is a type of Ehlers Danlos Syndrome and a type of autosomal recessive disease that at least has a material basis in some autosomal recessive inheritance. It is defined as an Ehlers-Danlos syndrome characterized by hyperextensible skin, hypermobile joints, and tissue fragility, which has its material basis in homozygous or heterozygous mutation in the tenascin-XB gene (TNXB) on chromosome 6p21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080732,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_classic_like_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the AEBP1 gene on chromosome 7p13 and that is characterized by severe joint and skin laxity, osteoporosis involving the hips and spine, osteoarthritis, soft redundant skin that can be acrogeria-like, delayed wound healing with abnormal atrophic scarring, and shoulder, hip, knee, and ankle dislocations."" .

","Ehlers Danlos Syndrome Classic Like 2 is classified as a type of Ehlers Danlos Syndrome and falls under the broader category of autosomal recessive diseases. It is specifically identified as a condition that inherently arises from autosomal recessive inheritance. The definition of Ehlers Danlos Syndrome Classic Like 2 elaborates that it is an Ehlers-Danlos syndrome variant caused by homozygous or compound heterozygous mutation in the AEBP1 gene located on chromosome 7p13. This condition is characterized by severe joint and skin laxity, osteoporosis affecting the hips and spine, osteoarthritis, soft redundant skin resembling acrogeria, delayed wound healing with abnormal atrophic scarring, and dislocations of shoulders, hips, knees, and ankles.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080733,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_dermatosparaxis_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that is characterized by severe skin fragility, sagging, redundant skin and that has_material_basis_in mutation in the gene encoding the procollagen protease ADAMTS2 on chromosome 5q35."" .

","Ehlers Danlos Syndrome Dermatosparaxis Type is a specific type of Ehlers Danlos Syndrome and an autosomal recessive disease, which is characterized by severe skin fragility and sagging, redundant skin. This condition fundamentally has its material basis in some form of autosomal recessive inheritance. Moreover, it is defined by having a mutation in the gene encoding the procollagen protease ADAMTS2 located on chromosome 5q35.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080734,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_kyphoscoliotic_type_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ehlers_danlos_syndrome ;
    :has_definition """"""An Ehlers-Danlos syndrome that is characterized by severe muscle hypotonia at birth, generalized joint laxity, scoliosis at birth, and scleral fragility and rupture of the ocular globe
and that has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding lysyl hydroxylase (PLOD1) on chromosome 1p36."""""" .

","Ehlers Danlos syndrome kyphoscoliotic type 1 is a type of autosomal recessive disease and is a subtype of Ehlers Danlos syndrome. It is characterized by a condition that at least has a material basis in some form of autosomal recessive inheritance. Specifically, Ehlers Danlos syndrome kyphoscoliotic type 1 is defined by severe muscle hypotonia at birth, generalized joint laxity, scoliosis at birth, and scleral fragility and rupture of the ocular globe, with its material basis being in homozygous or compound heterozygous mutations in the gene encoding lysyl hydroxylase (PLOD1) on chromosome 1p36.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080735,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_kyphoscoliotic_type_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that is characterized by severe muscle hypotonia at birth, progressive scoliosis, joint hypermobility, hyperelastic skin, myopathy, sensorineural hearing impairment, and normal pyridinoline excretion in urine and that has_material_basis_in homozygous or compound heterozygous mutation in the FKBP14 gene on chromosome 7p15."" ;
    :has_exact_match ""OMIM:614557"" .

","Ehlers-Danlos syndrome kyphoscoliotic type 2 is a type of Ehlers-Danlos syndrome and an autosomal recessive disease, which falls under the category of conditions that at least have a material basis in some form of autosomal recessive inheritance. It is defined as an Ehlers-Danlos syndrome that is marked by severe muscle hypotonia at birth, progressive scoliosis, joint hypermobility, hyperelastic skin, myopathy, sensorineural hearing impairment, and normal pyridinoline excretion in urine. The condition has its material basis in homozygous or compound heterozygous mutation in the FKBP14 gene on chromosome 7p15. Additionally, it has an exact match with the OMIM identifier 614557.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080736,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_musculocontractural_type_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that is characterized by distinctive craniofacial dysmorphism, congenital contractures of thumbs and fingers, clubfeet, severe kyphoscoliosis, muscular hypotonia, hyperextensible thin skin with easy bruisability and atrophic scarring, wrinkled palms, joint hypermobility, and ocular involvement and that has_material_basis_in homozygous or compound heterozygous mutation in the CHST14 gene on chromosome 15q14."" .

","Ehlers Danlos Syndrome Musculocontractural Type 1 is a category of Ehlers Danlos Syndrome and an autosomal recessive disease. It is also classified as a condition that fundamentally arises from some form of autosomal recessive inheritance. This syndrome is defined by a specific set of characteristics, including distinctive craniofacial dysmorphism, congenital contractures of thumbs and fingers, clubfeet, severe kyphoscoliosis, muscular hypotonia, hyperextensible thin skin with easy bruisability and atrophic scarring, wrinkled palms, joint hypermobility, and ocular involvement. The genetic basis for this syndrome is attributed to homozygous or compound heterozygous mutations in the CHST14 gene located on chromosome 15q14.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080737,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_musculocontractural_type_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that is characterized by progressive multisystem fragility-related manifestations, including joint dislocations and deformities; skin hyperextensibility, bruisability, and fragility, with recurrent large subcutaneous hematomas; cardiac valvular, respiratory, gastrointestinal, and ophthalmologic complications; and myopathy, featuring muscle hypoplasia, muscle weakness, and an abnormal muscle fiber pattern in histology in adulthood, resulting in gross motor developmental delay and that has_material_basis_in homozygous mutation in the DSE gene on chromosome 6q22."" .

","Ehlers Danlos Syndrome Musculocontractural Type 2 is categorized under autosomal recessive diseases and is a specific type of Ehlers Danlos Syndrome. This syndrome is associated with autosomal recessive inheritance and manifests symptoms such as muscle weakness. It is defined by its progressive multisystem fragility-related manifestations, which include joint dislocations and deformities, skin hyperextensibility, bruisability, and fragility leading to recurrent large subcutaneous hematomas, as well as complications in cardiac valvular, respiratory, gastrointestinal, and ophthalmologic systems. Additionally, it features myopathy characterized by muscle hypoplasia, muscle weakness, and an abnormal muscle fiber pattern in histology during adulthood, resulting in gross motor developmental delay. The material basis for this syndrome is a homozygous mutation in the DSE gene located on chromosome 6q22.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080738,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_spondylodysplastic_type_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that is characterized by short stature, developmental anomalies of the forearm bones and elbow, and bowing of extremities, in addition to the classic stigmata of Ehlers-Danlos syndrome, including joint laxity, skin hyperextensibility, and poor wound healing and that has_material_basis_in homozygous or compound heterozygous mutation in the B4GALT7 gene on chromosome 5q35."" .

","Ehlers-Danlos Syndrome Spondylodysplastic Type 1 is characterized as a type of Ehlers-Danlos Syndrome and falls under autosomal recessive diseases. It is defined by specific features including short stature, developmental anomalies of the forearm bones and elbow, bowing of extremities, alongside the classic signs of Ehlers-Danlos Syndrome such as joint laxity, skin hyperextensibility, and poor wound healing. These characteristics are attributed to homozygous or compound heterozygous mutations in the B4GALT7 gene located on chromosome 5q35. This syndrome also exemplifies a condition with a material basis in autosomal recessive inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080739,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ehlers_danlos_syndrome_spondylodysplastic_type_3 rdfs:subClassOf :ehlers_danlos_syndrome ;
    :has_definition ""An Ehlers-Danlos syndrome that has_material_basis_in homozygous mutation in the zinc transporter gene SLC39A13 on chromosome 11p11 and that is characterized by short stature, hyperelastic skin and hypermobile joints, protuberant eyes with bluish sclerae, finely wrinkled palms, and characteristic radiologic features."" .

","Ehlers-Danlos syndrome spondylodysplastic type 3 is a type of Ehlers-Danlos syndrome that is characterized by having its material basis in homozygous mutation in the zinc transporter gene SLC39A13 on chromosome 11p11. This condition is characterized by short stature, hyperelastic skin and hypermobile joints, protuberant eyes with bluish sclerae, finely wrinkled palms, and distinctive radiologic features.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080740,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:libman_sacks_endocarditis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_immunoglobulin_level ],
        :autoimmune_disease_of_cardiovascular_system,
        :endocarditis ;
    :has_definition ""An endocarditis that is characterized by Libman-Sacks vegetations, is common in patients with systemic lupus erythematosus and is commonly complicated with embolic cerebrovascular disease."" ;
    :has_exact_synonym ""Libmann–Sachs, Endocarditis in systemic lupus erythematosus"" .

","Libman Sacks endocarditis is a type of endocarditis and an autoimmune disease of the cardiovascular system, which is characterized by a phenotype that includes at least some abnormal immunoglobulin level. It is defined as an endocarditis characterized by Libman-Sacks vegetations, commonly seen in patients with systemic lupus erythematosus, and is frequently complicated with embolic cerebrovascular disease. Moreover, it has exact synonyms, including Libmann–Sachs and Endocarditis in systemic lupus erythematosus.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080741,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:limbic_encephalitis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_immunoglobulin_level ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :seizure ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :temporal_lobe ],
        :autoimmune_disease_of_central_nervous_system,
        :encephalitis ;
    :has_definition ""An encephalitis that is characterized by subacute onset of short-term memory deficits, seizures or psychiatric symptoms located_in the medial temporal lobes."" .

","Limbic encephalitis is a type of encephalitis and an autoimmune disease of the central nervous system. It is characterized by a subacute onset of short-term memory deficits, seizures, or psychiatric symptoms, which are located in the medial temporal lobes. Additionally, limbic encephalitis is associated with some abnormal immunoglobulin level phenotype, has seizures as a symptom, and is a disease that affects the temporal lobe.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080742,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autoimmune_cholangitis rdfs:subClassOf :autoimmune_hepatitis ;
    :has_definition ""An autoimmune hepatitis that is characterized by primary biliary cirrhosis clinical, biochemical, and histologic characteristics with antinuclear antibody positive sera."" ;
    :has_exact_synonym ""autoimmune cholangiopathy"" .

","Autoimmune cholangitis is a type of autoimmune hepatitis characterized by primary biliary cirrhosis clinical, biochemical, and histologic characteristics with antinuclear antibody-positive sera. It is also exactly synonymous with autoimmune cholangiopathy.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080743,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:transverse_myelitis rdfs:subClassOf :myelitis ;
    :has_definition ""A myelitis that is characterized by a band-like sensation across the trunk of the body, with sensory changes below."" .

","Transverse myelitis is a type of myelitis that is defined as a myelitis characterized by a band-like sensation across the trunk of the body, with sensory changes below.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080744,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:antisynthetase_syndrome rdfs:subClassOf :autoimmune_disease ;
    :has_definition ""An autoimmune disease that is characterized by myositis, arthralgia, Raynaud phenomenon, mechanic hands, interstitial lung disease, and serum autoantibodies to aminoacyl transfer RNA synthetases."" ;
    :has_exact_match ""MESH:C537778"" .

","Antisynthetase syndrome is a type of autoimmune disease that is characterized by myositis, arthralgia, Raynaud phenomenon, mechanic hands, interstitial lung disease, and serum autoantibodies to aminoacyl transfer RNA synthetases. Furthermore, antisynthetase syndrome has an exact match with MESH:C537778.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080745,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:polymyositis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_immunoglobulin_level ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        :autoimmune_disease_of_musculoskeletal_system,
        :myositis ;
    :has_definition ""A myositis that is characterized by muscle weakness affecting both sides of your body."" .

","Polymyositis is a type of autoimmune disease of the musculoskeletal system and a type of myositis. It is characterized by a condition that at least has the phenotype of abnormal immunoglobulin level and presents with symptoms such as muscle weakness. Moreover, polymyositis is defined as a myositis that is characterized by muscle weakness affecting both sides of your body.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080746,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:sweet_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :allergic_reaction ],
        :allergic_disease,
        :skin_disease ;
    :has_definition ""A skin disease that is characterized by sudden onset of well defined tender plaques or nodules accompanied by fever, arthralgias, ocular inflammation, headaches and, rarely, oral or genital lesions."" ;
    :has_exact_synonym ""Acute Febrile Neutrophilic Dermatosis"",
        ""Sweet's syndrome"" .

","Sweet syndrome is a type of allergic disease, a type of skin disease, and a type of condition that at least has symptoms of some allergic reactions. It is defined as a skin disease characterized by the sudden onset of well-defined tender plaques or nodules accompanied by fever, arthralgias, ocular inflammation, headaches, and, rarely, oral or genital lesions. Sweet syndrome is also known by its exact synonyms, Acute Febrile Neutrophilic Dermatosis and Sweet's syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080747,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:chronic_urticaria rdfs:subClassOf :urticaria ;
    :has_definition ""An urticaria that is characterized by the presence of urticaria for a period exceeding 6 weeks, assuming symptoms for most days of the week."" .

","Chronic urticaria is a type of urticaria characterized by the presence of urticaria for a period exceeding 6 weeks, assuming symptoms for most days of the week.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080748,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:chronic_inducible_urticaria rdfs:subClassOf :chronic_urticaria ;
    :has_definition ""A chronic urticaria that is characterized by a history of a consistent stimulus that initiates lesions, which are typically short-lived and fleeting, lasting a few minutes up to 2 hours."" .

","Chronic inducible urticaria is a type of chronic urticaria defined as a chronic condition characterized by a history of a consistent stimulus that initiates lesions. These lesions are typically short-lived and fleeting, lasting from a few minutes up to 2 hours.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080749,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:chronic_spontaneous_urticaria rdfs:subClassOf :chronic_urticaria ;
    :has_definition ""A chronic urticaria that is characterized by urticaria independent of any exogenous stimulus."" ;
    :has_exact_synonym ""chronic idiopathic urticaria"" .

","Chronic spontaneous urticaria is a type of chronic urticaria, which is defined as a chronic urticaria characterized by urticaria independent of any exogenous stimulus. It also has the exact synonym chronic idiopathic urticaria.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080750,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:erythema_nodosum rdfs:subClassOf :panniculitis ;
    :has_definition ""A panniculitis that is characterized by sudden onset of painful, erythematous, subcutaneous nodules mainly localized to the pretibial areas. Lesions are usually bilateral and symmetrical, ranging from 1 to 5 cm in diameter."" .

","Erythema nodosum is a type of panniculitis and is defined as a panniculitis characterized by the sudden onset of painful, erythematous, subcutaneous nodules mainly localized to the pretibial areas. The lesions are usually bilateral and symmetrical, ranging from 1 to 5 cm in diameter.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080751,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:keratosis_pilaris_atrophicans rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ichthyosis ;
    :has_definition ""An ichthyosis that is characterized by perifollicular keratosis and inflammation that progresses to atrophy and scarring of the facial skin."" .

","Keratosis pilaris atrophicans is a type of autosomal recessive disease and ichthyosis, characterized by a basis in autosomal recessive inheritance. It is defined as an ichthyosis that involves perifollicular keratosis and inflammation, which progresses to atrophy and scarring of the facial skin.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080752,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:keratosis_pilaris_atrophicans_faciei rdfs:subClassOf :keratosis_pilaris_atrophicans ;
    :has_definition ""A keratosis pilaris atrophicans that is characterized by scar-like follicular depressions and loss of hair primarily in the eyebrow area."" .

","Keratosis Pilaris Atrophicans Faciei is a type of Keratosis Pilaris Atrophicans, defined by scar-like follicular depressions and loss of hair, primarily in the eyebrow area.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080753,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:keratosis_follicularis_spinulosa_decalvans rdfs:subClassOf :keratosis_pilaris_atrophicans ;
    :has_definition ""A keratosis pilaris atrophicans that is characterized by scarring alopecia of the scalp, eyebrows, and axillae, sometimes associated with photophobia and keratoderma."" .

","Keratosis follicularis spinulosa decalvans is a type of keratosis pilaris atrophicans, which is defined as a keratosis pilaris atrophicans characterized by scarring alopecia of the scalp, eyebrows, and axillae, and it is sometimes associated with photophobia and keratoderma.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080754,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_keratosis_follicularis_spinulosa_decalvans rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :keratosis_follicularis_spinulosa_decalvans,
        :x_linked_recessive_disease ;
    :has_definition ""A keratosis follicularis spinulosa decalvans that has_material_basis_in mutation in the MBTPS2 gene."" .

","X-linked keratosis follicularis spinulosa decalvans is a specific type of keratosis follicularis spinulosa decalvans and falls under the category of X-linked recessive diseases. It is characterized by a condition that fundamentally arises from some form of X-linked recessive inheritance. Furthermore, this condition is defined as a keratosis follicularis spinulosa decalvans that has a material basis in a mutation in the MBTPS2 gene.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080755,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_keratosis_follicularis_spinulosa_decalvans rdfs:subClassOf :keratosis_follicularis_spinulosa_decalvans ;
    :has_definition ""A keratosis follicularis spinulosa decalvans that has_material_basis_in autosomal dominant inheritance."" .

","Autosomal dominant keratosis follicularis spinulosa decalvans is a type of keratosis follicularis spinulosa decalvans, defined as a keratosis follicularis spinulosa decalvans that has a material basis in autosomal dominant inheritance.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080756,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:atrophoderma_vermiculata rdfs:subClassOf :keratosis_pilaris_atrophicans ;
    :has_definition ""A keratosis pilaris atrophicans that typically presents in childhood with erythema and follicular keratotic papules that slowly progress to characteristic atrophy, which has been described as worm-eaten, reticular, or honeycomb, and occurs on the cheeks, preauricular area, and forehead."" .

","Atrophoderma vermiculata is a type of keratosis pilaris atrophicans and is defined as a keratosis pilaris atrophicans that typically presents in childhood with erythema and follicular keratotic papules. These slowly progress to characteristic atrophy, described as worm-eaten, reticular, or honeycomb, and occurs on the cheeks, preauricular area, and forehead.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080757,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:fanconi_renotubular_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :fanconi_syndrome ;
    :has_definition ""A Fanconi syndrome that has_material_basis_in heterozygous mutation in the GATM gene on chromosome 15q21."" .

",Fanconi renotubular syndrome 1 is a type of Fanconi syndrome and an autosomal dominant disease. It is defined as a Fanconi syndrome that has a material basis in a heterozygous mutation in the GATM gene on chromosome 15q21. This condition is also categorized as a type of disorder that inherently has a material basis in some form of autosomal dominant inheritance.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080758,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:fanconi_renotubular_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :fanconi_syndrome ;
    :has_definition ""A Fanconi syndrome that has_material_basis_in homozygous mutation in the SLC34A1 gene on chromosome 5q35."" .

","Fanconi renotubular syndrome 2 is a type of Fanconi syndrome and an autosomal recessive disease. It is characterized by a condition that has a material basis in autosomal recessive inheritance. Specifically, this syndrome has a definition as a Fanconi syndrome that arises from a homozygous mutation in the SLC34A1 gene located on chromosome 5q35.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080759,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:fanconi_renotubular_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :fanconi_syndrome ;
    :has_definition ""A Fanconi syndrome that is characterized by characterized by rickets, impaired growth, glucosuria, generalized aminoaciduria, phosphaturia, metabolic acidosis, and low molecular weight proteinuria and that has_material_basis_in heterozygous mutation in the EHHADH gene on chromosome 3q27."" .

","Fanconi renotubular syndrome 3 is a type of Fanconi syndrome and a form of autosomal dominant disease that at least has a material basis in some autosomal dominant inheritance. It is defined as a Fanconi syndrome characterized by rickets, impaired growth, glucosuria, generalized aminoaciduria, phosphaturia, metabolic acidosis, and low molecular weight proteinuria, which has its material basis in a heterozygous mutation in the EHHADH gene on chromosome 3q27.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080760,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:fanconi_renotubular_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :fanconi_syndrome ;
    :has_definition ""A Fanconi syndrome that has_material_basis_in heterozygous mutation in the HNF4A gene on chromosome 20q13."" .

","Fanconi renotubular syndrome 4 is a type of autosomal dominant disease and a type of Fanconi syndrome, which is characterized by a condition that has a material basis in some autosomal dominant inheritance. It is defined as a Fanconi syndrome that has its material basis in a heterozygous mutation in the HNF4A gene on chromosome 20q13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080761,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:fanconi_renotubular_syndrome_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :fanconi_syndrome ;
    :has_definition ""A Fanconi syndrome that is characterized by proximal renotubular dysfunction from birth, followed by progressive kidney disease and pulmonary fibrosis and that has_material_basis_in homozygous mutation in the NDUFAF6 gene on chromosome 8q22."" ;
    :has_exact_synonym ""Acadian-variant Fanconi syndrome"" .

","Fanconi renotubular syndrome 5 is a type of autosomal recessive disease and Fanconi syndrome, which also falls under the category of conditions with a material basis in autosomal recessive inheritance. It is defined as a Fanconi syndrome characterized by proximal renotubular dysfunction from birth, followed by progressive kidney disease and pulmonary fibrosis, and is caused by a homozygous mutation in the NDUFAF6 gene located on chromosome 8q22. Additionally, it is exactly synonymous with Acadian-variant Fanconi syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080762,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_limb_girdle_muscular_dystrophy_type_2z rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :progressive_weakness ],
        :autosomal_recessive_limb_girdle_muscular_dystrophy ;
    :has_definition ""An autosomal recessive limb-girdle muscular dystrophy that is characterized by young-adult onset of slowly progressive proximal upper and lower limb muscle weakness and atrophy and that has_material_basis_in homozygous mutation in the POGLUT1 gene on chromosome 3q13."" ;
    :has_exact_synonym ""limb-girdle muscular dystrophy 21"" .

","Autosomal recessive limb girdle muscular dystrophy type 2z is a type of autosomal recessive limb girdle muscular dystrophy that at least has symptoms of muscle weakness and progressive weakness. It is defined as an autosomal recessive limb-girdle muscular dystrophy characterized by young-adult onset of slowly progressive proximal upper and lower limb muscle weakness and atrophy, which has its material basis in homozygous mutation in the POGLUT1 gene on chromosome 3q13. Additionally, it has the exact synonym limb-girdle muscular dystrophy 21.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080763,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diffuse_gastric_cancer rdfs:subClassOf :stomach_cancer ;
    :has_definition ""A stomach cancer that is characterized by development of diffuse (signet ring cell) gastric cancer underneath the stomach lining."" .

","Diffuse gastric cancer is a type of stomach cancer, which is defined as a stomach cancer characterized by the development of diffuse (signet ring cell) gastric cancer underneath the stomach lining.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080764,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_diffuse_gastric_cancer rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diffuse_gastric_cancer ;
    :has_definition ""A diffuse gastric cancer that is characterized by characterized by the development of diffuse (signet ring cell) gastric cancer at a young age, associated with germline heterozygous mutations of CDH1, MAP3K6 and CTNNA1 genes."" .

","Hereditary diffuse gastric cancer is a type of autosomal dominant and diffuse gastric cancer, which inherently has a material basis in autosomal dominant inheritance. It is defined as a diffuse gastric cancer characterized by the development of diffuse (signet ring cell) gastric cancer at a young age, and is associated with germline heterozygous mutations of the CDH1, MAP3K6, and CTNNA1 genes.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080765,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_intellectual_developmental_disorder_72 rdfs:subClassOf :autosomal_recessive_intellectual_developmental_disorder ;
    :has_definition ""An autosomal recessive intellectual developmental disorder that has_material_basis_in homozygous mutation in the METTL5 gene on chromosome 2q31."" ;
    :has_exact_synonym ""autosomal recessive intellectual developmental disorder-72"",
        ""autosomal recessive mental retardation 72"" .

","Autosomal recessive intellectual developmental disorder 72 is a type of autosomal recessive intellectual developmental disorder. It is defined as an autosomal recessive intellectual developmental disorder that has its material basis in homozygous mutation in the METTL5 gene on chromosome 2q31. Additionally, autosomal recessive intellectual developmental disorder 72 is exactly synonymous with autosomal recessive intellectual developmental disorder-72 and autosomal recessive mental retardation 72.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080766,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:erythrokeratodermia_variabilis_et_progressiva_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :erythrokeratodermia_variabilis ;
    :has_definition ""An erythrokeratodermia variabilis that is characterized by erythematous hyperkeratotic plaques that develop within the first year of life, beginning on distal extremities and progressing to involve the face, wrists, and ankles, with sparing of volar surfaces and that has_material_basis_in heterozygous mutation in the TRPM4 gene on chromosome 19q13."" .

","Erythrokeratodermia variabilis et progressiva 6 is a subtype of erythrokeratodermia variabilis and an autosomal dominant disease, which inherently has a material basis in some form of autosomal dominant inheritance. It is defined as an erythrokeratodermia variabilis characterized by the development of erythematous hyperkeratotic plaques within the first year of life. These plaques initially appear on distal extremities and progressively involve the face, wrists, and ankles, while sparing volar surfaces. This condition has its material basis in a heterozygous mutation in the TRPM4 gene located on chromosome 19q13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080767,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autoimmune_myocarditis rdfs:subClassOf [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_symptom ;
                            owl:someValuesFrom :inflammation ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :disease_has_location ;
                                    owl:someValuesFrom :myocardium ] ;
                            rdf:rest :nil ] ] ],
        :autoimmune_disease_of_cardiovascular_system,
        :myocarditis ;
    :has_definition ""An autoimmune disease of cardiovascular system that is characterized by inflammation of the heart muscle."" .

","Autoimmune myocarditis is a type of autoimmune disease of the cardiovascular system, which is characterized by inflammation of the heart muscle. This condition is also a type of myocarditis. Moreover, autoimmune myocarditis falls under the category of conditions that intersect with those having at least one symptom of inflammation and diseases that are located in the myocardium.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080768,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:pyridoxine_dependent_epilepsy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :epilepsy ;
    :has_close_match ""UMLS_CUI:C1849508"" ;
    :has_definition ""An epilepsy that is characterized by intractable seizures within the first weeks to months of life that are not controlled with antiepileptic drugs but respond both clinically and electrographically to large daily supplements of pyridoxine."" ;
    :has_exact_match ""GARD:9298"",
        ""MESH:C536254"",
        ""ORDO:3006"",
        ""SNOMEDCT_US_2023_03_01:734434007"" .

","Pyridoxine dependent epilepsy is a type of epilepsy and an autosomal recessive disease, which also falls under the category of conditions that have a material basis in autosomal recessive inheritance. It is defined as an epilepsy characterized by intractable seizures occurring within the first weeks to months of life, which are not controlled by antiepileptic drugs but respond both clinically and electrographically to large daily supplements of pyridoxine. Moreover, pyridoxine dependent epilepsy is closely matched with UMLS_CUI:C1849508 and has exact matches with several medical databases and classifications including GARD:9298, MESH:C536254, ORDO:3006, and SNOMEDCT_US_2023_03_01:734434007.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0080769,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:early_onset_vitamin_b6_dependent_epilepsy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormality_of_vitamin_b_metabolism ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :pyridoxine_dependent_epilepsy ;
    :has_broad_synonym ""early-onset vitamin B6-dependent epilepsy"" ;
    :has_definition ""A pyridoxine-dependent epilepsy that has_material_basis_in homozygous or compound heterozygous mutation in the PLPBP gene on chromosome 8p11.23."" ;
    :has_exact_match ""OMIM:617290"" ;
    :has_exact_synonym ""EPEO1"",
        ""PDE-PLPBP"" .

","Early onset vitamin B6 dependent epilepsy 1 is a type of pyridoxine dependent epilepsy, which also falls under the category of conditions that at least have a material basis in some autosomal recessive inheritance and exhibit a phenotype characterized by some abnormality of vitamin B metabolism. This condition is defined as a pyridoxine-dependent epilepsy that has its material basis in homozygous or compound heterozygous mutation in the PLPBP gene on chromosome 8p11.23. It is broadly synonymous with early-onset vitamin B6-dependent epilepsy and has exact synonyms EPEO1 and PDE-PLPBP. Moreover, early onset vitamin B6 dependent epilepsy 1 has an exact match with OMIM:617290.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0080770,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_beta_thalassemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :beta_thalassemia ;
    :has_definition ""A beta thalassemia that has_material_basis_in one dominantly inheriteed mutated HBB gene and signs and symptoms of beta-thalassemia major or beta-thalassemia intermedia."" ;
    :has_exact_synonym ""inclusion body beta-thalassemia"" .

","Autosomal dominant beta thalassemia is a specific form of beta thalassemia and an autosomal dominant disease. It is characterized by a type of condition that fundamentally involves autosomal dominant inheritance. This condition is defined as a beta thalassemia that arises from a single dominantly inherited mutated HBB gene, leading to signs and symptoms associated with beta-thalassemia major or beta-thalassemia intermedia. Additionally, autosomal dominant beta thalassemia is also precisely known as inclusion body beta-thalassemia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080771,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:beta_thalassemia_major rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :beta_thalassemia ;
    :has_definition ""A beta thalassemia that is characterized by severe anemia and enlarged liver and spleen before 2 years of age."" ;
    :has_exact_synonym ""Cooley's anemia"" .

",Beta thalassemia major is a type of beta thalassemia and a type of condition that has a material basis in autosomal recessive inheritance. It is characterized by severe anemia and an enlarged liver and spleen before the age of 2 years. Beta thalassemia major is also exactly synonymous with Cooley's anemia.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080772,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:beta_thalassemia_intermedia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :beta_thalassemia ;
    :has_definition ""A beta thalassemia that is characterized by mild to moderate anemia along with slow growth and bone abnormalities appearing in early childhood or later in life."" .

","Beta thalassemia intermedia is a type of beta thalassemia and a type of condition that has a material basis in autosomal recessive inheritance. It is defined as a beta thalassemia characterized by mild to moderate anemia, alongside slow growth and bone abnormalities that appear in early childhood or later in life.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080773,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:delta_beta_thalassemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :beta_thalassemia ;
    :has_definition ""A beta thalassemia that is characterized by decreased or absent synthesis of both the delta- and beta-globin chains, which leads to a compensatory increase in fetal gamma-chain synthesis. This disorder results in a microcytic anemia that is clinically mild."" .

","Delta beta thalassemia is a type of autosomal dominant disease and a type of beta thalassemia, which is characterized by something that at least has a material basis in autosomal dominant inheritance. It is defined as a beta thalassemia that is characterized by decreased or absent synthesis of both the delta- and beta-globin chains, leading to a compensatory increase in fetal gamma-chain synthesis. This disorder results in a microcytic anemia that is clinically mild.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080774,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thalassemia_minor rdfs:subClassOf :beta_thalassemia ;
    :has_definition ""A beta thalassemia that has_material_basis_in one HBB gene mutation without typical thalassemia symptoms, but may have some symptoms of anemia."" .

","Thalassemia minor is a type of beta thalassemia defined as a beta thalassemia that has a material basis in one HBB gene mutation without typical thalassemia symptoms, but may have some symptoms of anemia.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080775,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:complete_androgen_insensitivity_syndrome rdfs:subClassOf :androgen_insensitivity_syndrome ;
    :has_definition ""An androgen insensitivity syndrome that is characterized by complete androgen insensitivity as the body cannot use androgens at all, having the external sex characteristics of females but no uterus."" .

","Complete androgen insensitivity syndrome is a type of androgen insensitivity syndrome that is defined by its characteristic of complete androgen insensitivity, meaning the body cannot utilize androgens at all. Individuals with this condition exhibit the external sex characteristics of females but do not have a uterus.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080776,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:partial_androgen_insensitivity_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :androgen_insensitivity_syndrome,
        :x_linked_recessive_disease ;
    :has_definition ""An androgen insensitivity syndrome that is characterized by a 46,XY karyotype and testes that produce age-appropriate androgen levels but have undermasculinized external genitalia due to defects in androgen action."" ;
    :has_exact_synonym ""Reifenstein syndrome"" .

","Partial Androgen Insensitivity Syndrome (PAIS) is a type of Androgen Insensitivity Syndrome that has a material basis in X-linked recessive inheritance, positioning it as a type of X-linked recessive disease. PAIS is characterized by a 46,XY karyotype with testes that produce age-appropriate androgen levels, but due to defects in androgen action, the external genitalia are undermasculinized. Additionally, PAIS is also exactly synonymous with Reifenstein syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080777,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lung_sarcomatoid_carcinoma rdfs:subClassOf :lung_carcinoma ;
    :has_definition ""A lung carcinoma that is characterized by the presence of a sarcomatoid component often associated with giant cell differentiation."" ;
    :has_exact_synonym ""Sarcomatoid carcinoma of the lung"",
        ""pulmonary sarcomatoid carcinoma"" .

","Lung sarcomatoid carcinoma is a type of lung carcinoma characterized by the presence of a sarcomatoid component often associated with giant cell differentiation. It is also exactly synonymous with ""Sarcomatoid carcinoma of the lung"" and ""pulmonary sarcomatoid carcinoma.""",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080778,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:transient_infantile_liver_failure rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :liver_disease ;
    :has_definition ""A liver disease that is characterized by elevated liver enzymes, jaundice, vomiting, coagulopathy, and hyperbilirubinemia, and the presence of increased serum lactate and that has_material_basis_in homozygous or compound heterozygous mutation in the TRMU gene, which is involved in mitochondrial protein translation, on chromosome 22q13."" .

","Transient infantile liver failure is a type of liver disease and an autosomal recessive disease that is characterized by elevated liver enzymes, jaundice, vomiting, coagulopathy, and hyperbilirubinemia, along with the presence of increased serum lactate. This condition at least has a material basis in some autosomal recessive inheritance and is specifically associated with homozygous or compound heterozygous mutation in the TRMU gene, which plays a role in mitochondrial protein translation, located on chromosome 22q13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080779,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:plasmablastic_lymphoma rdfs:subClassOf :diffuse_large_b_cell_lymphoma ;
    :has_definition ""A diffuse large B-cell lymphoma that is characterized by the presence of large neoplastic cells resembling B-immunoblasts which have the immunophenotypic profile of plasma cells."" .

","Plasmablastic lymphoma is a subtype of diffuse large B-cell lymphoma, which is defined as a diffuse large B-cell lymphoma characterized by the presence of large neoplastic cells resembling B-immunoblasts and having the immunophenotypic profile of plasma cells.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080780,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acute_erythroid_leukemia rdfs:subClassOf :acute_myeloid_leukemia ;
    :has_definition ""An acute myeloid leukemia that is characterized by a predominant immature erythroid population."" .

",Acute erythroid leukemia is a type of acute myeloid leukemia and it is defined as an acute myeloid leukemia that is characterized by a predominant immature erythroid population.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080781,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:benign_exocrine_pancreas_neoplasm rdfs:subClassOf :endocrine_organ_benign_neoplasm ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :benign_neoplasm ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :disease_has_location ;
                                    owl:someValuesFrom :exocrine_pancreas ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""An endocrine organ benign neoplasm arising from the exocrine pancreas."" .

","A benign exocrine pancreas neoplasm is the same as an entity that intersects with both a benign neoplasm and a disease, which is located at the exocrine pancreas. It is also a type of benign neoplasm of the endocrine organ. Additionally, a benign exocrine pancreas neoplasm is defined as an endocrine organ benign neoplasm that arises from the exocrine pancreas.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080782,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mucinous_pancreas_adenocarcinoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :derives_from ;
            owl:someValuesFrom [ owl:intersectionOf [ rdf:first :epithelial_cell ;
                            rdf:rest [ rdf:first [ a owl:Restriction ;
                                            owl:onProperty :has_origin ;
                                            owl:someValuesFrom :mucous_gland ] ;
                                    rdf:rest :nil ] ] ] ],
        :mucinous_adenocarcinoma,
        :pancreatic_adenocarcinoma ;
    :has_definition ""A pancreatic adenocarcinoma that derives_from epithelial cells originating in glandular tissue, which produce mucin."" .

","Mucinous pancreas adenocarcinoma is a type of mucinous adenocarcinoma and also a type of pancreatic adenocarcinoma. It is classified as a condition that derives from an intersection of epithelial cells and glands that originate from mucous glands. Furthermore, it is defined as a pancreatic adenocarcinoma that originates from epithelial cells in glandular tissue, which produce mucin.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080784,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:urinary_tract_infection rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :bacteria ],
        :bacterial_infectious_disease,
        :urinary_system_disease ;
    :has_definition ""An urinary system disease that is characterized by an infection in any part of the urinary system, including the kidneys, ureters, bladder or urethra."" ;
    :has_exact_match ""MESH:D014552"" ;
    :has_exact_synonym ""UTI"" .

","Urinary tract infection (UTI) is a type of bacterial infectious disease and a type of urinary system disease, which specifically originates from bacteria. It is characterized by an infection in any part of the urinary system, including the kidneys, ureters, bladder, or urethra. Additionally, ""UTI"" is an exact synonym for urinary tract infection, and it has an exact match with the MESH identifier D014552.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080785,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:brown_vialetto_van_laere_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :brown_vialetto_van_laere_syndrome ;
    :has_definition ""A Brown-Vialetto-Van Laere syndrome that is characterized by progressive bulbar palsy with sensorineural deafness that has_material_basis_in homozygous or compound heterozygous mutation in the C20ORF54 gene (SLC52A3) on chromosome 20p13."" .

","Brown-Vialetto-Van Laere Syndrome 1 is classified under various categories: it is a type of Brown-Vialetto-Van Laere Syndrome, a type of autosomal recessive disease, and a condition that fundamentally arises from autosomal recessive inheritance. Furthermore, it is defined as a specific form of Brown-Vialetto-Van Laere syndrome characterized by progressive bulbar palsy with sensorineural deafness, with its material basis being homozygous or compound heterozygous mutations in the C20ORF54 gene (SLC52A3) located on chromosome 20p13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080786,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:brown_vialetto_van_laere_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :brown_vialetto_van_laere_syndrome ;
    :has_definition ""A Brown-Vialetto-Van Laere syndrome that is characterized by early childhood onset of sensorineural deafness, bulbar dysfunction, and severe diffuse muscle weakness and wasting of the upper and lower limbs and axial muscles, resulting in respiratory insufficiency and that has_material_basis_in homozygous or compound heterozygous mutation in the SLC52A2 gene on chromosome 8q24."" .

","Brown-Vialetto-Van Laere Syndrome 2 is a specific type of Brown-Vialetto-Van Laere Syndrome, and it is also classified as a type of autosomal recessive disease. It is characterized by having its material basis in some form of autosomal recessive inheritance and displays symptoms including muscle weakness. Specifically, Brown-Vialetto-Van Laere Syndrome 2 is defined as a condition that emerges in early childhood, marked by sensorineural deafness, bulbar dysfunction, and severe, diffuse muscle weakness and wasting affecting the upper and lower limbs as well as axial muscles. This leads to respiratory insufficiency. The condition is caused by homozygous or compound heterozygous mutations in the SLC52A2 gene located on chromosome 8q24.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080787,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:proximal_symphalangism_1 rdfs:subClassOf :proximal_symphalangism ;
    :has_definition ""A proximal symphalangism that is characterized by ankylosis of the proximal interphalangeal joints, carpal and tarsal bone fusion, and, in some cases, conductive deafness and that has_material_basis_in heterozygous mutation in the NOG gene on chromosome 17q22."" .

","Proximal symphalangism 1 is a specific type of proximal symphalangism. It is defined as a form of proximal symphalangism characterized by ankylosis of the proximal interphalangeal joints, fusion of carpal and tarsal bones, and, in some instances, conductive deafness. This condition arises due to a heterozygous mutation in the NOG gene located on chromosome 17q22.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080788,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:proximal_symphalangism_2 rdfs:subClassOf :proximal_symphalangism ;
    :has_definition ""A proximal symphalangism that is characterized by absence of the cuboid bone and lack of shortness of the first and fifth metacarpal bones, and the presence of distal interphalangeal joint fusions and flat feet and that has_material_basis_in heterozygous mutation in the GDF5 gene on chromosome 20q11."" .

","Proximal symphalangism 2 is a specific type of proximal symphalangism, characterized by the absence of the cuboid bone, lack of shortness of the first and fifth metacarpal bones, and the presence of distal interphalangeal joint fusions and flat feet. This condition has its material basis in a heterozygous mutation in the GDF5 gene located on chromosome 20q11.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080789,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:treacher_collins_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :treacher_collins_syndrome ;
    :has_definition ""A Treacher Collins syndrome that has_material_basis_in heterozygous mutation in the 'treacle' gene (TCOF1) on chromosome 5q32."" .

",Treacher Collins Syndrome 1 is a type of Treacher Collins Syndrome and is also categorized under conditions that at least have a material basis in some autosomal dominant inheritance. It is defined as a Treacher Collins Syndrome that has its material basis in a heterozygous mutation in the 'treacle' gene (TCOF1) on chromosome 5q32.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080790,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:treacher_collins_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_recessive_disease,
        :treacher_collins_syndrome ;
    :has_definition ""A Treacher Collins syndrome that has_material_basis_in heterozygous mutation in the POLR1D gene on chromosome 13q12."" .

","Treacher Collins Syndrome 2 is a type of Treacher Collins Syndrome and an autosomal recessive disease. It is characterized by having a material basis in both autosomal dominant and autosomal recessive inheritance. Specifically, this syndrome is defined by a heterozygous mutation in the POLR1D gene on chromosome 13q12.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080791,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:treacher_collins_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :treacher_collins_syndrome ;
    :has_definition ""A Treacher Collins syndrome that has_material_basis_in compound heterozygous mutation in the POLR1C gene on chromosome 6p21."" .

","Treacher Collins Syndrome 3 is a type of Treacher Collins Syndrome and an autosomal recessive disease. It is characterized by having a material basis in some form of autosomal recessive inheritance. Specifically, this syndrome is defined by a compound heterozygous mutation in the POLR1C gene located on chromosome 6p21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080792,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:treacher_collins_syndrome_4 rdfs:subClassOf :treacher_collins_syndrome ;
    :has_definition ""A Treacher Collins syndrome that is characterized by craniofacial dysmorphisms including downslanting palpebral fissures, malar and mandibular hypoplasia, and microtia and that has_material_basis_in heterozygous mutation in the POLR1B gene on chromosome 2q14."" .

","Treacher Collins Syndrome 4 is a type of Treacher Collins Syndrome, characterized by craniofacial dysmorphisms such as downslanting palpebral fissures, malar and mandibular hypoplasia, and microtia. It has a material basis in a heterozygous mutation in the POLR1B gene on chromosome 2q14.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080794,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:childhood_acute_megakaryoblastic_leukemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :childhood_onset ],
        :acute_megakaryocytic_leukemia ;
    :has_definition ""An acute megakaryocytic leukemia that is characterized by fusion oncogenes involving transcriptional regulators in childhood."" ;
    :has_exact_synonym ""pediatric non-Down syndrome acute megakaryoblastic leukemia"" .

","Childhood acute megakaryoblastic leukemia is a type of acute megakaryocytic leukemia and is also known as pediatric non-Down syndrome acute megakaryoblastic leukemia. This type of leukemia begins during childhood onset. It is characterized by fusion oncogenes involving transcriptional regulators in childhood, defining it as an acute megakaryocytic leukemia.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080795,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acute_basophilic_leukemia rdfs:subClassOf :acute_myeloid_leukemia ;
    :has_definition ""An acute myeloid leukemia that is characterized by primary differentiation to basophils."" .

",Acute basophilic leukemia is a type of acute myeloid leukemia that is characterized by primary differentiation to basophils.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080796,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:core_binding_factor_acute_myeloid_leukemia rdfs:subClassOf :acute_myeloid_leukemia ;
    :has_definition ""An acute myeloid leukemia that is characterized by the presence of t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22). These cytogenetic abnormalities result in disruption of the transcription factor CBF, which is a regulator of normal hematopoiesis."" .

","Core binding factor acute myeloid leukemia is a type of acute myeloid leukemia characterized by the presence of t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22). These cytogenetic abnormalities disrupt the transcription factor CBF, a regulator of normal hematopoiesis.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080797,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nasal_type_extranodal_nk_t_cell_lymphoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :nasal_cavity ],
        :mature_t_cell_and_nk_cell_lymphoma,
        :nasal_cavity_cancer ;
    :has_definition ""A mature T-cell and NK-cell lymphoma that is characterized by an often angiocentric and angiodestructive cellular infiltrate composed of EBV positive NK/T cells."" .

","Nasal type extranodal NK T cell lymphoma is a type of mature T cell and NK cell lymphoma, as well as a type of nasal cavity cancer. It is defined as a mature T-cell and NK-cell lymphoma characterized by an often angiocentric and angiodestructive cellular infiltrate composed of EBV positive NK/T cells. Additionally, it falls under the category of diseases located in the nasal cavity.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080798,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:myeloid_leukemia_associated_with_down_syndrome rdfs:subClassOf :acute_megakaryocytic_leukemia ;
    :has_definition ""An acute megakaryocytic leukemia occurring in children with Down syndrome and that has_material_basis_in mutation in the GATA1 gene."" .

","Myeloid leukemia associated with Down syndrome is a type of acute megakaryocytic leukemia, which is defined as an acute megakaryocytic leukemia occurring in children with Down syndrome. This condition has its material basis in a mutation in the GATA1 gene.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080799,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:sinonasal_undifferentiated_carcinoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :paranasal_sinus ],
        :nasal_cavity_carcinoma,
        :paranasal_sinus_cancer ;
    :has_definition ""A nasal cavity carcinoma that arises from the sinonasal tract and that is characterized by the presence of small to medium size malignant cells."" .

",Sinonasal undifferentiated carcinoma is a type of paranasal sinus cancer and a type of nasal cavity carcinoma. It is also a type of condition where the disease is located in the paranasal sinus. It is defined as a nasal cavity carcinoma that originates from the sinonasal tract and is characterized by the presence of small to medium-sized malignant cells.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080800,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:salivary_gland_mucinous_adenocarcinoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :derives_from ;
            owl:someValuesFrom [ owl:intersectionOf [ rdf:first :epithelial_cell ;
                            rdf:rest [ rdf:first [ a owl:Restriction ;
                                            owl:onProperty :has_origin ;
                                            owl:someValuesFrom :mucous_gland ] ;
                                    rdf:rest :nil ] ] ] ],
        :mucinous_adenocarcinoma,
        :salivary_gland_carcinoma ;
    :has_definition ""A salivary gland carcinoma that is characterized by the presence of large pools of extracellular mucin in which clusters of malignant epithelial cells are found."" .

","Salivary gland mucinous adenocarcinoma is a type of salivary gland carcinoma and also a type of mucinous adenocarcinoma. It falls under a category that at least derives from an intersection involving epithelial cells and entities that originate from mucous glands. Additionally, salivary gland mucinous adenocarcinoma is defined as a salivary gland carcinoma characterized by the presence of large pools of extracellular mucin, within which clusters of malignant epithelial cells are found.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080801,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_craniometaphyseal_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :craniometaphyseal_dysplasia ;
    :has_definition ""A craniometaphyseal dysplasia that has_material_basis_in heterozygous mutation in the ANKH gene on chromosome 5p15."" .

","Autosomal dominant craniometaphyseal dysplasia is a type of disease characterized by autosomal dominant inheritance and falls under the broader category of craniometaphyseal dysplasia. This particular condition arises from a heterozygous mutation in the ANKH gene located on chromosome 5p15, which serves as its material basis.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080802,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_craniometaphyseal_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :craniometaphyseal_dysplasia ;
    :has_definition ""A craniometaphyseal dysplasia that has_material_basis_in homozygous mutation in the GJA1 gene on chromosome 6q22."" .

","Autosomal recessive craniometaphyseal dysplasia is a type of autosomal recessive disease and a type of craniometaphyseal dysplasia. It is characterized by having a material basis in autosomal recessive inheritance. Specifically, this condition is defined as a craniometaphyseal dysplasia that arises from a homozygous mutation in the GJA1 gene located on chromosome 6q22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080803,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cranioectodermal_dysplasia_1 rdfs:subClassOf :cranioectodermal_dysplasia ;
    :has_definition ""A cranioectodermal dysplasia that has_material_basis_in homozygous or compound heterozygous mutation in the IFT122 gene on chromosome 3q21."" .

","Cranioectodermal dysplasia 1 is a type of cranioectodermal dysplasia, defined as having a material basis in homozygous or compound heterozygous mutation in the IFT122 gene on chromosome 3q21.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080804,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cranioectodermal_dysplasia_2 rdfs:subClassOf :cranioectodermal_dysplasia ;
    :has_definition ""A cranioectodermal dysplasia that has_material_basis_in compound heterozygous mutation in the WDR35 gene on chromosome 2p24."" .

","Cranioectodermal dysplasia 2 is a specific type of cranioectodermal dysplasia, characterized by a definition that includes its material basis in compound heterozygous mutation in the WDR35 gene located on chromosome 2p24.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080805,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cranioectodermal_dysplasia_3 rdfs:subClassOf :cranioectodermal_dysplasia ;
    :has_definition ""A cranioectodermal dysplasia that has_material_basis_in homozygous mutation in the IFT43 gene on chromosome 14q24."" .

",Cranioectodermal dysplasia 3 is a type of cranioectodermal dysplasia and is defined as a cranioectodermal dysplasia that has its material basis in homozygous mutation in the IFT43 gene on chromosome 14q24.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080806,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cranioectodermal_dysplasia_4 rdfs:subClassOf :cranioectodermal_dysplasia ;
    :has_definition ""A cranioectodermal dysplasia that has_material_basis_in compound heterozygous mutation in the WDR19 gene on chromosome 4p14."" .

",Cranioectodermal dysplasia 4 is a type of cranioectodermal dysplasia and is defined as a cranioectodermal dysplasia that has its material basis in compound heterozygous mutation in the WDR19 gene on chromosome 4p14.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080807,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_craniodiaphyseal_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :craniodiaphyseal_dysplasia ;
    :has_definition ""A craniodiaphyseal dysplasia that has_material_basis_in heterozygous mutation in the SOST gene on chromosome 17q21."" .

","Autosomal dominant craniodiaphyseal dysplasia is a type of autosomal dominant disease, craniodiaphyseal dysplasia, and something that at least has a material basis in some autosomal dominant inheritance. It is defined as a craniodiaphyseal dysplasia that has a material basis in a heterozygous mutation in the SOST gene on chromosome 17q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080808,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mammary_analogue_secretory_carcinoma rdfs:subClassOf :salivary_gland_carcinoma ;
    :has_definition ""A salivary gland carcinoma that has_material_basis_in a chromosomal translocation that results in an ETV6-NTRK3 fusion gene."" .

","Mammary analogue secretory carcinoma is a type of salivary gland carcinoma, defined as a salivary gland carcinoma that has a material basis in a chromosomal translocation resulting in an ETV6-NTRK3 fusion gene.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080809,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:chronic_asthma rdfs:subClassOf :asthma ;
    :has_definition ""An asthma that is characterized by the development of persistent airway inflammation and recurrent attacks of breathlessness and wheezing, which vary in severity and frequency."" .

","Chronic asthma is a type of asthma that is defined by the development of persistent airway inflammation and recurrent attacks of breathlessness and wheezing, which vary in severity and frequency.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080810,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acute_asthma rdfs:subClassOf :asthma ;
    :has_definition ""An asthma that is characterized by severe and sudden onset of increasing wheezing, airways closing, smooth muscle contraction, mucus plugging and lower airway edema that may be reversible upon treatment."" .

","Acute asthma is a type of asthma defined by a severe and sudden onset of symptoms, including increasing wheezing, airways closing, smooth muscle contraction, mucus plugging, and lower airway edema, which may be reversible upon treatment.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080811,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:extrinsic_asthma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :allergic_reaction ],
        [ a owl:Restriction ;
            owl:onProperty :transmitted_by ;
            owl:someValuesFrom :airborne_transmission ],
        :allergic_disease,
        :chronic_asthma ;
    :has_definition ""A chronic asthma that is triggered by an allergen and that is characterized by an immune system overreaction to a harmless substance, such as pollen or dust, with the subsequent release of immunoglobin E (IgE) antibodies."" ;
    :has_exact_synonym ""atopic asthma"" .

","Extrinsic asthma is recognized as a chronic, allergic disease, which can be transmitted through airborne means and often presents symptoms such as allergic reactions. It is defined as a chronic asthma that is set off by an allergen, marked by an immune system overreaction to innocuous substances like pollen or dust, leading to the release of immunoglobin E (IgE) antibodies. Furthermore, extrinsic asthma is precisely synonymous with atopic asthma.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080812,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:intermittent_asthma rdfs:subClassOf :chronic_asthma ;
    :has_definition ""A chronic asthma that is characterized by severity with symptoms two or fewer days per week, nighttime awakenings two or fewer times per month, use of short-acting beta agonist for symptom control two or fewer days per week and no interference with normal activity."" .

","Intermittent asthma is a type of chronic asthma characterized by its severity with symptoms manifesting two or fewer days per week, nighttime awakenings occurring two or fewer times per month, the use of short-acting beta agonist for symptom control needed two or fewer days per week, and no interference with normal activity.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080813,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:persistent_mild_asthma rdfs:subClassOf :chronic_asthma ;
    :has_definition ""A chronic asthma that is characterized by severity with symptoms two or more days per week, nighttime awakenings three to four times per month, use of short-acting beta agonist for symptom control two or more days per week and minor limitation of normal activity."" .

","Persistent mild asthma is a type of chronic asthma that is defined by its severity, characterized by symptoms occurring two or more days per week, nighttime awakenings three to four times per month, the use of short-acting beta agonist for symptom control two or more days per week, and minor limitation of normal activity.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080814,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:persistent_moderate_asthma rdfs:subClassOf :chronic_asthma ;
    :has_definition ""A chronic asthma that is characterized by severity with daily symptoms, nighttime awakenings more than once per week, daily use of short-acting beta agonist for symptom control and some limitation of normal activity."" .

","Persistent moderate asthma is a type of chronic asthma, defined as a chronic asthma characterized by daily symptoms, nighttime awakenings more than once per week, daily use of short-acting beta agonist for symptom control, and some limitation of normal activity.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080815,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:childhood_onset_asthma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :childhood_onset ],
        :chronic_asthma ;
    :has_definition ""A chronic asthma that is characterized by first presentation in early childhood."" ;
    :has_exact_synonym ""childhood asthma"" .

","Childhood onset asthma is a type of chronic asthma and something that starts during early childhood. It is defined as a chronic asthma characterized by its first presentation in early childhood. Additionally, it has an exact synonym, which is childhood asthma.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080816,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:adult_onset_severe_asthma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        :chronic_asthma ;
    :has_definition ""A chronic asthma that is characterized by first presentation in adulthood."" .

","Adult onset severe asthma is a type of chronic asthma that begins in adulthood. It is defined as a chronic asthma characterized by its first presentation in adulthood, highlighting that its existence starts during adult onset.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080817,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:t2_high_asthma rdfs:subClassOf :chronic_asthma ;
    :has_definition ""A chronic asthma that is characterized by the pathophysiology phenotype combination (endotype) of early-onset allergic asthma, late-onset eosinophilic asthma, and aspirin-exacerbated respiratory disease."" ;
    :has_exact_synonym ""type 2 high endotype"" .

","T2 high asthma is a type of chronic asthma that is defined as a chronic asthma characterized by the pathophysiology phenotype combination (endotype) of early-onset allergic asthma, late-onset eosinophilic asthma, and aspirin-exacerbated respiratory disease. Additionally, it has the exact synonym ""type 2 high endotype.""",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080818,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:t2_low_asthma rdfs:subClassOf :chronic_asthma ;
    :has_definition ""A chronic asthma that is characterized by the pathophysiology phenotype combination (endotype) of non-atopic, smoking, obesity related, and elderly and that is characterized by neutrophilic (sputum neutrophils > 40–60%) or paucigranulocytic (i.e., normal sputum levels of both eosinophils and neutrophils) inflammation and a lack of response to corticosteroid therapy."" ;
    :has_exact_synonym ""type 2 low endotype"" .

","T2 low asthma is a type of chronic asthma that is defined as a chronic asthma characterized by a pathophysiology phenotype combination (endotype) of non-atopic, smoking, obesity-related, and elderly. It is further characterized by neutrophilic (sputum neutrophils > 40–60%) or paucigranulocytic (i.e., normal sputum levels of both eosinophils and neutrophils) inflammation and a lack of response to corticosteroid therapy. Additionally, T2 low asthma has an exact synonym, which is the type 2 low endotype.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080819,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:environmental_induced_asthma rdfs:subClassOf :intrinsic_asthma ;
    :has_definition ""An intrinsic asthma that is characterized by exposure to tobacco smoke and other inflammatory gases or particulate matter."" ;
    :has_exact_synonym ""irritant asthma"" .

",Environmental induced asthma is a type of intrinsic asthma and has the exact synonym irritant asthma. It is defined as an intrinsic asthma that is characterized by exposure to tobacco smoke and other inflammatory gases or particulate matter.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080820,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:occupational_asthma rdfs:subClassOf :environmental_induced_asthma ;
    :has_definition ""An environmental induced asthma that is characterized by a variable airflow limitation due to exposure to inhaled irritants in the workplace."" .

",Occupational asthma is a type of environmental induced asthma characterized by a variable airflow limitation due to exposure to inhaled irritants in the workplace.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080821,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:exercise_induced_bronchoconstriction rdfs:subClassOf :intrinsic_asthma ;
    :has_definition ""An intrinsic asthma that is characterized by narrowing of the airways during or shortly after exercise."" ;
    :has_exact_synonym ""exercise-induced asthma"" .

","Exercise-induced bronchoconstriction is a type of intrinsic asthma and has the definition of an intrinsic asthma that is characterized by the narrowing of the airways during or shortly after exercise. Furthermore, it has the exact synonym ""exercise-induced asthma"".",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080822,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:aspirin_induced_respiratory_disease rdfs:subClassOf :intrinsic_asthma ;
    :has_definition ""An intrinsic asthma that is characterized by severe and prolonged airway obstruction after the ingestion of aspirin or other non-steroidal anti-inflammatory drugs."" ;
    :has_exact_synonym ""aspirin-sensitive asthma"" .

","Aspirin-induced respiratory disease is a type of intrinsic asthma and has an exact synonym, aspirin-sensitive asthma. It is defined as an intrinsic asthma that is characterized by severe and prolonged airway obstruction after the ingestion of aspirin or other non-steroidal anti-inflammatory drugs.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080823,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:near_fatal_asthma rdfs:subClassOf :acute_asthma ;
    :has_definition ""An acute asthma that is characterized by a respiratory arrest or arterial carbon dioxide tension greater than 50 mmHg, with or without altered consciousness, requiring mechanical ventilation."" .

","Near fatal asthma is a type of acute asthma, which is defined as an acute asthma characterized by a respiratory arrest or arterial carbon dioxide tension greater than 50 mmHg, with or without altered consciousness, necessitating mechanical ventilation.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080824,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:persistent_severe_asthma rdfs:subClassOf :chronic_asthma ;
    :has_definition ""A chronic asthma that is characterized by severity with symptoms two or fewer days per week, nighttime awakenings two or fewer times per month, use of short-acting beta agonist for symptom control several times per day and extremely limited normal activity."" .

","Persistent severe asthma is a type of chronic asthma that is defined by its severity. It is characterized by symptoms that occur two or fewer days per week, nighttime awakenings that happen two or fewer times per month, the need to use short-acting beta agonist for symptom control several times per day, and extremely limited normal activity.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080825,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thunderstorm_triggered_asthma rdfs:subClassOf :allergic_asthma ;
    :has_definition ""An allergic asthma that is characterized by acute asthma attacks immediately following a thunderstorm resulting from inhalation of high concentrations of aeroallergens, most commonly grass pollen."" ;
    :has_exact_synonym ""thunderstorm asthma"",
        ""thunderstorm related asthma"" .

","Thunderstorm-triggered asthma is a type of allergic asthma, which is defined as an allergic asthma characterized by acute asthma attacks immediately following a thunderstorm resulting from the inhalation of high concentrations of aeroallergens, most commonly grass pollen. It also has exact synonyms, including thunderstorm asthma and thunderstorm-related asthma.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080826,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nocturnal_asthma rdfs:subClassOf :chronic_asthma ;
    :has_definition ""A chronic asthma that is characterized by significant decline in pulmonary function and increase of airway inflammation at night. During sleep, recumbent posture causes a reduction in the lung volumes, respiratory muscle tone, and lung compliance. The overnight physiological abnormalities include: increased airway inflammation and decreased steroid responsiveness, increased pulmonary capillary blood volume, functional differences in blood/air volume ratios and mechanical coupling of the parenchyma to the airways."" .

","Nocturnal asthma is a type of chronic asthma defined by a significant decline in pulmonary function and an increase in airway inflammation at night. This condition is characterized by various overnight physiological abnormalities during sleep, such as increased airway inflammation and decreased steroid responsiveness, increased pulmonary capillary blood volume, and functional differences in blood/air volume ratios. Additionally, the recumbent posture adopted during sleep leads to a reduction in lung volumes, respiratory muscle tone, and lung compliance, contributing to mechanical coupling of the parenchyma to the airways.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080827,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:human_cytomegalovirus_infection rdfs:subClassOf :viral_infectious_disease ;
    :has_definition ""A viral infectious disease that has_material_basis_in Human betaherpesvirus 5."" .

",Human cytomegalovirus infection is a type of viral infectious disease. It is defined as a viral infectious disease that has a material basis in Human betaherpesvirus 5.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080828,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vexas_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome that is characterized by blood clots in veins, recurrent fevers, pulmonary abnormalities and vacuoles in myeloid cells and that has_material_basis_in mutation in the UBA1 gene on chromosome Xp11."" ;
    :has_exact_synonym ""vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic syndrome"" .

","Vexas syndrome is a type of syndrome characterized by blood clots in veins, recurrent fevers, pulmonary abnormalities, and vacuoles in myeloid cells. It has a material basis in a mutation in the UBA1 gene on chromosome Xp11. Furthermore, Vexas syndrome is exactly synonymous with vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080829,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:low_grade_glioma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :central_nervous_system ],
        [ a owl:Restriction ;
            owl:onProperty :derives_from ;
            owl:someValuesFrom :glial_cell ],
        :brain_disease,
        :cell_type_benign_neoplasm,
        :central_nervous_system_benign_neoplasm,
        :spinal_cord_disease ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :benign_neoplasm ;
                    rdf:rest [ rdf:first [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                                                    owl:onProperty :derives_from ;
                                                    owl:someValuesFrom :glial_cell ] ;
                                            rdf:rest [ rdf:first [ a owl:Restriction ;
                                                            owl:onProperty :disease_has_location ;
                                                            owl:someValuesFrom :brain ] ;
                                                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                                                    owl:onProperty :disease_has_location ;
                                                                    owl:someValuesFrom :spinal_cord ] ;
                                                            rdf:rest :nil ] ] ] ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A cell type benign neoplasm that has_material_basis_in glial cells (astrocytes, oligodendrocytes or ependymocytes)."" ;
    :has_exact_synonym ""benign glioma"" .

","Low grade glioma, also known exactly as benign glioma, is defined as a cell type benign neoplasm that has its material basis in glial cells, including astrocytes, oligodendrocytes, or ependymocytes. It is essentially a benign neoplasm that intersects with both conditions derived from some glial cell and diseases located in the brain and spinal cord. This means low grade glioma is categorized under several types: a type of cell type benign neoplasm, a type of central nervous system benign neoplasm, a type of spinal cord disease, a type of brain disease, a type of entity that at least derives from some glial cell, and a type of disease having its location in the central nervous system.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0080830,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:childhood_low_grade_glioma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :childhood_onset ],
        :low_grade_glioma ;
    :has_definition ""A low-grade glioma that occurs in children and encompasses tumors of astrocytic, oligodendroglial, and mixed glial-neuronal histology."" ;
    :has_exact_synonym ""pediatric low-grade glioma"" .

","Childhood low grade glioma is a type of low grade glioma that specifically begins during childhood onset. It is defined as a low-grade glioma occurring in children and includes tumors of astrocytic, oligodendroglial, and mixed glial-neuronal histology. Additionally, childhood low grade glioma is exactly synonymous with pediatric low-grade glioma.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080831,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:subjective_cognitive_decline rdfs:subClassOf :cognitive_disorder ;
    :has_definition ""A cognitive disorder that is characterized by the presence of significant and persistent cognitive complaints."" .

",Subjective cognitive decline is a type of cognitive disorder characterized by the presence of significant and persistent cognitive complaints.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080832,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mild_cognitive_impairment rdfs:subClassOf :cognitive_disorder ;
    :has_definition ""A cognitive disorder that is characterized by objective impairment in cognition with minimal impairment of their capacity to undertake the instrumental activities of daily living."" .

","Mild cognitive impairment is a type of cognitive disorder, defined as a cognitive disorder that is characterized by objective impairment in cognition with minimal impairment of their capacity to undertake the instrumental activities of daily living.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080833,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:laryngomalacia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :stridor ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :laryngeal_disease,
        :physical_disorder ;
    :has_definition ""A laryngeal disease that is characterized by inward collapse of flaccid supraglottic structures during inspiration. The most common symptom is noisy breathing (stridor) that is often worse when the infant is on his/her back or crying."" ;
    :has_exact_synonym ""congenital laryngomalacia"" ;
    :has_narrower_match ""MESH:D055092"" .

","Laryngomalacia is a type of physical disorder and a specific kind of laryngeal disease, which is characterized by the inward collapse of flaccid supraglottic structures during inspiration. It is notably identified by noisy breathing (stridor), a symptom that becomes more pronounced when the infant is either on their back or crying. This condition is also known as congenital laryngomalacia and has a unique identifier, MESH:D055092, indicating its classification within medical databases. The disease primarily stems from abnormalities in prenatal development or birth.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080834,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acquired_laryngomalacia rdfs:subClassOf :laryngeal_disease ;
    :has_definition ""A laryngeal disease that is characterized by acquired collapse of laryngeal suprastructures."" .

",Acquired laryngomalacia is a type of laryngeal disease that is defined as a laryngeal disease characterized by acquired collapse of laryngeal suprastructures.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080835,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:torch_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :physical_disorder,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by congenital infection with toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and other organisms."" .

","Torch syndrome is a type of physical disorder, a syndrome, and something that, at minimum, has its basis in some abnormality of prenatal development or birth. It is defined as a syndrome characterized by congenital infection with toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and other organisms.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080836,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:growth_hormone_insensitivity_syndrome_with_immune_dysregulation_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by short stature due to insensitivity to growth hormone and that has_material_basis_in homozygous mutation in the STAT5B gene on chromosome 17q21."" .

","Growth hormone insensitivity syndrome with immune dysregulation 1 is a type of syndrome that falls under autosomal recessive diseases. It is defined as a syndrome characterized by short stature due to insensitivity to growth hormone, which has its material basis in a homozygous mutation in the STAT5B gene on chromosome 17q21. This condition is also an example of a disorder that arises from autosomal recessive inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080837,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:growth_hormone_insensitivity_syndrome_with_immune_dysregulation_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition """"""A syndrome that is characterized by short stature due to insensitivity to growth hormone and
that has_material_basis_in heterozygous mutation in the STAT5B gene on chromosome 17q21."""""" .

","Growth hormone insensitivity syndrome with immune dysregulation 2 is a syndrome that falls under the category of autosomal dominant diseases and is characterized by a type of condition that inherently has a material basis in autosomal dominant inheritance. This specific syndrome is defined by a short stature resulting from insensitivity to growth hormone, which is caused by a heterozygous mutation in the STAT5B gene located on chromosome 17q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080839,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_warfarin_sensitivity rdfs:subClassOf :inherited_metabolic_disorder ;
    :has_definition ""An inherited metabolic disorder that is characterized by bleeding complications when given warfarin for anticoagulation and that has_material_basis_in variation in the F9 gene on chromosome Xq27."" .

",X-linked warfarin sensitivity is a type of inherited metabolic disorder characterized by bleeding complications when given warfarin for anticoagulation. This condition has a material basis in variation in the F9 gene located on chromosome Xq27.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080840,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:optic_atrophy_12 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :optic_atrophy ;
    :has_definition ""An optic atrophy that is characterized by slowly progressive visual impairment with onset usually in the first decade and that has_material_basis_in heterozygous mutation in the AFG3L2 gene on chromosome 18p11."" .

","Optic atrophy 12 is a type of autosomal dominant disease and a type of optic atrophy, which is characterized by a material basis in autosomal dominant inheritance. It has a definition as an optic atrophy that is characterized by slowly progressive visual impairment, typically beginning in the first decade of life, and it has its material basis in a heterozygous mutation in the AFG3L2 gene on chromosome 18p11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080841,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:pemphigoid rdfs:subClassOf [ owl:intersectionOf [ rdf:first :dermatitis ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_symptom ;
                                    owl:someValuesFrom :blister ] ;
                            rdf:rest :nil ] ] ],
        :autoimmune_disease_of_skin_and_connective_tissue,
        :bullous_skin_disease ;
    :has_definition ""An autoimmune disease of skin and connective tissue that is characterized by subepidermal blistering especially in the lower abdomen, groin, and flexor surfaces of the extremities, creating tense blisters that do not break easily."" .

","Pemphigoid is an autoimmune disease affecting the skin and connective tissue, which is classified as a type of bullous skin disease. It is characterized by an intersection of dermatitis and conditions that exhibit the symptom of blister formation. Specifically, pemphigoid is defined as an autoimmune condition of the skin and connective tissue characterized by subepidermal blistering, particularly in the lower abdomen, groin, and flexor surfaces of the extremities, resulting in tense blisters that do not break easily.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080842,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:intracranial_meningioma rdfs:subClassOf :meningioma ;
    :has_definition ""A meningioma that arises within the cranial cavity."" .

","Intracranial meningioma, which is a type of meningioma, is defined as a meningioma that arises within the cranial cavity.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080843,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:supratentorial_meningioma rdfs:subClassOf :meningioma ;
    :has_definition ""A meningioma that affects the supratentorial brain."" .

",Supratentorial meningioma is a type of meningioma that is defined as a meningioma affecting the supratentorial brain.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080844,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:omodysplasia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :omodysplasia ;
    :has_definition ""An omodysplasia that is characterized by severe congenital micromelia with shortening and distal tapering of the humeri and femora to give a club-like appearance and that has_material_basis_in homozygous or compound heterozygous mutation in the GPC6 gene on chromosome 13q32."" .

","Omodysplasia 1 is a type of autosomal recessive disease, which is also a specific form of omodysplasia. It is characterized by a severe congenital condition known as micromelia, where there is shortening and distal tapering of the humeri and femora, giving them a club-like appearance. This condition has its material basis in homozygous or compound heterozygous mutations in the GPC6 gene located on chromosome 13q32. It falls under the category of diseases that have a material basis in some form of autosomal recessive inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080845,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:omodysplasia_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :omodysplasia ;
    :has_definition ""An omodysplasia that is characterized by shortened humeri, dislocated radial heads, shortened first metacarpals, craniofacial dysmorphism, and variable genitourinary anomalies and that has_material_basis_in heterozygous mutation in the FZD2 gene on chromosome 17q21."" .

","Omodysplasia 2 is a type of omodysplasia and also a type of autosomal dominant disease, which implies it is something that at least has a material basis in autosomal dominant inheritance. It is defined as an omodysplasia characterized by shortened humeri, dislocated radial heads, shortened first metacarpals, craniofacial dysmorphism, and variable genitourinary anomalies. This condition has its material basis in a heterozygous mutation in the FZD2 gene on chromosome 17q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080846,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:latent_autoimmune_diabetes_in_adults rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_immunoglobulin_level ],
        :type_1_diabetes_mellitus ;
    :has_definition ""A type 1 diabetes mellitus that is characterized by a less intensive autoimmune process, highly variable β-cell destruction, different degrees of insulin resistance and heterogeneous titre and pattern of islet autoantibody, sharing features with both type 1 and type 2 diabetes mellitus."" ;
    :has_exact_match ""MESH:D000071698"" ;
    :has_exact_synonym ""LADA"",
        ""type 1.5 diabetes"" .

","Latent autoimmune diabetes in adults (LADA) is a type of Type 1 diabetes mellitus that is also characterized by a less intensive autoimmune process, highly variable β-cell destruction, different degrees of insulin resistance, and heterogeneous titre and pattern of islet autoantibody, sharing features with both type 1 and type 2 diabetes mellitus. It is defined as a type of diabetes that at least has the phenotype of some abnormal immunoglobulin level and its existence starts during adult onset. Furthermore, LADA is exactly synonymous with type 1.5 diabetes and LADA, and it has an exact match with MESH:D000071698.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080848,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:long_covid rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :headache ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :breathing_problems ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :chest_pain ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :memory_loss ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :fatigue ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :confusion ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :ageusia ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :dizziness ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :concentration_difficulty ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :tachycardia ],
        :coronavirus_infectious_disease ;
    :has_definition ""A Coronavirus infectious disease that is characterized by long-term persistent and fluctuating symptoms, in individuals with COVID-19, persisting beyond three to four weeks, including the loss of the ability to smell and taste, breathlessness, fatigue, difficulty in breathing, difficulty concentrating, memory loss, confusion, headache, heart palpitations, chest pain, pain with deep breaths, dizziness, and tachycardia."" ;
    :has_exact_synonym ""PASC"",
        ""chronic COVID-19"",
        ""post-COVID syndrome"",
        ""post-acute sequelae of SARS-CoV-2 infection"" .

","Long COVID is a type of Coronavirus infectious disease that is characterized by long-term persistent and fluctuating symptoms in individuals with COVID-19, persisting beyond three to four weeks. It includes symptoms such as confusion, headache, tachycardia, memory loss, chest pain, dizziness, breathing problems, fatigue, ageusia (loss of the ability to smell and taste), and concentration difficulty. Long COVID also has exact synonyms: PASC, chronic COVID-19, post-COVID syndrome, and post-acute sequelae of SARS-CoV-2 infection.",16,True
doid,http://purl.obolibrary.org/obo/DOID_0080849,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ocular_motor_apraxia_cogan_type rdfs:subClassOf :eye_disease ;
    :has_definition ""An eye disease that is characterized by defective or absent horizontal voluntary eye movements, and defective or absent horizontal ocular attraction movements."" .

","Ocular motor apraxia Cogan type is a type of eye disease that is characterized by defective or absent horizontal voluntary eye movements, and defective or absent horizontal ocular attraction movements.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080850,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:pemphigus_foliaceus rdfs:subClassOf :pemphigus ;
    :has_definition ""A pemphigus that is characterized by blistering lesions on otherwise healthy-looking skin."" ;
    :has_exact_synonym ""pemphigus foliaceous"" .

",Pemphigus foliaceus is a type of pemphigus that is characterized by blistering lesions on otherwise healthy-looking skin. It is also exactly known as pemphigus foliaceous.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080851,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:iga_pemphigus rdfs:subClassOf :pemphigus ;
    :has_definition ""A pemphigus that is characterized by painful and pruritic vesiculopustular eruptions. These eruptions form as a result of circulating IgA antibodies against keratinocyte cell surface components responsible for cell to cell adherence."" .

","IgA pemphigus is a type of pemphigus characterized by painful and pruritic vesiculopustular eruptions. These eruptions form due to circulating IgA antibodies against keratinocyte cell surface components, which are responsible for cell-to-cell adherence.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080852,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:paraneoplastic_pemphigus rdfs:subClassOf :pemphigus ;
    :has_definition ""A pemphigus that is characterized by painful blisters and denuded areas of the mouth, lips, oesophagus and skin."" .

","Paraneoplastic pemphigus is a type of pemphigus characterized by painful blisters and denuded areas of the mouth, lips, esophagus, and skin.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080854,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anaplastic_pleomorphic_xanthoastrocytoma rdfs:subClassOf :malignant_astrocytoma ;
    :has_definition ""A malignant astrocytoma that is characterized by the presence of five or more mitoses per 10 high-power fields."" .

","Anaplastic pleomorphic xanthoastrocytoma is a type of malignant astrocytoma, which is defined as a malignant astrocytoma characterized by the presence of five or more mitoses per 10 high-power fields.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080855,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:parkinsonism rdfs:subClassOf :movement_disease ;
    :has_definition ""A movement disorder that is characterized by disturbances of balance, gait and posture."" .

","Parkinsonism is a type of movement disease defined as a movement disorder that is characterized by disturbances of balance, gait, and posture.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080856,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vascular_parkinsonism rdfs:subClassOf :parkinsonism ;
    :has_definition ""A Parkinsonism that is characterized by postural instability, a broad-based gait with the absence of tremors of vascular origin."" .

","Vascular parkinsonism is a type of parkinsonism that is defined as a form of parkinsonism characterized by postural instability, a broad-based gait, and the absence of tremors, all of which are of vascular origin.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080857,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :primary_ovarian_insufficiency,
        :x_linked_monogenic_disease ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in premutations in the FMR1 gene on chromosome Xq27.3, within a region defined as POF1 (Xq26-q28)."" ;
    :has_exact_synonym ""FMR1-related primary ovarian insufficiency"",
        ""Fragile X-associated primary ovarian insufficiency"",
        ""premature ovarian failure 1"" .

","Primary ovarian insufficiency 1 is a type of X-linked monogenic disease and also falls under the category of primary ovarian insufficiency. It is characterized by having a material basis in some form of X-linked inheritance. Specifically, this condition is defined as a primary ovarian insufficiency that originates from premutations in the FMR1 gene located on chromosome Xq27.3, within the region designated as POF1 (Xq26-q28). Furthermore, primary ovarian insufficiency 1 is precisely referred to as FMR1-related primary ovarian insufficiency, Fragile X-associated primary ovarian insufficiency, and premature ovarian failure 1.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0080858,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_2a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :primary_ovarian_insufficiency,
        :x_linked_dominant_disease ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in mutation in the DIAPH2 gene on chromosome Xq22."" .

","Primary ovarian insufficiency 2a is a type of primary ovarian insufficiency and a specific type of X-linked dominant disease, which at least has a material basis in some X-linked dominant inheritance. It is defined as a primary ovarian insufficiency that has a material basis in a mutation in the DIAPH2 gene on chromosome Xq22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080859,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_2b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :primary_ovarian_insufficiency,
        :x_linked_recessive_disease ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in mutation in the POF1B gene."" .

","Primary ovarian insufficiency 2b is a type of primary ovarian insufficiency and is also categorized as a type of X-linked recessive disease, indicating that it is a condition that at least has a material basis in some X-linked recessive inheritance. It is defined as a primary ovarian insufficiency that has its material basis in a mutation in the POF1B gene.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080860,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in heterozygous mutation in the FOXL2 gene on chromosome 3q22."" .

","Primary ovarian insufficiency 3 is a type of primary ovarian insufficiency and an autosomal dominant disease. It is characterized by a condition that essentially has a material basis in autosomal dominant inheritance. Specifically, this condition is defined by a primary ovarian insufficiency that results from a heterozygous mutation in the FOXL2 gene located on chromosome 3q22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080861,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :primary_ovarian_insufficiency,
        :x_linked_monogenic_disease ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in caused by mutation in the BMP15 gene on chromosome Xp11."" .

",Primary ovarian insufficiency 4 is a type of primary ovarian insufficiency and an X-linked monogenic disease that at least has a material basis in X-linked inheritance. It is defined as a primary ovarian insufficiency that is caused by a mutation in the BMP15 gene on chromosome Xp11.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080862,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in heterozygous mutation in the NOBOX gene on chromosome 7q35."" .

",Primary ovarian insufficiency 5 is a type of primary ovarian insufficiency and an autosomal dominant disease that specifically has its material basis in autosomal dominant inheritance. It is defined as a primary ovarian insufficiency that results from a heterozygous mutation in the NOBOX gene on chromosome 7q35.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0080863,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in heterozygous or homozygous mutation in the FIGLA gene on chromosome 2p13."" .

","Primary ovarian insufficiency 6 is a type of primary ovarian insufficiency and an autosomal dominant disease. It is characterized by a condition that at least has a material basis in some form of autosomal dominant inheritance. Specifically, this primary ovarian insufficiency is defined by having a material basis in either a heterozygous or homozygous mutation in the FIGLA gene located on chromosome 2p13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080864,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in heterozygous mutation in the NR5A1 gene on chromosome 9q33."" .

","Primary ovarian insufficiency 7 is a type of primary ovarian insufficiency and an autosomal dominant disease. It is characterized by a condition that essentially has a material basis in some form of autosomal dominant inheritance. Specifically, it is defined as a primary ovarian insufficiency that has its material basis in a heterozygous mutation in the NR5A1 gene located on chromosome 9q33.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080865,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in homozygous mutation in the STAG3 gene on chromosome 7q22."" .

","Primary ovarian insufficiency 8 is a type of autosomal recessive disease and a type of primary ovarian insufficiency, which has its material basis in some autosomal recessive inheritance. It is defined as a primary ovarian insufficiency that has its material basis in a homozygous mutation in the STAG3 gene on chromosome 7q22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080866,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in compound heterozygous mutation in the HFM1 gene on chromosome 1p22."" .

","Primary ovarian insufficiency 9 is a type of primary ovarian insufficiency and an autosomal recessive disease, which specifically has a material basis in some form of autosomal recessive inheritance. It is defined as a primary ovarian insufficiency that has its material basis in a compound heterozygous mutation in the HFM1 gene on chromosome 1p22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080867,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_10 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that is characterized by primary amenorrhea, hypergonadotropic ovarian insufficiency, and genomic instability in somatic cells and that has_material_basis_in homozygous mutation in the MCM8 gene on chromosome 20p."" .

","Primary ovarian insufficiency 10 is a type of primary ovarian insufficiency and an autosomal recessive disease that at least has a material basis in some autosomal recessive inheritance. It is defined as a primary ovarian insufficiency characterized by primary amenorrhea, hypergonadotropic ovarian insufficiency, and genomic instability in somatic cells, with its material basis in a homozygous mutation in the MCM8 gene on chromosome 20p.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080868,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_11 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that is characterized by secondary amenorrhea and hypergonadotropic ovarian insufficiency, with elevated serum follicle-stimulating hormone levels before age 40 years and that has_material_basis_in heterozygous mutation in the ERCC6 gene on chromosome 10q11."" .

","Primary ovarian insufficiency 11 is a type of autosomal dominant disease and a type of primary ovarian insufficiency. It is characterized by secondary amenorrhea and hypergonadotropic ovarian insufficiency, with elevated serum follicle-stimulating hormone levels before age 40 years. This condition has a material basis in some autosomal dominant inheritance and specifically has its material basis in a heterozygous mutation in the ERCC6 gene on chromosome 10q11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080869,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_12 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in homozygous mutation in the SYCE1 gene on chromosome 10q26."" ;
    :has_exact_match ""OMIM:616947"" .

","Primary Ovarian Insufficiency 12 is a type of autosomal recessive disease, a type of primary ovarian insufficiency, and a type of condition that at least has a material basis in some autosomal recessive inheritance. It is defined as a primary ovarian insufficiency that has a material basis in homozygous mutation in the SYCE1 gene on chromosome 10q26. Additionally, Primary Ovarian Insufficiency 12 has an exact match with OMIM:616947.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080870,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_13 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in homozygous mutation in the MSH5 gene on chromosome 6p21."" .

","Primary ovarian insufficiency 13 is a type of primary ovarian insufficiency and an autosomal recessive disease, which specifically involves a material basis in autosomal recessive inheritance. It is defined as a primary ovarian insufficiency that has its material basis in a homozygous mutation in the MSH5 gene on chromosome 6p21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080871,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_14 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that has_material_basis_in homozygous mutation in the GDF9 gene on chromosome 5q31."" .

","Primary ovarian insufficiency 14 is a type of primary ovarian insufficiency and an autosomal recessive disease, which also falls into the category of disorders that at least have a material basis in some form of autosomal recessive inheritance. It is defined as a primary ovarian insufficiency that has its material basis in a homozygous mutation in the GDF9 gene located on chromosome 5q31.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080872,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_15 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that is characterized by onset of oligomenorrhea in the third decade of life, with small ovaries, reduced number of follicles, and elevated gonadotropic hormones and that has_material_basis_in homozygous mutation in the FANCM gene on chromosome 14q21."" .

","Primary ovarian insufficiency 15 is a type of autosomal recessive disease and a subtype of primary ovarian insufficiency, which fundamentally has its material basis in autosomal recessive inheritance. It is defined as a primary ovarian insufficiency that manifests through oligomenorrhea starting in the third decade of life, accompanied by small ovaries, a reduced number of follicles, and elevated gonadotropic hormones. This condition is specifically attributed to a homozygous mutation in the FANCM gene located on chromosome 14q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080873,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_16 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that is characterized by onset of amenorrhea early in the fourth decade of life, accompanied by elevated follicle-stimulating hormone levels and low estradiol levels and that has_material_basis_in heterozygous mutation in the BNC1 gene on chromosome 15q25."" .

","Primary ovarian insufficiency 16 is a type of primary ovarian insufficiency and a type of autosomal dominant disease, which essentially has a material basis in some form of autosomal dominant inheritance. Furthermore, it is defined as a primary ovarian insufficiency characterized by the onset of amenorrhea early in the fourth decade of life, accompanied by elevated follicle-stimulating hormone levels and low estradiol levels. This condition specifically has its material basis in a heterozygous mutation in the BNC1 gene located on chromosome 15q25.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080874,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ovarian_insufficiency_17 rdfs:subClassOf :primary_ovarian_insufficiency ;
    :has_definition ""A primary ovarian insufficiency that is characterized by early cessation of menses after initial menarche, with small ovaries and uterus and that has_material_basis_in homozygous mutation in the XRCC2 gene on chromosome 7q36."" .

","Primary ovarian insufficiency 17 is a type of primary ovarian insufficiency. It is defined as a primary ovarian insufficiency characterized by the early cessation of menses after initial menarche, accompanied by small ovaries and uterus. This condition has a material basis in a homozygous mutation in the XRCC2 gene located on chromosome 7q36.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080875,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:idh_mutant_anaplastic_astrocytoma rdfs:subClassOf :anaplastic_astrocytoma ;
    :has_definition ""An anaplastic astrocytoma carrying IDH mutations."" .

",IDH mutant anaplastic astrocytoma is a type of anaplastic astrocytoma defined as an anaplastic astrocytoma carrying IDH mutations.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080876,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:idh_wildtype_anaplastic_astrocytoma rdfs:subClassOf :anaplastic_astrocytoma ;
    :has_definition ""An anaplastic astrocytoma lacking mutations in IDH1 or IDH2 genes."" .

",IDH wildtype anaplastic astrocytoma is a type of anaplastic astrocytoma defined as an anaplastic astrocytoma that lacks mutations in the IDH1 or IDH2 genes.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080877,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:astrocytoma_idh_mutant_grade_4 rdfs:subClassOf :idh_mutant_anaplastic_astrocytoma ;
    :has_definition ""An IDH-mutant anaplastic astrocytoma that is characterized by the presence of necrosis and/or microvascular proliferation or homozygous deletion of CDKN2A and/or CDKN2B genes. The term glioblastoma no longer applies to central nervous system WHO grade 4 IDH-mutant astrocytomas."" .

","Astrocytoma IDH mutant grade 4 is a type of IDH mutant anaplastic astrocytoma, defined as an IDH-mutant anaplastic astrocytoma that is characterized by the presence of necrosis and/or microvascular proliferation or homozygous deletion of CDKN2A and/or CDKN2B genes. It is noted that the term glioblastoma no longer applies to central nervous system WHO grade 4 IDH-mutant astrocytomas.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080878,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:idh_wildtype_glioblastoma rdfs:subClassOf :glioblastoma ;
    :has_definition ""A glioblastoma that is characterized by high cellularity, high mitotic activity, necrosis or microvascular proliferation and that lacks mutations in IDH genes."" .

","IDH wildtype glioblastoma is a type of glioblastoma that is defined as a glioblastoma characterized by high cellularity, high mitotic activity, necrosis or microvascular proliferation, and that lacks mutations in IDH genes.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080879,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:histone_mutated_tumor rdfs:subClassOf :high_grade_glioma ;
    :has_definition ""A high grade glioma that has_material_basis_in mutations in the genes encoding histones."" ;
    :has_exact_synonym ""histone mutated tumour"" .

","A histone mutated tumor, also exactly known as a histone mutated tumour, is a type of high-grade glioma. It is defined as a high-grade glioma that has its material basis in mutations in the genes encoding histones.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080880,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diffuse_glioma_h3_g34_mutant rdfs:subClassOf :histone_mutated_tumor ;
    :has_definition ""A histone mutated tumor that has_material_basis_in mutations in codon 34 of the H3 histone family 3A protein."" .

","Diffuse glioma H3 G34 mutant is a type of histone mutated tumor, which is defined as a histone mutated tumor that has its material basis in mutations in codon 34 of the H3 histone family 3A protein.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080881,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:pleomorphic_xanthoastrocytoma_braf_mutant rdfs:subClassOf :anaplastic_pleomorphic_xanthoastrocytoma ;
    :has_definition ""An anaplastic pleomorphic xanthoastrocytoma that has_material_basis_in BRAF mutations."" .

","Pleomorphic xanthoastrocytoma BRAF mutant is a type of anaplastic pleomorphic xanthoastrocytoma, which is defined as an anaplastic pleomorphic xanthoastrocytoma that has a material basis in BRAF mutations.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080882,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:idh_mutant_and_1p_19q_codeleted_oligodendroglioma rdfs:subClassOf :anaplastic_oligodendroglioma ;
    :has_definition ""An anaplastic oligodendroglioma that has_material_basis_in IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion)."" ;
    :has_exact_synonym ""Oligodendroglioma, IDH-mutant and 1p/19q-codeleted"",
        ""anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted"" .

","IDH mutant and 1p 19q codeleted oligodendroglioma is a type of anaplastic oligodendroglioma, which is defined as an anaplastic oligodendroglioma that has a material basis in IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion). It has the exact synonyms ""Oligodendroglioma, IDH-mutant and 1p/19q-codeleted"" and ""anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted.""",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080883,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vitamin_d_dependent_rickets rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :hematopoietic_system ],
        :bone_development_disease,
        :hematopoietic_system_disease ;
    :has_definition ""A bone development disease that is characterized by softening and weakening of the bones, hypocalcemia, high levels of parathyroid hormone and hypophosphatemia."" .

","Vitamin D dependent rickets is a type of bone development disease and also a type of hematopoietic system disease, indicating that this disease affects the hematopoietic system. This condition is defined as a bone development disease characterized by the softening and weakening of the bones, hypocalcemia, high levels of parathyroid hormone, and hypophosphatemia.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080884,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vitamin_d_dependent_rickets_type_2a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :vitamin_d_dependent_rickets ;
    :has_definition ""A vitamin D-dependent rickets that is characterized by abnormally high levels of calcitriol and that has_material_basis_in mutation in the gene encoding the vitamin D receptor (VDR) on chromosome 12q."" .

","Vitamin D-dependent rickets type 2a is a type of autosomal recessive disease and a specific form of vitamin D-dependent rickets. It is characterized by abnormally high levels of calcitriol and has its material basis in a mutation in the gene encoding the vitamin D receptor (VDR) on chromosome 12q. This condition is also a type of disease that, at the very least, has a material basis in some autosomal recessive inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080885,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vitamin_d_dependent_rickets_type_2b rdfs:subClassOf :vitamin_d_dependent_rickets ;
    :has_definition ""A vitamin D-dependent rickets that is characterized by abnormal expression of a hormone response element-binding protein that interferes with the normal function of the vitamin D receptor."" .

","Vitamin D dependent rickets type 2b is a type of vitamin D dependent rickets, defined as a vitamin D-dependent rickets characterized by the abnormal expression of a hormone response element-binding protein that interferes with the normal function of the vitamin D receptor.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080886,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vitamin_d_dependent_rickets_type_1a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :vitamin_d_dependent_rickets ;
    :has_definition ""A vitamin D-dependent rickets that is characterized by abnormally low levels of calcitriol and that has_material_basis_in mutation in the gene encoding 25-hydroxyvitamin D3-1-alpha-hydroxylase (CYP27B1) on chromosome 12q13."" .

","Vitamin D-dependent rickets type 1a is a type of vitamin D-dependent rickets and an autosomal recessive disease. It is characterized by a specific condition that inherently has a material basis in autosomal recessive inheritance. This particular type of rickets is defined by abnormally low levels of calcitriol, resulting from mutations in the gene encoding 25-hydroxyvitamin D3-1-alpha-hydroxylase (CYP27B1) located on chromosome 12q13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080887,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vitamin_d_dependent_rickets_type_1b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :vitamin_d_dependent_rickets ;
    :has_definition ""A vitamin D-dependent rickets that is characterized by abnormally low levels of calcitriol and that has_material_basis_in homozygous, compound heterozygous, or heterozygous mutation in the CYP2R1 gene on chromosome 11p15."" .

","Vitamin D-dependent rickets type 1b is a type of autosomal recessive disease and also a specific form of vitamin D-dependent rickets. It is characterized as a condition that at least has a material basis in some autosomal recessive inheritance. Furthermore, vitamin D-dependent rickets type 1b is defined as a vitamin D-dependent rickets that is marked by abnormally low levels of calcitriol. This condition has its material basis in homozygous, compound heterozygous, or heterozygous mutations in the CYP2R1 gene located on chromosome 11p15.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080888,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spinal_ependymoma_mycn_amplified rdfs:subClassOf :spinal_cord_ependymoma ;
    :has_definition ""A spinal cord ependymoma that is characterized by MYCN amplification."" ;
    :has_exact_synonym ""Spinal Cord Ependymoma, MYCN Amplified"",
        ""spinal ependymoma, MYCN"" .

","Spinal ependymoma MYCN amplified is a type of spinal cord ependymoma that is characterized by MYCN amplification. It has the exact synonyms Spinal Cord Ependymoma, MYCN Amplified and spinal ependymoma, MYCN.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080889,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:posterior_fossa_ependymoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :posterior_cranial_fossa ],
        :high_grade_ependymoma ;
    :has_definition ""A high grade ependymoma that is located within the posterior fossa."" .

",Posterior fossa ependymoma is a high-grade ependymoma that is located within the posterior cranial fossa. It is defined as a high-grade ependymoma situated in the posterior fossa.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080890,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:supratentorial_ependymoma rdfs:subClassOf :high_grade_ependymoma ;
    :has_definition ""A high grade ependymoma that is located within the supratentorial brain."" .

",Supratentorial ependymoma is a type of high-grade ependymoma defined as a high-grade ependymoma located within the supratentorial region of the brain.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080891,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:yap1_mamld1_fusion_positive_supratentorial_ependymoma rdfs:subClassOf :supratentorial_ependymoma ;
    :has_definition ""A supratentorial ependymoma that has_material_basis_in YAP1-MAMLD1 fusion."" .

",YAP1-MAMLD1 fusion positive supratentorial ependymoma is a type of supratentorial ependymoma. It is defined as a supratentorial ependymoma that has its material basis in YAP1-MAMLD1 fusion.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080892,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:rela_fusion_positive_ependymoma rdfs:subClassOf :supratentorial_ependymoma ;
    :has_definition ""A supratentorial ependymoma that has_material_basis_in presence of a RELA fusion gene."" ;
    :has_exact_synonym ""C11orf95 fusion-positive supratentorial ependymoma"",
        ""Supratentorial C11ORF95-RELA fused ependymoma"" .

","Rela fusion positive ependymoma is a type of supratentorial ependymoma, defined as a supratentorial ependymoma that has its material basis in the presence of a RELA fusion gene. It is also exactly synonymous with C11orf95 fusion-positive supratentorial ependymoma and Supratentorial C11ORF95-RELA fused ependymoma.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080893,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bainbridge_ropers_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :loss_of_function_variant ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by delayed psychomotor development, severe intellectual disability with poor or absent speech, hypotonia, feeding difficulties, poor growth, and dysmorphic facial features and that has_material_basis_in heterozygous mutation in the ASXL3 gene on chromosome 18q12."" ;
    :has_exact_synonym ""ASXL3-related disorder"" .

","Bainbridge Ropers Syndrome is a type of syndrome and an autosomal dominant disease. It is characterized by delayed psychomotor development, severe intellectual disability with poor or absent speech, hypotonia, feeding difficulties, poor growth, and dysmorphic facial features. This syndrome has a material basis in both autosomal dominant inheritance and loss of function variant, specifically in heterozygous mutation in the ASXL3 gene on chromosome 18q12. Furthermore, Bainbridge Ropers Syndrome is exactly synonymous with ASXL3-related disorder.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080894,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lipofibromatosis_like_neural_tumor rdfs:subClassOf :connective_tissue_cancer ;
    :has_definition ""A connective tissue cancer that has_material_basis_in LMNA-NTRK1 gene fusion."" .

","Lipofibromatosis-like neural tumor is a type of connective tissue cancer, defined as a connective tissue cancer that has its material basis in LMNA-NTRK1 gene fusion.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080895,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:rapidly_involuting_congenital_hemangioma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :hemangioma,
        :physical_disorder ;
    :has_definition ""A hemangioma that is characterized by complete regression."" .

","Rapidly involuting congenital hemangioma is a type of physical disorder, hemangioma, and something that at least has its basis in some abnormality of prenatal development or birth. It is defined as a hemangioma that is characterized by complete regression.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080896,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:pericytoma_with_t_7_12_ rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :translocation ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :gene_fusion ],
        :perivascular_tumor ;
    :has_definition ""A perivascular tumor that is characterized by a perivascular pattern of spindle-to-ovoid cell proliferation and that has_material_basis_in t(7;12)(p22;q13) translocation with resultant ACTB-GLI1 fusion."" .

","Pericytoma with t(7;12) is a type of perivascular tumor and also falls into the category of entities that at least have a material basis in some translocation and some gene fusion. It is defined as a perivascular tumor characterized by a perivascular pattern of spindle-to-ovoid cell proliferation, having a material basis in t(7;12)(p22;q13) translocation with resultant ACTB-GLI1 fusion.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080897,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:solitary_fibrous_tumor_hemangiopericytoma rdfs:subClassOf :connective_tissue_cancer ;
    :has_definition ""A connective tissue cancer that is characterized as the combination of solitary fibrous tumors and hemangiopericytomas."" .

",Solitary fibrous tumor hemangiopericytoma is a type of connective tissue cancer and is defined as a connective tissue cancer characterized as the combination of solitary fibrous tumors and hemangiopericytomas.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080898,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebellofaciodental_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by delayed development, intellectual disability, abnormal facial and dental findings, and cerebellar hypoplasia and that has_material_basis_in homozygous or compound heterozygous mutation in the BRF1 gene on chromosome 14q32."" ;
    :has_exact_synonym ""cerebellar-facial-dental syndrome"" .

","Cerebellofaciodental syndrome, also known exactly as cerebellar-facial-dental syndrome, is a syndrome that falls under the category of autosomal recessive diseases, meaning it at least has a material basis in some form of autosomal recessive inheritance. This syndrome is characterized by delayed development, intellectual disability, abnormal facial and dental findings, and cerebellar hypoplasia. It has a material basis in homozygous or compound heterozygous mutation in the BRF1 gene located on chromosome 14q32.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080899,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lung_pleomorphic_carcinoma rdfs:subClassOf [ owl:intersectionOf [ rdf:first :cancer ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :disease_has_location ;
                                    owl:someValuesFrom :lung ] ;
                            rdf:rest :nil ] ] ],
        :lung_cancer,
        :pleomorphic_carcinoma ;
    :has_definition ""A pleomorphic carcinoma that is characterized by the presence of malignant glandular or squamous cells associated with malignant giant and spindle cells and that is located_in the lung."" .

","Lung pleomorphic carcinoma is a type of lung cancer, pleomorphic carcinoma, and something that is at the intersection of cancer and a disease located in the lung. It is defined as a pleomorphic carcinoma characterized by the presence of malignant glandular or squamous cells, along with malignant giant and spindle cells, and is located in the lung.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080900,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oral_rhabdomyosarcoma rdfs:subClassOf [ owl:intersectionOf [ rdf:first :cancer ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :disease_has_location ;
                                    owl:someValuesFrom :oral_cavity ] ;
                            rdf:rest :nil ] ] ],
        :oral_cavity_cancer,
        :rhabdomyosarcoma ;
    :has_definition ""A rhabdomyosarcoma located in the oral cavity."" .

","Oral rhabdomyosarcoma is a type of rhabdomyosarcoma and a type of oral cavity cancer. It represents an intersection of cancers and diseases located in the oral cavity. Additionally, oral rhabdomyosarcoma is defined as a rhabdomyosarcoma located in the oral cavity.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080901,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bladder_sarcomatoid_transitional_cell_carcinoma rdfs:subClassOf [ owl:intersectionOf [ rdf:first :cancer ;
                    rdf:rest [ rdf:first [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                                                    owl:onProperty :derives_from ;
                                                    owl:someValuesFrom :epithelial_cell ] ;
                                            rdf:rest [ rdf:first [ a owl:Restriction ;
                                                            owl:onProperty :disease_has_location ;
                                                            owl:someValuesFrom :urinary_bladder ] ;
                                                    rdf:rest :nil ] ] ] ;
                            rdf:rest :nil ] ] ],
        :sarcomatoid_transitional_cell_carcinoma,
        :urinary_bladder_cancer ;
    :has_definition ""A sarcomatoid transitional cell carcinoma that is located_in the bladder."" .

","Bladder sarcomatoid transitional cell carcinoma is a type of urinary bladder cancer and a subtype of sarcomatoid transitional cell carcinoma. It is defined as a sarcomatoid transitional cell carcinoma that is located in the bladder. Furthermore, it represents an intersection of cancers and diseases that originate from epithelial cells and are located in the urinary bladder.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080902,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bladder_small_cell_carcinoma rdfs:subClassOf :bladder_carcinoma ;
    :has_definition ""A bladder carcinoma that is characterized as an undifferentiated neoplasm composed of primitive-appearing cells."" .

","Bladder small cell carcinoma is a type of bladder carcinoma, characterized as an undifferentiated neoplasm composed of primitive-appearing cells.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080903,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:embryonal_tumor_with_multilayered_rosettes_c19mc_altered rdfs:subClassOf :embryonal_tumor_with_multilayered_rosettes ;
    :has_definition ""An embryonal tumor with multilayered rosettes that is characterized by the presence of multilayered rosettes formation and the presence of amplification of the C19MC region on chromosome 19 (19q13.42)."" ;
    :has_exact_synonym ""ependymoblastoma"" .

","Embryonal tumor with multilayered rosettes C19MC altered is a type of embryonal tumor with multilayered rosettes, which is defined as an embryonal tumor with multilayered rosettes that is characterized by the formation of multilayered rosettes and the amplification of the C19MC region on chromosome 19 (19q13.42). It is also exactly synonymous with ependymoblastoma.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080904,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:astroblastoma_mn1_altered rdfs:subClassOf :astroblastoma ;
    :has_definition ""An astroblastoma that is characterized by astroblastoma-like morphology with MN1 rearrangements involving the meningioma 1 (MN1) gene on chromosome 22q."" ;
    :has_exact_synonym ""CNS high-grade neuroepithelial tumors with MN1 alteration"" .

",Astroblastoma MN1 altered is a type of astroblastoma that is defined as an astroblastoma characterized by astroblastoma-like morphology with MN1 rearrangements involving the meningioma 1 (MN1) gene on chromosome 22q. It also has the exact synonym CNS high-grade neuroepithelial tumors with MN1 alteration.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080905,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:central_nervous_system_neuroblastoma rdfs:subClassOf :central_nervous_system_germ_cell_tumor ;
    :has_definition ""A central nervous system germ cell tumor that is characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation and that arising from the cerebral hemispheres."" .

","Central nervous system neuroblastoma is a type of central nervous system germ cell tumor. It is defined as a central nervous system germ cell tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation, arising from the cerebral hemispheres.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080906,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cns_neuroblastoma_with_foxr2_activation rdfs:subClassOf :central_nervous_system_neuroblastoma ;
    :has_definition ""A central nervous system neuroblastoma that is characterized by FOXR2 activation and that is composed of small, round cells with hyperchromatic nuclei surrounded by a clear halo."" ;
    :has_exact_synonym ""CNS NB-FOXR2"",
        ""CNS neuroblastoma, FOXR2-activated"",
        ""central nervous system neuroblastoma with FOXR2 activation"" .

","CNS neuroblastoma with FOXR2 activation is a type of central nervous system neuroblastoma characterized by FOXR2 activation and composed of small, round cells with hyperchromatic nuclei surrounded by a clear halo. This condition has exact synonyms, including CNS NB-FOXR2, CNS neuroblastoma, FOXR2-activated, and central nervous system neuroblastoma with FOXR2 activation.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080907,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cockayne_syndrome_a rdfs:subClassOf :cockayne_syndrome ;
    :has_definition ""A Cockayne syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding the group 8 excision repair cross-complementing protein on chromosome 5q11."" ;
    :has_exact_synonym ""Cockayne syndrome type 1"",
        ""Cockayne syndrome type I"" .

","Cockayne Syndrome A is a type of Cockayne Syndrome, which is defined by a Cockayne syndrome that has a material basis in homozygous or compound heterozygous mutation in the gene encoding the group 8 excision repair cross-complementing protein on chromosome 5q11. Furthermore, Cockayne Syndrome A is exactly synonymous with both Cockayne Syndrome Type 1 and Cockayne Syndrome Type I.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080908,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cockayne_syndrome_b rdfs:subClassOf :cockayne_syndrome ;
    :has_definition ""A Cockayne syndrome that is characterized by severe physical and mental retardation, microcephaly, progressive neurologic and retinal degeneration, skeletal abnormalities, gait defects, and sun sensitivity with no increased frequency of cancer, and that has_material_basis_in homozygous or compound heterozygous mutation in the gene encoding the group 6 excision repair cross-complementing protein on chromosome 10q11."" ;
    :has_exact_synonym ""Cockayne syndrome 2"",
        ""Cockayne syndrome type II"" .

","Cockayne Syndrome B is a type of Cockayne Syndrome that is defined by severe physical and mental retardation, microcephaly, progressive neurologic and retinal degeneration, skeletal abnormalities, gait defects, and sun sensitivity, without an increased frequency of cancer. It has its material basis in homozygous or compound heterozygous mutations in the gene encoding the group 6 excision repair cross-complementing protein on chromosome 10q11. Furthermore, Cockayne Syndrome B is exactly synonymous with Cockayne Syndrome 2 and Cockayne Syndrome Type II.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080909,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:castration_resistant_prostate_carcinoma rdfs:subClassOf :prostate_carcinoma ;
    :has_broader_match ""MESH:D064129"" ;
    :has_definition ""A prostate carcinoma that is characterized by continued growth and spread despite the surgical removal of the testes or medical intervention to block androgen production."" .

","Castration-resistant prostate carcinoma is a type of prostate carcinoma characterized by continued growth and spread despite the surgical removal of the testes or medical intervention to block androgen production. Furthermore, it has a broader match with MESH:D064129.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080910,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebrooculofacioskeletal_syndrome rdfs:subClassOf :cockayne_syndrome ;
    :has_definition ""A Cockayne syndrome that is characterized by very severe prenatal developmental anomalies including microcephaly, congenital cataracts, severe mental retardation, facial dysmorphism, and arthrogryposis."" .

","Cerebrooculofacioskeletal syndrome is a type of Cockayne syndrome and it is defined as a Cockayne syndrome characterized by very severe prenatal developmental anomalies, including microcephaly, congenital cataracts, severe mental retardation, facial dysmorphism, and arthrogryposis.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080911,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebrooculofacioskeletal_syndrome_1 rdfs:subClassOf :cerebrooculofacioskeletal_syndrome ;
    :has_definition ""A cerebrooculofacioskeletal syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the ERCC6 gene on chromosome 10q11."" .

","Cerebrooculofacioskeletal syndrome 1 is a type of cerebrooculofacioskeletal syndrome, defined by a cerebrooculofacioskeletal syndrome that has its material basis in homozygous or compound heterozygous mutation in the ERCC6 gene on chromosome 10q11.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080912,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebrooculofacioskeletal_syndrome_2 rdfs:subClassOf :cerebrooculofacioskeletal_syndrome ;
    :has_definition ""A cerebrooculofacioskeletal syndrome that has_material_basis_in compound heterozygous mutation in the DNA repair gene XPD (ERCC2) on chromosome 19q13."" .

",Cerebrooculofacioskeletal syndrome 2 is a type of cerebrooculofacioskeletal syndrome with a definition that encompasses being a cerebrooculofacioskeletal syndrome that has its material basis in compound heterozygous mutation in the DNA repair gene XPD (ERCC2) located on chromosome 19q13.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080913,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebrooculofacioskeletal_syndrome_3 rdfs:subClassOf :cerebrooculofacioskeletal_syndrome ;
    :has_definition ""A cerebrooculofacioskeletal syndrome that has_material_basis_in homozygous mutation in the ERCC5 gene on chromosome 13q33."" .

","Cerebrooculofacioskeletal syndrome 3 is a type of cerebrooculofacioskeletal syndrome, defined by a cerebrooculofacioskeletal syndrome that has its material basis in homozygous mutation in the ERCC5 gene on chromosome 13q33.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080914,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebrooculofacioskeletal_syndrome_4 rdfs:subClassOf :cerebrooculofacioskeletal_syndrome ;
    :has_definition ""A cerebrooculofacioskeletal syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the ERCC1 gene on chromosome 19q13."" .

","Cerebrooculofacioskeletal syndrome 4 is a type of cerebrooculofacioskeletal syndrome, which is defined as a cerebrooculofacioskeletal syndrome that has its material basis in homozygous or compound heterozygous mutation in the ERCC1 gene on chromosome 19q13.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080915,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:histiocytic_sarcoma rdfs:subClassOf :histiocytic_and_dendritic_cell_cancer ;
    :has_definition ""A histiocytic and dendritic cell cancer that is characterized by the presence of neoplastic cells with morphologic and immunophenotypic characteristics similar to those seen in mature histiocytes."" ;
    :has_exact_match ""MESH:D054747"" .

","Histiocytic sarcoma is a type of histiocytic and dendritic cell cancer, which is defined as a histiocytic and dendritic cell cancer characterized by the presence of neoplastic cells with morphologic and immunophenotypic characteristics similar to those seen in mature histiocytes. Additionally, histiocytic sarcoma has an exact match with the MESH identifier D054747.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080916,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:erythroleukemia rdfs:subClassOf :acute_erythroid_leukemia ;
    :has_definition ""An acute erythroid leukemia characterized by the presence of at least 50% erythroid precursors and at least 20% myeloblasts in the bone marrow."" .

","Erythroleukemia is a type of acute erythroid leukemia, which is defined as an acute erythroid leukemia characterized by the presence of at least 50% erythroid precursors and at least 20% myeloblasts in the bone marrow.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080917,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:sporatic_amyotrophic_lateral_sclerosis rdfs:subClassOf :amyotrophic_lateral_sclerosis ;
    :has_definition ""An amyotrophic lateral sclerosis that is characterized by random occurance of ALS without any known cause or familial member with ALS."" .

",Sporadic amyotrophic lateral sclerosis is a type of amyotrophic lateral sclerosis that is defined as an amyotrophic lateral sclerosis characterized by the random occurrence of ALS without any known cause or a familial member with ALS.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080918,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:polymicrogyria rdfs:subClassOf :brain_disease ;
    :has_definition ""A brain disease that is characterized by malformation of the developing brain characterized by abnormal cortical lamination and an unusual folding pattern of the cerebral cortex such that all or part of the brain surface is taken up by an excessive number of small folds (gyri)."" .

",Polymicrogyria is a type of brain disease defined as a malformation of the developing brain characterized by abnormal cortical lamination and an unusual folding pattern of the cerebral cortex. This results in all or part of the brain surface being taken up by an excessive number of small folds (gyri).,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080919,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:unilateral_focal_polymicrogyria rdfs:subClassOf :polymicrogyria ;
    :has_definition ""A polymicrogyria that is characterized by excessive cortical folding and abnormal cortical layering, that affects only one small region of the brain and that may show no neurologic involvement."" .

","Unilateral focal polymicrogyria, which is a type of polymicrogyria, is defined as a polymicrogyria characterized by excessive cortical folding and abnormal cortical layering. It affects only one small region of the brain and may show no neurologic involvement.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080920,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bilateral_generalized_polymicrogyria rdfs:subClassOf :polymicrogyria ;
    :has_definition ""A polymicrogyria that is characterized severe intellectual disability, problems with movement, and seizures and that affects the entire brain."" .

","Bilateral generalized polymicrogyria is a type of polymicrogyria that is characterized by severe intellectual disability, problems with movement, and seizures, and it affects the entire brain.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080921,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bilateral_frontal_polymicrogyria rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_feature ;
            owl:someValuesFrom :intellectual_disability ],
        :polymicrogyria ;
    :has_definition ""A polymicrogyria that is characterized as a symmetric and bilateral form (in both brain hemispheres) that only involves the frontal lobes without including the area located behind the Sylvius fissure or the area located behind the Rolando sulcus. Symptoms included delayed motor and language milestones; spastic (stiffness) hemiparesis (weakness in one side of the body) or quadriparesis (weakness in all four limbs of the body); and mild to moderate intellectual disability."" .

","Bilateral frontal polymicrogyria is a type of polymicrogyria and also falls under the category of diseases that feature some intellectual disability. It is defined as a polymicrogyria characterized by a symmetric and bilateral form in both brain hemispheres, exclusively involving the frontal lobes without affecting the area behind the Sylvius fissure or the area behind the Rolando sulcus. The symptoms of this condition include delayed motor and language milestones, spastic hemiparesis (stiffness and weakness in one side of the body) or quadriparesis (weakness in all four limbs), and mild to moderate intellectual disability.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080922,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bilateral_frontoparietal_polymicrogyria rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :polymicrogyria ;
    :has_definition ""A polymicrogyria that is characterized by excessive cortical folding and abnormal cortical layering, that involves the frontoparietal region of the brain and that presents with hypotonia, developmental delay, moderate to severe intellectual disability, pyramidal signs, epileptic seizures, non progressive cerebellar ataxia, dysconjugate gaze and/or strabismus and that has_material_basis_in homozygous mutation in the ADGRG1 gene on chromosome 16q21."" .

","Bilateral frontoparietal polymicrogyria is a type of polymicrogyria that falls under the category of autosomal recessive diseases. It is also recognized as a condition that, at a minimum, has a material basis in some form of autosomal recessive inheritance. This specific polymicrogyria is defined by its excessive cortical folding and abnormal cortical layering, primarily affecting the frontoparietal region of the brain. It is characterized by symptoms including hypotonia, developmental delay, moderate to severe intellectual disability, pyramidal signs, epileptic seizures, non-progressive cerebellar ataxia, dysconjugate gaze, and/or strabismus. The condition has its material basis in a homozygous mutation in the ADGRG1 gene located on chromosome 16q21.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080923,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bilateral_parasagittal_parieto_occipital_polymicrogyria rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :polymicrogyria ;
    :has_definition ""A polymicrogyria that is characterized by bilateral malformation of cortical development, centered around the parasagittal and mesial aspects of the parietooccipital cortex and that has_material_basis_in homozygous mutation in the FIG4 gene on chromosome 6q21."" ;
    :has_exact_synonym ""bilateral temporooccipital polymicrogyria"" .

","Bilateral parasagittal parieto occipital polymicrogyria is a type of autosomal recessive disease, polymicrogyria, and is something that at least has a material basis in some autosomal recessive inheritance. It is defined as a polymicrogyria characterized by bilateral malformation of cortical development, centered around the parasagittal and mesial aspects of the parietooccipital cortex, and has a material basis in homozygous mutation in the FIG4 gene on chromosome 6q21. Additionally, it has an exact synonym: bilateral temporooccipital polymicrogyria.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080924,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bilateral_perisylvian_polymicrogyria rdfs:subClassOf :polymicrogyria ;
    :has_definition ""A polymicrogyria that is characterized by strikingly restricted polymicrogyria limited to the cortex surrounding the Sylvian fissure and that has_material_basis_in homozygous deletion of one 15-bp tandem repeat in a regulatory region of exon 1m of the ADGRG1 gene on chromosome 16q21."" .

",Bilateral perisylvian polymicrogyria is a type of polymicrogyria characterized by strikingly restricted polymicrogyria limited to the cortex surrounding the Sylvian fissure. It has a material basis in a homozygous deletion of one 15-bp tandem repeat in a regulatory region of exon 1m of the ADGRG1 gene on chromosome 16q21.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080925,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cytochrome_p450_oxidoreductase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :steroid_inherited_metabolic_disorder ;
    :has_definition ""A steroid inherited metabolic disorder that is characterized by combined deficiency of P450C17 and P450C21 and accumulation of steroid metabolites and that has_material_basis_in homozygous or compound heterozygous mutations in the POR gene, which encodes cytochrome p450 oxidoreductase, on chromosome 7q11.2."" .

","Cytochrome p450 oxidoreductase deficiency is a type of autosomal recessive disease and a steroid inherited metabolic disorder, which inherently has a material basis in autosomal recessive inheritance. This disorder is defined as a steroid inherited metabolic disorder characterized by combined deficiency of P450C17 and P450C21, along with the accumulation of steroid metabolites. This condition arises due to homozygous or compound heterozygous mutations in the POR gene, encoding cytochrome p450 oxidoreductase, located on chromosome 7q11.2.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080926,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:7q11_23_duplication_syndrome rdfs:subClassOf :chromosomal_duplication_syndrome ;
    :has_definition ""A chromosomal duplication syndrome that is characterized by motor, speech and language delay, behavior problems, intellectual disability, low muscle tone (hypotonia), an increased head circumference (macrocephaly), facial dysmorphism, seizures, brain abnormalities, and heart defects such as enlargement of the blood vessel that carries blood from the heart to the rest of the body (aortic dilatation) and that has_material_basis_in an extra copy of a region of the long arm of chromosome 7."" ;
    :has_exact_synonym ""7q11.23 microduplication syndrome"",
        ""William-Beuren region duplication syndrome"",
        ""chromosome 7q11.23 duplication syndrome"" .

","7q11 23 duplication syndrome is a type of chromosomal duplication syndrome characterized by a range of symptoms including motor, speech and language delay, behavior problems, intellectual disability, low muscle tone (hypotonia), an increased head circumference (macrocephaly), facial dysmorphism, seizures, brain abnormalities, and heart defects such as enlargement of the blood vessel that carries blood from the heart to the rest of the body (aortic dilatation). This condition occurs due to an extra copy of a region on the long arm of chromosome 7. It is also known by exact synonyms such as 7q11.23 microduplication syndrome, William-Beuren region duplication syndrome, and chromosome 7q11.23 duplication syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080927,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:apolipoprotein_a_iv_associated_amyloidosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :kidney ],
        :amyloidosis,
        :kidney_disease ;
    :has_definition ""An amyloidosis that is characterized by slowly progressive renal dysfunction, increased serum creatinine, mostly normal urine analysis with no significant proteinuria and associated heart disease."" ;
    :has_exact_synonym ""AApoAIV amyloidosis"",
        ""renal AApoAIV amyloidosis"" .

","Apolipoprotein A IV associated amyloidosis is a type of kidney disease and a specific form of amyloidosis that occurs in the kidneys. It is recognized by a slowly progressive renal dysfunction, increased serum creatinine, mostly normal urine analysis with no significant proteinuria, and associated heart disease. Additionally, it is also known by its exact synonyms: AApoAIV amyloidosis and renal AApoAIV amyloidosis.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080928,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:dialysis_related_amyloidosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :kidney ],
        :amyloidosis,
        :kidney_disease ;
    :has_definition ""An amyloidosis that is characterized by the deposition of amyloid fibrils, principally composed of β2 microglobulins (β2M), in the osteoarticular structures and viscera and that is a serious complication of long-term dialysis therapy."" ;
    :has_exact_synonym ""ABeta2M amyloidosis"",
        ""Amyloidosis Beta2M"",
        ""Aβ2M amyloidosis"",
        ""Beta2-microglobulinic amyloidosis"",
        ""dialysis-related beta2-microglobulin amyloidosis"" .

","Dialysis-related amyloidosis is a type of amyloidosis and a form of kidney disease, indicating it is a disease that affects the kidneys. It is characterized by the deposition of amyloid fibrils, predominantly composed of β2 microglobulins (β2M), in the osteoarticular structures and viscera, representing a significant complication of long-term dialysis therapy. Furthermore, dialysis-related amyloidosis is also known by several exact synonyms, including ABeta2M amyloidosis, Amyloidosis Beta2M, Aβ2M amyloidosis, Beta2-microglobulinic amyloidosis, and dialysis-related beta2-microglobulin amyloidosis.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0080929,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:variant_a_beta2m_amyloidosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :amyloidosis,
        :autosomal_dominant_disease,
        :inherited_metabolic_disorder ;
    :has_definition ""An amyloidosis that is characterized by accumulation and extensive visceral deposition of anamyloidogenic variant of beta 2 microglobulin leading to progressive gastrointestinal dysfunction, Sjögren syndrome and autonomic neuropathy."" ;
    :has_exact_synonym ""Autosomal dominant beta2-microglobulinic amyloidosis"" .

","Variant a beta2m amyloidosis is a type of autosomal dominant disease, inherited metabolic disorder, and amyloidosis, which at least has a material basis in some autosomal dominant inheritance. It is defined as an amyloidosis characterized by the accumulation and extensive visceral deposition of an amyloidogenic variant of beta 2 microglobulin, leading to progressive gastrointestinal dysfunction, Sjögren syndrome, and autonomic neuropathy. Furthermore, it has an exact synonym: Autosomal dominant beta2-microglobulinic amyloidosis.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0080930,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_localized_cutaneous_amyloidosis_1 rdfs:subClassOf :primary_cutaneous_amyloidosis ;
    :has_definition ""A primary cutaneous amyloidosis that has_material_basis_in heterozygous mutation in the gene encoding oncostatin M receptor-beta (OSMR) on chromosome 5p13."" ;
    :has_exact_synonym ""familial primary localized cutaneous amyloidosis-1"" .

","Primary localized cutaneous amyloidosis 1 is a type of primary cutaneous amyloidosis, defined as a primary cutaneous amyloidosis that has its material basis in a heterozygous mutation in the gene encoding oncostatin M receptor-beta (OSMR) on chromosome 5p13. It is also exactly synonymous with familial primary localized cutaneous amyloidosis-1.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080931,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_localized_cutaneous_amyloidosis_2 rdfs:subClassOf :primary_cutaneous_amyloidosis ;
    :has_definition ""A primary cutaneous amyloidosis that has_material_basis_in heterozygous mutation in the IL31RA gene on chromosome 5q11."" .

",Primary localized cutaneous amyloidosis 2 is a type of primary cutaneous amyloidosis. It is defined as a primary cutaneous amyloidosis that has its material basis in a heterozygous mutation in the IL31RA gene located on chromosome 5q11.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080932,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_localized_cutaneous_amyloidosis_3 rdfs:subClassOf :primary_cutaneous_amyloidosis ;
    :has_definition ""A primary cutaneous amyloidosis that is characterized by deposits of keratinocyte-derived amyloid in the skin and that has_material_basis_in homozygous or compound heterozygous mutation in the GPNMB gene on chromosome 7p15. Onset occurs before puberty and involves macular or reticulate hyperpigmentation admixed with symmetrically distributed guttate hypopigmented and hyperpigmented lesions."" ;
    :has_exact_synonym ""Amyloidosis cutis dyschromica"" .

",Primary localized cutaneous amyloidosis 3 is a type of primary cutaneous amyloidosis and has the exact synonym Amyloidosis cutis dyschromica. It is defined as a primary cutaneous amyloidosis characterized by deposits of keratinocyte-derived amyloid in the skin. This condition has a material basis in homozygous or compound heterozygous mutation in the GPNMB gene on chromosome 7p15. The onset of primary localized cutaneous amyloidosis 3 occurs before puberty and involves macular or reticulate hyperpigmentation admixed with symmetrically distributed guttate hypopigmented and hyperpigmented lesions.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0080933,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunoglobulin_light_chain_amyloidosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :liver ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :kidney ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :heart ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :nerve ],
        :amyloidosis,
        :heart_disease,
        :inherited_metabolic_disorder,
        :kidney_disease,
        :liver_disease ;
    :has_definition ""An amyloidosis that is characterized by misfolded and aggregated amyloidogenic immunoglobulin light chains produced by marrow clonal plasma cells."" ;
    :has_exact_synonym ""AL amyloidosis"",
        ""Amyloidosis primary systemic"",
        ""Light chain amyloidosis"",
        ""Primary AL amyloidosis"",
        ""Primary systemic AL amyloidosis"",
        ""Primary systemic amyloidosis"",
        ""Systemic AL amyloidsis"" .

","Immunoglobulin light chain amyloidosis is a type of heart disease, liver disease, kidney disease, inherited metabolic disorder, and amyloidosis. It is associated with diseases that have a basis in some structural variant and are located in the heart, nerves, liver, and kidneys. This condition is characterized by misfolded and aggregated amyloidogenic immunoglobulin light chains produced by marrow clonal plasma cells. Immunoglobulin light chain amyloidosis is also known by several exact synonyms, including AL amyloidosis, Amyloidosis primary systemic, Light chain amyloidosis, Primary AL amyloidosis, Primary systemic AL amyloidosis, Primary systemic amyloidosis, and Systemic AL amyloidsis.",18,True
doid,http://purl.obolibrary.org/obo/DOID_0080934,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunoglobulin_heavy_chain_amyloidosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :kidney ],
        :amyloidosis,
        :kidney_disease ;
    :has_definition ""An amyloidosis that is characterized by the aggregation and deposition of amyloid fibrils composed of monoclonal immunoglobulin heavy-chain fragments, usually produced by a plasma cell neoplasm."" ;
    :has_exact_synonym ""AH amyloidosis"",
        ""Amyloidosis derived from immunoglobulin heavy chain"",
        ""Heavy chain amyloidosis"",
        ""Ig heavy-chain–associated amyloidosis"" .

","Immunoglobulin heavy chain amyloidosis is a type of kidney disease and a type of amyloidosis that is particularly located in the kidneys. This condition is defined as an amyloidosis characterized by the aggregation and deposition of amyloid fibrils composed of monoclonal immunoglobulin heavy-chain fragments, usually produced by a plasma cell neoplasm. It is also known by several exact synonyms including AH amyloidosis, Amyloidosis derived from immunoglobulin heavy chain, Heavy chain amyloidosis, and Ig heavy-chain–associated amyloidosis.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0080935,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunoglobulin_heavy_and_light_chain rdfs:subClassOf :amyloidosis ;
    :has_definition ""An amyloidosis that is characterized by both Ig heavy chains and LC contribute to the amyloid fibrils."" ;
    :has_exact_synonym ""AH/AL amyloidosis"",
        ""Ig heavy-and-light-chain amyloidosis"" .

","Immunoglobulin heavy and light chain is a type of amyloidosis characterized by both Ig heavy chains and light chains contributing to the amyloid fibrils. It has exact synonyms, including AH/AL amyloidosis and Ig heavy-and-light-chain amyloidosis.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080936,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:serum_amyloid_a_amyloidosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :kidney ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :liver ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :spleen ],
        :amyloidosis,
        :kidney_disease,
        :liver_disease,
        :splenic_disease ;
    :has_definition ""An amyloidosis that is characterized by sustained high levels of inflammatory serum amyloid A protein when inflammation is present in the body."" ;
    :has_exact_synonym ""AA amyloidosis"",
        ""Apo serum amyloid A amyloidosis"",
        ""inflammation AA amyloidosis"",
        ""secondary amyloidosis"" .

","Serum amyloid A amyloidosis is a type of amyloidosis that affects various organs, including the spleen, liver, and kidneys. It is defined as an amyloidosis characterized by sustained high levels of inflammatory serum amyloid A protein when inflammation is present in the body. Additionally, serum amyloid A amyloidosis is known by several exact synonyms: AA amyloidosis, Apo serum amyloid A amyloidosis, inflammation AA amyloidosis, and secondary amyloidosis.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0080937,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:wild_type_amyloidosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :heart ],
        :amyloidosis,
        :heart_disease ;
    :has_definition ""An amyloidosis that is characterized by progressive instability, misfolding and formation of amloid fibrils of the transthyretin protein."" ;
    :has_exact_synonym ""ATTRwt amyloidosis"",
        ""Age related amyloidosis"",
        ""Old age amyloidosis"",
        ""senile systemic amyloidosis"",
        ""wild-type ATTR amyloidosis"",
        ""wild-type transthyretin cardiac amyloidosis"" .

","Wild type amyloidosis is a type of heart disease and a specific form of amyloidosis that occurs in the heart. It is characterized by the progressive instability, misfolding, and formation of amyloid fibrils of the transthyretin protein. Wild type amyloidosis is also known by several exact synonyms: ATTRwt amyloidosis, Age-related amyloidosis, Old age amyloidosis, Senile systemic amyloidosis, Wild-type ATTR amyloidosis, and Wild-type transthyretin cardiac amyloidosis.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0080938,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nonobstructive_coronary_artery_disease rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :severe_chest_pain ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_feature ;
            owl:someValuesFrom :coronary_stenosis ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :pain ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :neck_pain ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :shoulder_pain ],
        :coronary_artery_disease ;
    :has_definition ""A coronary artery disease that is characterized by atherosclerotic plaque that would not be expected to obstruct blood flow or result in anginal symptoms and stenosis of coronary artery less than 50 percent."" ;
    :has_exact_synonym ""non-CAD"" .

","Nonobstructive coronary artery disease is a type of coronary artery disease characterized by atherosclerotic plaque that would not be expected to obstruct blood flow or result in anginal symptoms, and stenosis of the coronary artery is less than 50 percent. It exhibits symptoms such as pain, shoulder pain, severe chest pain, and neck pain. Additionally, this condition features some degree of coronary stenosis. Nonobstructive coronary artery disease is also precisely known as non-CAD.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0080939,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_angioedema_type_i rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_recessive_disease,
        :hereditary_angioedema ;
    :has_definition ""A hereditrary angioedema that has_material_basis_in heterozygous mutation in the C1 inhibitor gene (C1NH, SERPING1) on chromosome 11q."" .

","Hereditary angioedema type I is a type of hereditary angioedema, classified under autosomal recessive diseases. It has a material basis in both autosomal dominant and autosomal recessive inheritance patterns. Moreover, it is defined as a hereditary angioedema that arises from a heterozygous mutation in the C1 inhibitor gene (C1NH, SERPING1) on chromosome 11q.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080940,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_angioedema_type_iii rdfs:subClassOf :hereditary_angioedema ;
    :has_definition ""A hereditary angioedema that is characterized clinically by recurrent skin swelling, abdominal pain attacks, and potentially life-threatening upper airway obstruction and that has_material_basis_in heterozygous mutation in the gene encoding coagulation factor XII (F12) on chromosome 5q35."" .

","Hereditary angioedema type III is a type of hereditary angioedema, characterized clinically by recurrent skin swelling, abdominal pain attacks, and potentially life-threatening upper airway obstruction. It has a material basis in a heterozygous mutation in the gene encoding coagulation factor XII (F12) on chromosome 5q35.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080941,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acquired_angioedema rdfs:subClassOf :angioedema ;
    :has_definition ""An angioedema that is characterized by an acquired deficiency of (C1-INH) caused by either consumption or inactivation."" .

","Acquired angioedema is a type of angioedema that is characterized by an acquired deficiency of C1-INH (C1-Inhibitor), caused by either consumption or inactivation.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080942,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:anauxetic_dysplasia rdfs:subClassOf :spondyloepimetaphyseal_dysplasia ;
    :has_definition ""A spondyloepimetaphyseal dysplasia that is characterized by the prenatal onset of extreme short stature, an adult height of less than 85 cm, hypodontia, and mild mental retardation."" .

","Anauxetic dysplasia is a type of spondyloepimetaphyseal dysplasia, which is defined as a spondyloepimetaphyseal dysplasia characterized by the prenatal onset of extreme short stature, an adult height of less than 85 cm, hypodontia, and mild mental retardation.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080943,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xx_sex_reversal_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :46_xx_sex_reversal,
        :autosomal_dominant_disease ;
    :has_definition ""A 46,XX sex reversal that is characterized by genital virilization in 46,XX individuals, associated with congenital heart disease and variable somatic anomalies including blepharophimosis-ptosis-epicanthus inversus syndrome and congenital diaphragmatic hernia and that has_material_basis_in heterozygous mutation in the NR2F2 gene on chromosome 15q26."" .

","46 XX sex reversal 5 is a type of autosomal dominant disease and a specific form of 46 XX sex reversal. It is characterized by a condition that at least has a material basis in some autosomal dominant inheritance. The definition of 46 XX sex reversal 5 includes it being a 46,XX sex reversal that is characterized by genital virilization in 46,XX individuals. This condition is also associated with congenital heart disease and variable somatic anomalies including blepharophimosis-ptosis-epicanthus inversus syndrome and congenital diaphragmatic hernia. Its material basis is in a heterozygous mutation in the NR2F2 gene on chromosome 15q26.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0080944,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_behcet_like_autoinflammatory_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease that is characterized by characterized by ulceration of mucosal surfaces, particularly in the oral and genital areas and that has_material_basis_in heterozygous mutation in the TNFAIP3 gene on chromosome 6q23."" ;
    :has_exact_synonym ""A20 haploinsufficiency"" .

","Familial Behcet like autoinflammatory syndrome is classified as a type of autosomal dominant disease, primary immunodeficiency disease, and a condition that fundamentally arises from some form of autosomal dominant inheritance. It is defined as a primary immunodeficiency disease characterized by ulceration of mucosal surfaces, especially in the oral and genital areas, and is caused by a heterozygous mutation in the TNFAIP3 gene on chromosome 6q23. Additionally, it is exactly synonymous with A20 haploinsufficiency.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080945,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:abdominal_obesity_metabolic_syndrome_4 rdfs:subClassOf :abdominal_obesity_metabolic_syndrome ;
    :has_definition ""An abdominal obesity-metabolic syndrome that is characterized by obesity, hypertension, and early-onset coronary artery disease and that has_material_basis_in heterozygous mutation in the CELA2A gene on chromosome 1p36."" .

","Abdominal obesity metabolic syndrome 4 is a type of abdominal obesity metabolic syndrome, characterized by obesity, hypertension, and early-onset coronary artery disease. This condition is caused by a heterozygous mutation in the CELA2A gene located on chromosome 1p36.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080946,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:retinal_dystrophy_with_leukodystrophy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :peroxisomal_disease ;
    :has_definition ""A peroxisomal disease that is characterized by a peroxisomal enzyme deficiency caused by impaired very long chain fatty acid (VLCFA) metabolism and that has_material_basis_in homozygous mutation in the ACBD5 gene on chromosome 10p12."" ;
    :has_exact_synonym ""ACBD5 deficiency"" .

","Retinal dystrophy with leukodystrophy is a type of disease that falls into the categories of autosomal recessive disease, peroxisomal disease, and those that have a material basis in some autosomal recessive inheritance. It is defined as a peroxisomal disease characterized by a peroxisomal enzyme deficiency caused by impaired very long chain fatty acid (VLCFA) metabolism, which has its material basis in homozygous mutations in the ACBD5 gene located on chromosome 10p12. Additionally, this condition is exactly synonymous with ACBD5 deficiency.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0080947,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acute_flaccid_myelitis rdfs:subClassOf :myelitis ;
    :has_definition ""A myelitis that is characterized by acute onset of flaccid weakness of one or more limbs."" .

",Acute flaccid myelitis is a type of myelitis that is defined by an acute onset of flaccid weakness in one or more limbs.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0080948,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:agenesis_of_corpus_callosum_cardiac_ocular_and_genital_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome that is characterized by global developmental delay and/or intellectual disability, corpus callosum agenesis or hypoplasia, craniofacial dysmorphisms, and ocular, cardiac, and genital anomalies and that has_material_basis_in heterozygous mutation in the CDH2 gene on chromosome 18q12."" .

","Agenesis of corpus callosum cardiac ocular and genital syndrome is a type of syndrome characterized by global developmental delay and/or intellectual disability, corpus callosum agenesis or hypoplasia, craniofacial dysmorphisms, and ocular, cardiac, and genital anomalies. This syndrome has a material basis in heterozygous mutation in the CDH2 gene on chromosome 18q12.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0080949,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:alcoholic_ketoacidosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_disease_driver ;
            owl:someValuesFrom :alcohol ],
        :metabolic_acidosis ;
    :has_definition ""A metabolic acidosis that is characterized by the buildup of ketones in the blood due to alcohol use. Ketones are a type of acid that form when the body breaks down fat for energy."" .

","Alcoholic ketoacidosis is a type of metabolic acidosis and also falls under the category of conditions that are driven by the consumption of alcohol. It is defined as a metabolic acidosis characterized by the accumulation of ketones in the blood, which occurs as a result of the body breaking down fat for energy due to alcohol use. Ketones are a type of acid.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0080950,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:alopecia_mental_retardation_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :alopecia_mental_retardation_syndrome,
        :autosomal_recessive_disease ;
    :has_definition ""An alopecia-mental retardation syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the LSS gene on chromosome 21q22."" .

","Alopecia mental retardation syndrome 4 is a type of autosomal recessive disease and a variant of alopecia mental retardation syndrome. It is categorized under conditions that have a material basis in autosomal recessive inheritance. Specifically, this syndrome is defined by an alopecia-mental retardation syndrome that originates from homozygous or compound heterozygous mutations in the LSS gene located on chromosome 21q22.",4,True
